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Abstract 
Abstract 
Concomitant with the Spanish influenza and extending to the 1920s encephalitis 
lethargica (EL), also termed von Economo's disease or sleepy sickness, occurred in 
epidemic proportion. A previous epidemic of encephalitis lethargica also appeared at the 
time of 1889 influenza pandemic. Certain clinical and pathological features of 
encephalitis lethargica of 1916-1920 strongly suggested a viral aetiology and 
subsequently it was suggested that influenza virus was the responsible pathogen 
(Ravenholt & Foege, 1982). Sensitive molecular techniques are now available which 
can be applied both to fresh tissue and old formalin fixed and paraffin blocked sections 
using RT-PCR. Recent genetic analyses of haemagglutinin (HA) and neuraminidase 
(NA) genes of 1918 influenza virus have failed to identify virulence motifs 
(Taubenberger et al., 1997 & 1999; Reid et al., 1999,2000 & 2002). These methods 
were applied to eight brain samples from patients who died of encephalitis lethargica in 
1916-1920 for the presence of influenza genes. The sections of brain from eight 
archival, unique cases of EL had been neuropathologically reviewed and the diagnosis 
confirmed prior to analysis using established reverse transcription-polymerase chain 
reaction (RT-PCR). Although our genetic study detected ß-actin genes in the archived 
brains, we found no evidence of influenza genes. An animal model of influenza 
neuropathogenesis was established for investigations of the 
localisation of influenza 
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genes in brain tissue using in situ hybridisation (ISH). Influenza gene sequences were 
detected in ependymal cells, choroid plexus, hippocampal neurons, periventricular 
regions of the lateral ventricle and cerebral aqueduct, and cells of the raphe nucleus. A 
persistent influenza infection in the brains of infected mice is reported. Therefore short 
influenza sequences could, in theory and based on a simple longevity comparison of 
man and mouse, be detected in brain tissues of infected subjects for a period of 1.9 -6.7 
years after its initial exposure to influenza infection. 
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Chapter 1 Introduction 
1.1 General introduction to the historical aspects of the 1918 influenza and 
encephalitis lethargica (EL) pandemics 
The precise cause of the high mortality during the pandemic influenza in 1918 
remains unknown. The number of deaths in the 1918 "Spanish" influenza pandemic was 
estimated to be more than 40 million people worldwide and most deaths appeared 
among young adults. Two possible contributory factors to the enhanced virulence were 
mutations in the haemagglutinin or other genes such as NS 1 (O'Neill et al., 1998; Wolff 
et al., 1998; Basler et al., 2001; Taubenberger et al., 2001; Geiss et al., 2002; Salvatore 
et al., 2002). It has been suggested that two consecutive epidemics of encephalitis 
lethargica appeared at the time of the corresponding influenza pandemics of 1889-90 
and 1918-19 (Hall, 1924). Certain clinical and pathological features of encephalitis 
lethargica strongly suggested a viral aetiology and subsequently it was suggested that 
influenza virus was responsible (Ravenholt and Foege, 1982). In addition, studies by 
Gamboei et al. (1974) have demonstrated the presence of influenza antigen in brain 
samples collected from patients with a postencephalitic Parkinsonian clinical 
presentation. 
1.1.1 The influenza pandemic in 1918-19 (Spanish influenza) 
The historic influenza pandemic occurred in 3 waves. The first wave appeared in 
the spring and summer in 1918 (Reid et al., 2002, in press). As an example, starting on 
March 4,1918, numerous soldiers at Camp Funston, Kansas were reported to have 
suffered from influenza symptoms, including fever and headache. The epidemic waned 
rapidly after 2 weeks. Other camps in Europe also reported epidemics of influenzal 
disease in March and April 1918. There were reports of influenza-like or influenza 
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epidemics in China, India and France in the spring of 1918 (Phillips and Killingray, 
2002). During the spring wave, influenza was not a notifiable disease and the deaths 
were diagnosed as uncomplicated cases of pneumonia. It is difficult to provide a report 
of the spring epidemic due to lack of the network of local public health departments. 
Influenza was called the "Three Day Fever" and "la grippe" in France. An estimated 
eight million Spaniards caught influenza in May and June 1918 (Phillips and Killingray, 
2002). Within months everyone outside of Spain named it the "Spanish influenza". 
Great Britain began to pay attention to the new influenza in June 1918. The mortality 
figures for England and Wales showed an abrupt rise in the latter part of June. The 
German soldiers caught influenza in April, on the Western Front, and the new influenza 
was named "Flanders Fever". The disease passed from army to army with ease. Spanish 
influenza appeared in North Africa in May 1918 and occurred in Bombay and Calcutta 
in June 1918. In July 1918, a variety of additional countries reported numerous cases of 
influenza and pneumonia. 
The second wave of Spanish influenza began in September-October 1918 and 
involved almost the entire world over a short period of time. The greatest morbidity and 
mortality was noted during this wave. The outbreak in Australia was delayed for eight 
months by a quarantine procedure. The most unusual epidemiological behaviour was 
that the disease appeared on the same day in widely separated parts of the world, 
although direct spread occurred in local areas. This could be explained by an earlier 
seeding. Our own studies have pinpointed the origin of the pandemic in the military 
base at Etaples, France in the winter of 1917 (Oxford et al., 2002). 
A third wave of Spanish influenza appeared in the spring of 1919 but with lower 
morbidity and mortality rates than in the great wave of October 1918. 
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1.1.2 Secondary invaders associated with the influenza pandemic 
The precise genetic nature of the virus, which caused the so-called Spanish 
pandemic, has not yet been completely established. To date four of the eight genes have 
been sequenced. One of the most striking features of the 1918/19 pandemic of influenza 
is the diversity of opinion at the time concerning the aetiology of the disease. In the 
years following the pandemic of 1889/90 scientific opinion was that a small Gram- 
negative bacillus caused influenzal infection as described by Pfeiffer in 1892 during the 
so-called "Russian" influenza pandemic (Pfeiffer, 1892). Early in the 1918 outbreak, 
bacteriologists directed their efforts to the isolation of this bacillus from the upper 
respiratory tract of influenza patients. It was surprising to learn of the comparatively 
small proportion of instances in which many authors found the bacillus to be present. A 
mixed population of bacteria was often described including the Pneumococcus, 
Streptococcus, Influenza bacillus, Staphylococcus aureus, Micrococcus catarrhalis, and 
Pneumonia bacillus. Studies by Brown and Palfrey (1919) at Camp Greene, N. C. during 
the peak of 1918 pandemic suggested that the aetiological organism was not the Bacillus 
influenzae. The pneumococcus or streptococcus or both were present in a large 
proportion of all cultures made from cases clinically diagnosed as influenza. The 
complications were due entirely to the pneumococcus, and the lobar pneumonia was the 
cause of the deaths in 72% of their cases. Other studies based on cases of fatal 
bronchopneumonia by Kerr, Berkley and Coffen (1919) concluded that the aetiology 
was obscure. The role played by the organisms isolated was probably that of secondary 
invaders which, by virtue of a lowered body resistance, were capable of producing the 
peculiar pathological conditions in which the pathological picture involved usually both 
lower lobes and was unlike any type of pneumonia seen in America. 
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Leopold (1919) classified three groups of cases based on his observations during 
the year of 1918 at Camp Dix, N. J. Group I comprised those cases associated with 
empyema that occurred chiefly during the spring of 1918. These were under the general 
heading of pneumonia and empyema due chiefly to the Streptococcus haemolyticus 
either alone or in combination with other organisms. During the spring of 1918, the 
epidemic appeared in many of the national army cantonments (Cole and MacCallum, 
1918). The chief symptoms were intense dyspnoea, cyanosis, and the obvious 
indications of profound sepsis, which were described as interstitial bronchopneumonia 
or purulent bronchiolitis. The outstanding feature of the disease was the rapid 
development of an empyema in 85% of all cases. Group II consisted of the usual 
pneumococcus pneumonia, embracing Types I, II, III and IV. These cases occurred 
mostly during June, July and August 1918. There were cases of true lobar pneumonia in 
the hospitals at all times. Group III comprised the so-called influenzal 
bronchopneumonia, which occurred as a tremendously virulent epidemic during 
September, October, and early November 1918. Most deaths were probably due to 
influenzal virus bronchopneumonia (Schorer, 1919). 
Judson (1919) based on his study in Philadelphia suggested that the possible 
causative agent was a filterable virus. He observed that the epidemic differed markedly 
from preceding epidemics and was characterised by rapid and severe onset, extreme 
contagiousness, and high death rate. The incubation period was from one to four days. 
There was extreme susceptibility in the young adult and comparative insusceptibility of 
those past middle age. Many patients with influenza were also infected with strains of 
the pneumococcus and streptococcus of high virulence. Hinkelmann et al. (1919) also 
suggested that the disease of Spanish influenza was not influenza of the form well 
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known and of past epidemics based on their study using experimental animals. They 
revealed that the organism isolated from the sputum of patients suffering from 
influenza, both of the mild, the severe, and the fatal form, had a powerful affinity for the 
respiratory tract of the laboratory animals, producing the identical symptoms and the 
same pathology as that had focused in cases of influenza in man, both by way of the 
respiratory tract and by way of the circulation. They also found that the action of the 
unknown organism was strikingly specific and did not depend upon such secondary 
invaders as streptococci or pneumococci. The principal feature in their pathological 
findings was a diffused bronchopneumonia with special involvement of the left lower 
apex. Yamanouchi, Iwashima and Iakakami reported that the causative agent in the 
1918-19 epidemic in Japan was a filterable virus (1919). 
Olitsky and Gates (1920) provided evidence which led to a better understanding of 
the causative agent responsible for the 1918 to 19 pandemic. Rabbits were infected with 
nasopharyngeal secretions from patients with influenza infection. A specific substance 
was found in the nasopharyngeal secretions only in cases of epidemic influenza that 
were not due to a secondary bacterial infection. This substance was present only in the 
early hours of the disease. It had not been found later than 36 hours after the onset, or in 
cases of bacterial pneumonia, or in secretions from asymptomatic individual either 
during the epidemic or during non-epidemic periods. Rabbits were inoculated directly 
via intratracheal catheter. Sick animals were sacrificed on the second to fourth day post- 
infection. Histopathological analysis of the lung tissue revealed haemorrhagic foci 
throughout the lung. It was suggested that the "substance" was a non-bacterial infectious 
agent. The human influenza A virus of the H1N1 subtype which caused the 1918 
pandemic was not actually isolated in the laboratory until 1933 (Smith et al., 1933). 
23 
Chapter 1 Introduction 
1.1.3 Spanish influenza and its sequelae 
A wide diversity of mixed complications was observed with the 1918 influenza 
pandemic. In most acute diseases the subsidence of symptoms is usually followed by a 
return to normal and a freedom from all symptoms. In about one half the cases a 
syndrome or a group of symptoms materially different from that observed during the 
acute course of the disease appeared on the subsidence of the acute symptoms (Daland, 
1919; Deluca, 1919; Lee, 1919; Loomis and Walsh, 1919; Stangl, 1919). In some cases, 
one set of symptoms was present, in others several independent groups were in 
evidence. Meanwhile, cases of sequelae affecting almost every portion of the body and 
every organ were not uncommon (Reilly, 1919). Many patients had several recurrences 
of the disease and experienced unwellness at any time since the first attack. A set of 
influenzal sequelae which were commonly described by authors include: cough, usually 
persisted for weeks and even months with or without marked pneumonia; various chest 
symptoms including enlarged hilus shadows, enlarged glands at the base of the lung, 
enlarged right heart, area of bronchopneumonia and vague shadows indicating pleural 
adhesions; headache, was very common and persisted for months, mostly suboccipital or 
temporal if it was induced by coughing; heart symptoms, dyspnoea and palpitation were 
common; nervous disturbances, among the nervous symptoms, melancholia and 
sleeplessness were prominent. 
Bronchopneumonia is a complication of the pandemic that was most commonly 
seen but is not an essential feature of the disease. Acute alveolar and interstitial 
emphysema in influenzal bronchopneumonia was reported widely. A striking type of 
reaction observed was a condition of acute alveolar emphysema with a deposition of a 
hyaline fibrinous material on the alveolar walls. This was the one distinctive feature in 
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the pathology of influenza pneumonias and its constant occurrence was regarded as 
indicative of the entity of the initial lung infection, a filterable virus. The character of 
the hyaline fibrin deposit around air vesicles and upon the alveolar walls suggested a 
pouring exudate into the alveoli from the bronchioles and alveolar ducts at a time when 
air was able to pass (Reckord, 1919). 
Observations by Sabshin (1919) demonstrated that the greatest mortality of the 
pandemic was due to cardiac or general circulatory complications. During the 1918 
pandemic, recurrent infection in the same individual within 4 to 12 weeks after the 
primary one was not uncommon. In these cases, the circulatory system was the primary 
seat of complications in some form or other, which occurred during the acute stages, the 
course of convalescence, and patients with a history of recent influenza. In all these 
cases, the circulatory disturbance was the primary cause of death, the other phenomena 
being secondary. 
Nervous and mental disturbances following influenza infection were reported by 
various authors. During convalescence of influenza infection, the facial, cervical, and 
sciatic neuralgias encountered were often very persistent (Claude, 1919). A patient 
might develop acute myelitis. Mental disturbances were much more frequent, and 
always developing in 8 to 15 days after defervescence when the subjects were up and 
apparently well post-infection. Most surprisingly, studies by Hodges provided a variety 
of nervous and psychic effects in cases of influenza (1919). Of 28 cases showing 
symptoms of genuine psychoses, 11 were classed as toxi-infectious delirium, 8 as 
dementia, 3 as encephalitis, and 4 as other psychoses, while 2 could not be rationally 
grouped. The average interval between the termination of the acute influenzal attack and 
the incidence of a psychosis was 12 days. Neither the duration nor the severity of the 
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influenza materially influenced the psychoses. Two or three of the toxi-infectious cases 
were becoming gradually more like a frank dementia. The mental disturbances met with 
did not differ materially from the same conditions arising from other cases. Two of the 
cases grouped as encephalitis were instances of encephalitis lethargica, and the other, 
acute haemorrhagic encephalitis. Encephalitis or inflammation of the brain was a not 
uncommon condition in infancy and young children following influenza infection. The 
form of encephalitis which occurred during the epidemic of influenza was characterised 
by the fact that the disease was present for days, even for weeks before the intensity 
became maximal (Buzzard, 1918; Sharfin, 1919). Lyon et al. observed nervous 
manifestations in the patients suffering from influenzal pneumonia and also from 
uncomplicated influenza at Camp Upton (1919). Menniger (1919) also described nearly 
a hundred cases of psychoses following influenza. However, there is probably no other 
acute infectious disease, which gives rise to, or results in so many diversified types of 
mental disturbances, ranging from the simplest fatigue states of a transitory nature to 
some of the severest defect mental conditions, which may wipe away at a blow the 
entire mental life (Claude, 1919; Sharfin, 1919; Menninger, 1919,1920,1921,1922, 
1926). Furthermore, in reports of the pandemic of influenza and its complications 
involving the respiratory, circulatory and nervous systems, reference has also been made 
to toxaemia and to the symptoms of shock and meningitis (McDuffie, 1919; 
Hinkelmann et al., 1919, Sabshin, 1919; Loewe and Strauss, 1920). 
Keeton and Cushman (1918) described the delirium as being observed early as 
well as late in the disease. In all their 3,400 cases studied, showed that nearly 1 percent 
of patients had symptoms suggestive of meningitis or cerebral involvement. Evidence of 
infection in this system was also present in statements regarding toxaemia and delirium 
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in the reports made by Friedlander et al. (1918) and by Synnotte and Clark (1918). 
Bloomfield et al. (1919) reported evidence of systemic infection in cases of influenza. 
Strouse and Bloch (1918) also described a case of meningitis but with the spinal fluid 
unchanged except for increased tension in the 500 cases studied clinically by them. 
Studies by Neal (1919) showed that meningeal symptoms and conditions occurred 
during the epidemic of influenza in patients convalescing from attacks, which clinically 
had appeared to be influenza. 
1.2 Pathological lesions of the lung in influenza virus pneumonia 
During the pandemic of 1918 observers noted that in the acute stage of the 
influenza desquamation of the tracheal, bronchial, and bronchiolar ciliated cells could 
be found, the remaining epithelium being changed into a flattened layer of cells (Opie et 
al., 1921; Winternitz et al., 1920). MacCallum (1919) reported normal epithelium in 
bronchi and bronchioli, but referred often to disappearance and occasionally to 
flattening of the epithelial lining. A few workers also described a peculiar "haemo- 
oedematous pneumonia" (Goodpasture, 1919; MacCallum, 1919; Winternitz et al. 
1920). Winternitz (1920) also described the peculiar pulmonary hyaline membranes 
whilst LeCount (1919) reported the focal capillary thrombosis associated with necrosis 
of the alveolar walls. Winterritz et al. (1920) were observers who clearly recognised 
that the "unknown agent" of influenza destroyed both the epithelium of the air passages 
and that of the alveolar ducts and alveoli during the pandemic of 1918. They recognised 
the epithelia of the air passages and pulmonary alveoli as the specific sites at which the 
"unknown agent" of influenza attacked the respiratory tract. 
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The pathogenesis of the lesions of the air passages and lungs in human influenza 
were reviewed and demonstrated by Mulder and Hers (1972). Generally speaking, the 
early structural changes in the ciliated epithelium of trachea, bronchi, and bronchioli 
caused by influenza virus in the absence of bacterial infection are very variable. The 
histological changes are a consequence of both shrinkage and desquamation or 
flattening of surviving or only slightly damaged cells. Epithelial cells damaged by virus 
may be found scattered within apparently normal ciliated epithelium. As the epithelial 
lesions develop, vacuole formations caused by shrinkage of the ciliated cells appear 
within the cell layer. Virus infected epithelial cells as a result of influenza virus 
infection may be phagocytosed by leucocytes, autophagocytosis of degenerate epithelial 
cells by non-affected adjacent cells, or by the elimination of infected cells by 
desquamation. The histological features can be regarded as the result of an increase of 
the permeability of the vascular capillary wall, which leads to hyperaemia, oedema and 
cellular infiltration of the tunica propria and submucosa. In cases in which much of the 
epithelia of the trachea and main bronchi escape influenza virus infection, hyperaemia is 
absent. Polymorphonuclear neutrophil leucocytes penetrate from blood capillary into 
virus-infected areas of ciliated epithelium in the absence of any evidence of secondary 
bacterial infection. Influenza virus infection of the ciliated epithelium causes a more or 
less dense mononuclear infiltration in the tunica propria and the submucosal region 
around mucous glands. Regeneration of the ciliated epithelium damaged by influenza 
virus starts approximately 5 days after the onset of the disease. Viral damage leads to a 
disappearance of the ciliated cells and only 1 or 2 layers of flattened cells may remain as 
covering of the basement membrane. The final stage of regeneration in the trachea and 
bronchi is shown by the appearance of normal ciliated cells. At a certain stage of 
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influenza virus pneumonia, the alveolar cells partially or completely disappear, whereas 
regenerating alveolar epithelium may appear in the late stages of the disease. Alveolar 
macrophages may be present in large numbers in the alveolar air spaces where they have 
phagocytosed virus-infected alveolar cells. On the other hand, macrophages may support 
the growth of influenza virus and it is highly probable that such degenerative changes 
may occur in these cells when they are infected with virus (Mulder and Hers, 1972). 
Hyperaemia of the alveolar wall is one of the first inflammatory vascular reactions in 
influenza virus pneumonia and is invariably present. The septa are thickened by dilation 
of the capillary bed. Leucocytic infiltration of the hyperaemic alveolar septa is always 
present in the early stages of influenza virus pneumonia. The leucocytes are mainly 
neutrophils. In the later stages of influenza virus pneumonia the infiltration of 
leucocytes diminished. Only in the later stages of influenza virus pneumonia do 
lymphocytes and plasma cells appear. In addition to hyperaemia and leucocytic 
infiltration of the alveolar walls, capillary thrombosis, focal necrosis of the alveolar 
wall, and hyaline membranes develop at about the same time. Capillary bleeding into 
the alveolar air spaces is often seen near the necrotic areas, associated with the 
exudation of plasma and strands of fibrin. The alveolar air spaces adjacent to areas of 
necrosis of alveolar walls usually contain an accumulation of degenerate virus infected 
alveolar cells. Dilatation of the alveolar ducts is a common finding in the acute stage of 
fatal influenza virus pneumonia (Mulder and Hers, 1972). 
1.3 Neurological sequelae following influenza infection 
Many neurological disorders have been reported in patients following influenza A 
infections, including acute psychosis, encephalopathy, depression, Guillain-Barre 
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syndrome, post-influenzal encephalitis, and polyneuritis (Leigh, 1946; Greenfield, 1950; 
Jennings, 1952; Dubowitz, 1958; Goodbody et al., 1958; Stuart-Harris, 1965). Recent 
reports show that infection with influenza B has been most directly implicated in the 
aetiology of Reye's syndrome and acute encephalitis (CDC, 1997; McCullers et al. 
1999), although their pathogenesis is not fully understood. Wells (1971) showed that a 
preceding infection due to influenza A virus played a role in causing neurological 
complications. In addition, pre-natal exposure to influenza may give rise to a higher rate 
of infant mortality and also possibly to congenital abnormalities and schizophrenia 
(Coffey et al., 1959; Griffith et al., 1972; Griffiths et al., 1980; Mednick et al., 1988; 
O'Callaghan et al., 1991; Sham et al., 1992). Studies by Mattock et al. (1988) suggested 
that intrauterine influenza might act as a predisposing factor to the development of 
idiopathic Parkinson's disease in later life. Mattock et al. (1988) therefore proposed that 
influenza was an obvious candidate cytotoxic to the developing foetal substantia nigra 
and resulting in later complications of an afflicted individual. More interestingly, 
Conover and Roessmann (1990) demonstrated the presence of influenza antigens in the 
brain in regard to histological evidence of an intrauterine influenza viral infection. 
1.4 General introduction to the epidemic of encephalitis lethargica (EL) in 1916- 
1920 
Encephalitis lethargica (epidemic encephalitis, EL, Von Economo's Disease or 
sleepy sickness) appeared from 1916 to the 1928's, and a high proportion of survivors 
developed Parkinsonism after months or years. Parkinsonism was very rare in children 
before the advent of epidemic encephalitis. The relationship of the epidemic of 
encephalitis lethargica to infection with influenza has never been fully proven, but the 
evidence is highly suggestive. Studies by Greenfield (1950) strongly suggested that 
30 
Chapter 1 Introduction 
encephalitis lethargica was due to pre-infection by a virus, particularly an influenza 
infection. Additionally, epidemiological studies by Ravenholt and Foege (1982) 
supported the hypothesis that the pandemic of encephalitis lethargica and post- 
encephalitic Parkinsonism were late sequelae of 1918 influenza infection. Von 
Economo (1917 and 1931) described lethargic encephalitis in the winter and spring of 
1916 and 1917 in Austria, although a number of cases also occurred in the later months 
of 1916 both in Austria and France. However, "sleepy sickness" was firstly described 
in 1872 at Tubingen, and in 1890 similar cases were reported from Italy after a 
pandemic of influenza (The so-called Russian pandemic). According to the descriptions 
given by von Economo, the disease usually began with fever and headache; followed by 
lethargy and somnolence, ocular palsies leading to ptosis, strabimus, and pupillary 
disturbances; which worsened into coma that caused death and, mild confusions. The 
infected subjects showed signs of cranial nerve palsies. The conditions lasted several 
weeks or months. France was attacked by EL in the first quarter of 1918. In 1918 the 
epidemic was also reported in places as far apart as Ireland, Uruguay, Algeria, Germany 
and Greece (September and October, 1918). The first case that appeared in America 
(New York City) was in September 1918 (Crafts, 1927). By January 1919, the disease 
had spread all over the United States. The disease became popularly known as "Sleepy 
Sickness" due to its obvious symptoms: a febrile catarrh, lethargy, somnolence, or 
stupor, cranial nerve palsies, and great feebleness. During the first quarter of 1919 cases 
again became more numerous in England and France, and a certain number of cases 
were noted in other parts of Europe and also in parts of Russia (Ukraine). The first wave 
of encephalitis lethargica practically disappeared by June 1919, but in the following 
September fresh cases began again and lasted until the late 1920s (Rice-Oxley, 1918; 
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Bassoe, 1920; Bramwell, 1920; McClure, 1921; Fyfe, 1923; Hall, 1923 and 1924; 
Crafts, 1927). 
Generally speaking, the most serious outbreak of EL in Europe occurred in the 
first quarter of 1920 (Crafts, 1927). In England, the most serious outbreak had occurred 
between the end of 1920 and first quarter of 1921. The winter of 1922-23 showed a 
distinct recrudescence in many countries (Hall, 1924). However, the peaks of the 
outbreak occurred in 1920 and 1924. After 1924, the incidence declined markedly. 
Undoubtedly sporadic but unrecognised cases of encephalitis had been occurring at 
intervals even earlier and also nowadays. The epidemic encephalitis gradually 
disappeared during the 1930s. A considerable proportion of patients developed later 
neurological complications as sequelae (Foster, 1921; Mackenzie, 1923; Devine, 1923; 
Buzzard, 1918 and 1923; Crafts, 1927; Hall, 1935). 
1.4.1 Clinical disease of encephalitis lethargica 
Cruchet and Calmettes recorded cases of encephalitis lethargica during the winters 
of 1915-16 and 1916-17. The clinical pictures presented throughout the pandemic are 
very varied. When in 1917 von Economo first described the condition, the well known 
lethargic type of the disease with somnolence, lethargy, and ocular palsies leading to 
ptosis, strabismus, and pupillary disturbances, greatly predominated. Later it was found 
that the manifestations were much more varied and widespread from cases which 
closely resembled paralysis agitans, and to the excited and myoclonic and choreiform 
types of the disease. Finally the occurrence of epidemic hiccup became recognised. In 
the excited and myoclonic patients and in epidemic hiccup the lethargy so typical of the 
more ordinary forms of the disease is replaced by mental excitement, delirium, and 
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insomnia. Cases in which myoclonic movements were present occurred sporadically in 
1918 but became prevalent at the end of 1919. These were described as a form of acute 
epidemic encephalitis in January 1920. The characteristic of this variety is the 
occurrence of twitching of the muscles of the limbs, and rhythmic shock-like 
movements of the abdominal muscles. Cranial nerve palsies may or may not occur. Von 
Economo noted cases of hiccup in 1917, but hiccup did not appear in epidemic form 
until the end of 1919, when an outbreak coincided with the epidemic of the myoclonic 
form. One important feature of epidemic encephalitis is that it mainly appeared in the 
same months (January, February, March, and April) of two successive years. 
In the case of Australia "X" disease, Cleland and Campbell (1919) observed two 
sharply localised epidemics of a form of encephalitis lethargica occurring in the summer 
of 1917 and 1918. There is suspicion, however that this disease is not EL per se but 
rather was caused by an arbovirus. On the basis of their investigations, they recorded 
that the disease was acute and severe, often with an abrupt onset, and was fatal in 70% 
of the cases. It affected children mainly, but did not spare adults, and was characterised 
by the general signs of cerebral irritation, such as rigidity, convulsions, increased reflex, 
excitability, mental obfuscation, and coma, accompanied by fever and gastrointestinal 
disturbances. Indefinite symptoms were present for two to five days. It either terminated 
in death by exhaustion and coma on a general average of 4 to 6 days, or in rapid 
convalescence, which was generally complete within 10 to 12 days, though some flaccid 
paralyses might remain. 
1.4.2 Histological aspects of encephalitis lethargica 
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A great variety of microorganisms are capable of producing an inflammation of 
the brain, but EL represents a very particular disease with persistent long term 
symptoms. During acute encephalitis, the inflammation may affect any part of the brain 
and produce a variety of physical signs and symptoms. However pathologically with EL, 
the chief changes in microscopic appearance were met with in the pons and 
neighbouring portions of the mid-brain (Economo, 1917 and 1931). In relation to the 
distribution of the disease in the central nervous system, it is very difficult to clearly 
indicate the most characteristic lesion. The most significant microscopic change is the 
presence of large numbers of round cells in the perivascular lymph sheath of the vessels, 
which have entered the brain substances. 
In the lethargic form of encephalitis, the microscopic change is localised 
particularly in the regions of the cerebral peduncles (cerebral tracts) and the locus nigra 
of the midbrain. 
1.4.3 Sequelae of encephalitis lethargica and its possible relation to influenza 
The occurrence of an encephalitis as a sequel to one or other of the infective 
fevers was intensively and repeatedly described in the literature during 1918-1924. 
However the chronic neurological sequelae of epidemic and/or pandemic influenza have 
not been well studied from the virological point of view, and the topographical 
localisation of influenza genes in the brains in infected subjects is unclear and is the 
subject of this thesis. 
Buzzard (1923) defined two broad classes of sequelae of encephalitis lethargica 
due to the fact that the disease of encephalitis lethargica had little uniformity during the 
active phase of the disease in regard to its features, its severity, or its length since its 
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first appearance in UK in 1916-1918. It is very difficult to separate the primary results 
of the inflammatory process from signs and symptoms, which appear at a time when the 
inflammation of the cerebral tissues may be presumed to have died away. In addition, 
the disease may affect every function of the central nervous system, which in itself is no 
easy task in providing clear defining terms. However, the first group defined by Buzzard 
consists of those disorders of function which appear for the first time after the disease 
has spent itself, whereas the other comprises progressive alterations in defects of 
function which has been left as more or less permanent legacies of the disease. A good 
example of the former group is epilepsy and of the latter is the progressive 
intensification of the Parkinsonian syndrome already inaugurated during the acute 
phase. 
In terms of mental sequelae, the outcome remains uncertain both in regard to 
severity and duration. In the simple cases of mental sequelae the patients may complain 
only of those symptoms which are associated with the term "nervous exhaustion" and 
which include lack of energy, of concentration and decision, depression, restlessness, 
and insomnia. In severe cases the patients experience a complete alteration of mental 
capacity or a revolutionary change in behaviour and adaptation after the initial attack by 
the disease. 
Persistent insomnia is a fairly common sequel of acute epidemic encephalitis in 
children as observed by Happ and Blackfan (1920). Studies by Paterson et al. in 1921 
concluded that the younger the child at the onset of the disease, and the longer the acute 
stage of the illness, the greater will be the degree of mental deficiency which follows it. 
Another observer also reported a child case of severe mental disturbances following an 
initial attack by encephalitis lethargica (Gellatly, 1923). 
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Involuntary movements may occur during the acute phase or may make their first 
appearance weeks or months later. Muscular spasms occur chiefly when the patient is at 
rest and occupied. Ellis (1920) reported cases with combinations of insomnia, followed 
by acute delirium and rhythmical spasmodic contractions of muscle in 1920. Brain 
(1923) described a case showing a mild attack of the lethargic form of encephalitis with 
ocular palsies following brief attacks of hiccup. Various disorders in the nervous 
mechanism of respiration have been recorded in the literature of encephalitis lethargica. 
Pardee in 1923 reported spasmodic forced respiration following the attack of epidemic 
encephalitis. Hiccup due to spasmodic contractions of the diaphragm are not an 
infrequent complication of encephalitis lethargica, and may persist as sequelae for many 
months after the acute illness. Observers also reported optic neuritis as a late symptom 
in the convalescing phase since the initial attack of epidemic encephalitis (Symonds, 
1920). It is unclear whether lethargy is regarded as sequelae or as a recrudescence of the 
active disease. Price in 1922 reported an interesting case, which demonstrated 
recurrence of symptoms one and one-half years after apparent recovery from epidemic 
encephalitis. 
A high proportion of survivors of encephalitis lethargica developed Parkinsonism 
after months or years. Parkinsonism was very rare in children before the epidemic 
encephalitis. Buzzard (1918) reported one of the first cases of this kind in 1918. He 
observed a patient with a progressive Parkinsonian syndrome, who complained of 
shortness of breath, which came on in attacks for no apparent reason. Hall in 1935 
expressed his opinion that many of the Parkinsonian cases affected as the result of 
epidemic encephalitis had received much wider damage to the central nervous system 
than that which brought about this syndrome alone. Hall's unique studies and 
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observations on the prognosis in epidemic encephalitis were based on following-up 
completely 289 out of over 500 cases of post-encephalitic Parkinsonism and he showed 
that nearly three-quarters of Parkinsonians were alive at least 10 years from the date of 
the acute infection and some as many as 15 or 16 years later. Cooper in 1936 concluded 
that there was no relationship between the types of acute attack and the later 
developments of various mental sequelae from 174 patients who had their acute attack 
in 1922-24. Overall, encephalitis lethargica is distinguished from all other known 
infections by the numerous, peculiar, and often long-delayed after effects. 
Not expectedly given the extent of the influenza pandemic and the number of 
subclinical cases, an analysis of influenza at the time failed to establish a definite 
relation to the duration of the two diseases occurring during the 1918 era: pneumonia / 
bronchopneumonia and encephalitis lethargica. The clinical course and manifestations 
varied from patient to patient. On the other hand, two cases of encephalitis lethargica 
reported by Major Brasher (1919) and his colleagues showed that there was no obvious 
connection between von Economo's cases of "encephalitis lethargica" and an epidemic 
of influenza attack, although the two cases of encephalitis lethargica appeared during the 
epidemic of influenza in October 1918. However, quite a large number of the cases of 
encephalitis lethargica that occurred in London in the early part of 1918 manifested an 
initial stage that was clinically indistinguishable from influenza. Crookshank in 1919 
grouped three types of onset regarding encephalitis lethargica and influenza pandemics. 
In one an early "influenza" is separated by a distinct but variable interval from the onset 
of "nervous" symptoms; in another the "influenza" runs into the "nervous" stages and in 
the third the "nervous" symptoms occur without obvious precedent illness. 
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In summary, acute encephalitis occurs during epidemics of influenza, and 
epidemics of lethargic and other forms of encephalitis usually follow the more 
widespread pandemics of influenza (1889 and 1918). However, the definitive 
relationship between the two diseases, if any, remains unclear and obscure. 
1.5 The brain samples from cases encephalitis lethargica (1916-1920) 
Eight human brain samples from patients who died of encephalitis lethargica from 
1916-1920 were located in the Pathology Collection at the London Hospital. Both the 
original diagnosis and the post-mortem examinations have been documented at the 
Royal London Hospital. Dr J. F. Geddes, the Department of Histopathology and Morbid 
Anatomy, has viewed sections from the original blocks (Fig 1.1). It was a purpose of the 
present study to investigate the possible causative agent responsible for the pandemics 
of the two diseases (EL and acute influenza) occurring during this era to determine if a 
relationship between the two could be established using the archival human tissue. 
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Fig 1.1: A photograph of an H&E stained section of midbrain from a case of 
encephalitis lethargica showing infiltrate and cuffing phenomenon 
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The picture is from the midbrain tegmentum of a three-month-old boy dying in 1920 of 
encephalitis lethargica (Case7/1920). It shows an intensive perivascular lymphocyte 
infiltrate (arrowed). The photo was kindly provided by Dr. J, F, Geddes, Department of 
Histopathology and Morbid Anatomy, Royal London Hospital. 
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1.6 General introduction to influenza 
Influenza virus is a major respiratory pathogen causing seasonal outbreaks of 
acute infection reviewed by Alexander and Brown (2000) and by Oxford (2002). The 
severity of each influenza epidemic varies and may depend on the virulence of the strain 
circulating in the community. 
Worldwide pandemics of influenza are due to the emergence of antigenically new 
strains of influenza virus to which there is no pre-existing immunity. This is due to the 
unpredictable nature of antigenic changes in the viral surface glycoproteins, 
haemagglutinin (HA) and neuraminidase (NA), evading the host immune defences. 
There have been three major influenza pandemics in the 20th century namely in 1918, 
1957, and 1968. More than 40 million people died during the pandemic of 1918 
throughout the world (Crosby, 1989; Patterson et al., 1991; Taubenberger et al., 1997; 
Taubenberger et al., 2000; Oxford, 2000 and 2002). In addition, the pandemic of 1918- 
19 was not only the worst killer in the 20th century in man but may also have caused 
various forms of neurological sequelae post-infection such as encephalitis lethargica 
(Ravenholt and Foege, 1982). The causative agent of the 1918 influenza pandemic 
appears to have derived from classical swine H1N1 viruses (Taubenberger et al., 1997; 
Reid et al., 2002, in press). Subsequent genetic analyses from other RNA sequences of 
the 1918 virus such as NA, NS, NP and M genes provide further evidence that all the 
genes examined appear to be more closely related to human origin and swine strains 
than avian strains (Reid et al., 2000; Basler et al., 2001; Taubenberger et al., 2002). 
However, at present the major virus genetic factors responsible for the virulence of the 
virus and the pandemic of 1918 remain obscure and unknown. 
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1.7 Classification and nomenclature of influenza virus related to the origin of 
pandemic influenza 
Influenza viruses are members of the family Orthomyxoviridae and are enveloped 
segmented single strand RNA viruses of negative polarity. There are three types of 
influenza virus, A, B, and C, differentiated serologically on the basis of their internal 
antigens, in particular, the nucleoprotein (NP) and the matrix protein (M) (Palese et al., 
1982). The three types of virus are also characterised by their biological differences. 
Influenza A viruses are the principal cause of epidemic influenza in man and species 
such as avian, equine, and swine, whereas influenza B and C viruses are predominantly 
infectious pathogens for humans, and they are usually associated with milder disease. 
Influenza C causes disease in pigs (Guo et al., 1983) whilst influenza A has recently 
been found to infect cows (Brown et al. 1998; Graham et al., 2002) and influenza B to 
infect seals (Osterhaus et al., 2000). 
Influenza viruses are named on the basis of the antigenic relationships of the 
surface glycoproteins (HA and NA) since 1971, and is shown as follows: the type of 
virus (A, B or C), the host of origin if a non-human virus, the place of isolation, the 
isolation number, the year of isolation. The parenthesis if applicable indicating the host 
of origin was replaced and given by simple sequential numbers. Only viruses of Hl, 2, 
3,5,7,9, and of Ni or 2 subtypes are known to infect humans (WHO, 1980; Murphy 
and Webster, 1996). Thus avian influenza A H5N1 virus infected humans in Hong Kong 
but only in a limited manner (de Jong et al., 1997; Claas et al., 1998; Subbarao et al., 
1998; Saito et al., 2001; Webby et al., 2001; Chin et al., 2002). Peiris et al. (1999) later 
reported that two children who had suffered from mild influenza had been caused by 
infection with avian influenza A H9N2 viruses. A notable feature of the H9N2 virus is 
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that the six genes encoding the internal components of the virus are similar to those of 
the 1997 H5N1 human and avian isolates (Lin et al., 2000; Saito et al., 2001; Shaw et 
al., 2002). Further studies by Guo et al. (2001) demonstrated that both human and 
chicken H9N2 viruses with multiple lineages of HA genes are co-circulating in China. 
The H9N2 viruses are not easily transmitted from human to human (Uyeki et al., 2002). 
Gambaryan et al. (2002) also suggests that the chicken play a potential intermediate host 
for the transmission of viruses from aquatic birds to humans. 
1.8 Morphology of influenza virus 
Influenza A viruses are pleomorphic with a diameter of 80 to l20 nm. The 
enveloped influenza virus derives its lipid bilayer from the host cell plasma membrane. 
The envelope contains two radially projecting spikes of virus, namely HA and NA. 
These two surface glycoproteins are morphologically distinguishable. Both 
glycoproteins are anchored by the membrane protein containing a short sequence of 
hydrophobic amino acids that make contact with the layer of matrix protein (Ml). Inside 
the matrix layer (Ml) is the nucleoprotein forming helical structures that consist of the 
three-polymerase proteins (PB2, PB 1 and PA) and the viral RNA. 
1.9 Genes and gene products 
Six single stranded (ss) RNA segments (1-6) of the influenza A genome code for 
an individual protein. Segments 7 and 8 are bicistronic and code for two proteins. 
Segment 7 codes for proteins M1 and M2, and segment 8 codes for proteins NS 1 and 
NEP (nuclear export protein, formerly known as non-structural protein 2, NS2). Thus 
there are at least 10 virus-coded proteins from the 8 segments of genome 
(Bancroft and 
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Parslow, 2002; Capua and Alexander, 2002). More recently a new virus coded protein 
has been identified (Chen et al., 2001). 
The 3'- and 5'-terminal noncoding regions of the genome RNA, consisting of 12 
and 13 nucleotides, respectively, are highly conserved among the eight segments, and 
the two regions are partially complementary to each other, forming a panhandle 
structure (Skehel et al., 1978; Robertson, 1979; Desselberger et al., 1980; Palese et al., 
1980; Hsu et al., 1987; Baudin et al., 1994; Cheong et al., 1996; Krumpp et al., 1997; 
Brownlee and Sharps, 2002). Luytjes et al. (1989) demonstrated that twenty-two 5'- 
terminal and twenty-six 3'-terminal nucleotides of the influenza A virus vRNA were 
sufficient to provide the signals for RNA transciption, RNA replication, and packaging 
of the vRNA into influenza virus particles. The 3'-noncoding regions contain the 
promoter sequences responsible for genome replication and transcription (Luytjes et al., 
1989; Li et al., 1992; Seong et al., 1992; Piccone et al., 1993, Neumann et al., 1995; 
Pleschka et al., 1996; Brownlee et al., 2002; Leahy et al., 2002). 
The HA is synthesised as a single polypeptide from RNA segment 4, which is 
composed of 1765 nucleotides. The cleavage of polypeptide HA into the HAI and HA2 
is a prerequisite for viral infectivity with a loss of arginine in the cleavage site by a host 
cell protease (Garten et al., 1981 and 1982; Webster et al., 1987; Stieneke-Grober et al., 
1992; Horimoto and Kawaoka, 1994; Zhirnov et al., 2002). Until the influenza virus HA 
is cleaved the virus is avirulent to the host. The HA proteins make up approximately 
37% of the total viral protein and is uniformly distributed in the virion. The HA has 
three major functions in the infectious cycle: virus attachment to the N-acetyl 
neuraminic acid (sialic acid) containing receptors on the host cell(Rogers et al., 1983; 
Mohsin et al., 2002), it mediates release of virus from cytoplasmic vacuoles 
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(endosomes) by a membrane fusion process and initiates replication (Kido et al., 1992; 
Rott et al. 1995; Klenk et al., 1988; Steinhauer et al., 1998; Markovic et al., 2001; 
Deshpande et al., 2001; Wanger et al., 2002; Remata et al., 2002), and it is a major 
antigenic protein that undergoes frequent antigenic changes giving rise to new influenza 
epidemics. A recent study by Suzuki et al. (2000) suggests that the sialic acid of host 
cell is a contributory determinant to the host specificity located at the tip of the HA 
molecule and displayed by the influenza viruses (Suzuki et al., 2000). 
Neuraminidase is coded for by RNA segment 6, and is a single polypeptide chain 
that does not undergo any post-translational cleavage. The NA protein accounts for 
approximately 7% of the total viral protein and around 10% of the virus surface spikes 
(Bucher et al., 1975; Air and Laver, 1989) The function for NA is to enzymatically 
remove sialic acid residues, allowing the release of virus from infected cells and 
assisting the virus in the penetration of the mucus layer of the epithelial cells in the 
respiratory tract (Air et al., 1989; Colman, 1994; Morris et al., 2002). The amino acids 
surrounding the catalytic site are conserved throughout the influenza A NA subtypes and 
also influenza B NA subtypes. Recently, other workers suggest that the NA protein also 
has an additional mode of action which induces apoptosis in cells (Morris et al., 2002; 
Mohsin et al., 2002). 
The nucleoprotein is coded for by RNA segment 5. The NP constitutes the major 
protein component of the RNA forming a core or a helical structure (Baudin et al., 
1994; Ruigrok et al., 1995; Ortega et al., 2000; Martin-Benito et al., 2001). The NP is 
implicated in mediating an active transport of ribonucleoproteins (RNPs) into the 
nucleus by direct interaction with the cellular importin a/ß pathway (O'Neill et al., 
1995; Wang et al., 1997). Ortega et al. (2000) suggests that NP is incorporated as 
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dimers into newly synthesised RNPs, whilst Prokudina et al. (2001) demonstrated that 
the efficiency of intracellular NP oligomerisation depends on the host origin of 
influenza A virus strain. The NP also plays a major role in the nucleus during virus 
replication in which a phosphorylation event is required either for nuclear export, or to 
regulate retention of NP in the nucleus; and that regulation may be mediated by kinase 
activated by cell-cell contact (Bui et al., 2002). 
The matrix proteins, MI and M2, are coded by RNA segment 7. MI is a non- 
glycosylated protein containing 252 amino acids, and is a major protein accounting for 
35 to 40% of the mass of the virus particle. There are three major roles for M1 protein. 
Firstly, M1 is involved in assembly of the virus at the plasma membrane prior to 
budding. Since M1 is closely associated with both the RNP complexes and the surface 
glycoproteins, it may play an important role the structural integrity of the virion. Finally, 
M1 is found in the nucleus, cytoplasm, and plasma membrane of infected cells and may 
be involved in down regulation of virus-associated transcriptase. M1 is also highly 
conserved during evolution (Smith and Palese, 1989). M2 is an integral membrane 
protein (Zebedee and Lamb, 1988) that is abundantly expressed at the surface of virus- 
infected cells but is a relatively minor component of virions (Zebedee and Lamb, 1988). 
M2 proteins are ion channels (Pinto et al., 1992; Takeuchi and Lamb, 1994; Ohuchi et 
al. 1994; Takeda et al., 2002; Watanabe et al., 2002), which are believed to function 
during uncoating and to mediate intracellular pH (Whittaker et al., 1996; Hay, 1998). 
Whittaker et al (1996) suggests that the M2 protein catalyses the entry of H+ into the 
virions prior to the fusion, promoting the dissociation of the M1 protein from the viral 
RNPs. Such separation of the M1 from the RNPs is essential for the subsequent 
transport of RNPs from the cytoplasm into the nucleus. The M2 protein is also 
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conserved in all known strains of influenza virus and is evolved to contribute to the 
efficient replication of the virus in a single cycle (Takeda et al., 2002). Both the M1 and 
M2 proteins also play a role in inducing apoptosis in infected cells (Morris et al., 2002). 
RNA segment 8 codes for two nonstructural proteins, NS 1 and NEP. Both 
proteins are found in infected cells. The non-structural protein NS 1 is made in large 
quantities during the early stages of infection, whereas NEP is found in later stages in 
the infection cycle (Paragas et al., 2001). The NEP is believed to interact with the Ml 
protein (Lamb et al., 1978; Richard son et al., 1991; Yasuda et al., 1993), but the 
functions of NEP are not fully understood. The NEP proteins of both influenza B and C 
viruses possess nuclear export activities (Paragas et al., 2001). It was suggested that 
NS 1 protein might enhance the rate of translation initiation of viral mRNA (De la Luna 
et al., 1995). The NS 1 protein is an RNA-binding protein that has been implicated in a 
number of regulatory functions during influenza virus infection, inducing the regulation 
of synthesis, transport, splicing, and translation of mRNAs (Nemeroff et at., 1998; 
Fortes et al., 1994; Qiu et al., 1994; Lu et al., 1994 and 1995; Wolff et al., 1996 and 
1998, Marion et al., 1997; Shimizu et al., 1994; Enami et al. 1994; de la Luna et al. 
1995). Other workers also reported that NS 1 protein was a virally encoded inhibitor of 
the IFN-mediated antiviral response (Garcia-Sastre et al., 1998; Zhimov et al., 2002; 
Takasuka et al., 2002; Seo et al., 2002), which may be an important factor in the 
pathogenicity of influenza virus infection (Talon et al., 2000; Basler et al., 2001; 
Taubenberger et al., 2001; Kim et al., 2002; Geiss et al., 2002). Salvatore et al. (2002) 
also reports that the NS 1 protein enhances translation but iS not required for shutoff of 
the host protein synthesis (Salvatore et al., 2002). 
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1.10 Influenza infection cycle 
Influenza virus enters the respiratory tract in droplets and attaches to sialic acid 
receptors on the epithelial cells via the HA. The virus penetrates the cell by receptor- 
mediated endocytosis and is then transported to endosomes. There is a change in the 
configuration of the HA which leads to the opening of the trimer and the repositioning 
of the HA2 fusion sequence. Fusion between the viral membrane and the endosome 
membrane triggers (Klenk et al., 1975; Lazarowitz and Choppin, 1975; Klenk and Rott, 
1988) migration of the viral RNA and the three subunits of the polymerase to the host 
cell nucleus where transcription and replication occur (Barrett et al., 1979; Helenius, 
1992). The viral RNA-dependent RNA polymerase complex catalyses the synthesis of 
three different RNA products: mRNA, cRNA, and vRNA. Influenza RNA transcription 
and initiation occur by a cap-snatching mechanism (Plotch et al., 1981; Mikulasova et 
al., 2000) in which 9 to 17 heterologous nucleotides of the 5' terminus of host cell 
mRNA is required for incorporating into the viral mRNA. Polyadenylation of the 
mRNAs take place with a five- to seven-U stretch close to the 5' end of the negative 
strand template which is used as a signal. Viral encoded endonuclease requires a 7- 
methylated G cap and cleaves host cell mRNA leaving a free hydroxyl group at the 3' 
end thus preventing the process of dephosphorylation. The individual roles of the three- 
polymerase subunits in the cap-snatching process have been partially assigned. The 
conserved protein motifs of the PB 1 subunit appear to be essential for polymerase 
activity (Biswas et al., 1994). The PB 1 may be responsible for elongation of the nascent 
chain (Braam, et al., 1983; Li et al., 2001). The PB2 subunit has been shown to interact 
with cap-1 structures (Ulmanen et at., 1981; Blaas et at., 1982; Li et al., 2001), and is 
possibly involved in the recruitment of capped cellular RNAs which is responsible for 
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the endonucleolytic cleavage of the host cellular mRNA (Shi et al., 1995; Blok et al., 
1996). A recent report suggests that the endonuclease domain resides in the PB 1 subunit 
(Li et al., 2001) The function of subunit PA is not fully known. However, the PA 
subunit is mostly involved in viral RNA synthesis in infected cells (Mahy, 1983). In 
addition, studies by Nieto et al. (1994) have suggested that nuclear transport of PA 
could be a prerequisite for proteolysis. This reflects a physiological role for PA activity 
during influenza virus infection since PA protein is located in the nucleus in late 
infection. During early influenza infection the PA protein remains in the cytosol, 
whereas other core influenza viral proteins, PB2, PB 1, and NP are located in the 
nucleus. The delay in nuclear targeting suggests that the transport of the PA subunit to 
the nucleus may be regulated during infection (Nieto et al., 1992). Other workers 
suggest that the PA induces a generalised proteolytic process but is unclear whether this 
activity is directly involved in the transcription and replication process (Sanz-Ezquerro 
et al., 1995; Perales et al., 2000). More recently, Hara et al. (2001) showed that PA is a 
serine protease with serine at position 624 at the active site. Recently, Fodor et al. 
(2002) demonstrates that the PA subunit is required not only for replication but also for 
transcription of viral RNA. It is believed that all the three polymerase subunits are 
required for efficient synthesis of all three influenza RNA transcripts (Perales et at., 
1997). Replication of the viral RNAs is carried out in two steps: synthesis of positive- 
strand replicative intermediates that are exact copies of the virion RNAs and use of 
these molecules as templates to synthesise new copies of negative-stranded viral 
progeny RNAs. 
The new viruses are assembled at the host cell surface membrane and released by 
a process of budding. Assembly of the virus occurs in two steps: the nucleocapsid 
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structure is assembled in the nucleus and the viral envelope is assembled at the host cell 
surface membrane. The HA is cleaved by a host cell exopeptidase into HAI and HA2. 
The M1 protein mediates interaction between the NP and the cytoplasmic domains of 
the glycoproteins by inserting into the nascent patches of virus envelope. The terminal 
sequences of vRNA consist of all essential RNA signals required for packaging (Luytjes 
et al., 1989). However, the mechanism of packaging of the RNA segments into 
infectious particles remains unknown. Two models have been proposed for the 
packaging. One is the random-packaging model in which genome RNA segments are 
randomly picked up among a pool of eight different RNAs bearing a common packaging 
signal (Enami et al., 1991; Bancroft and Parslow, 2002). The other model is in favour of 
selective packaging of each RNA segment into a virion (Smith and Hay 1982). The 
second model is based on the findings that the eight RNA segments are present in an 
infectious particle in approximately equimolar quantities and the relative amount of 
each RNA segment in infected cells does not reflect that in a virion. 
The RNPs have to exit the nucleus prior to assembly into progeny virions, but the 
mechanism of RNP export is not fully understood. It is suggested that M1 accumulates 
in the nucleus and interacts with RNPs, promoting their migration out of the nucleus 
(Martin et al., 1991; Bui et al., 2000; Zoueva et al., 2002). Additionally, O'Neill et al. 
(1998) showed that the NEP protein was to mediate the nuclear export of vRNAs by 
acting as an adaptor between viral RNP complexes and the nuclear machinery of the 
cell. Digard et al. (1999) proposed that interactions between NP and actin filaments play 
a role in regulating the localisation of RNPs by causing their cytoplasmic retention late 
in infection. Neumann et al. (2000) proposed that NEP interacts with M1 associated 
RNPs as well as a cellular factor (chromosome region maintenance 1 protein) to form a 
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functional export complex. An alternative export pathway based on direct interaction of 
NP with the CRM1 export pathway has also been proposed (Elton et al., 2001). It has 
been suggested that interactions between M1 associated with the RNPs and the 
cytoplasmic domains of HA and NA in the lipid rafts may facilitate the assembly of the 
virion components and promote viral budding (Garcia-Sastre et al., 1995; Jin et al., 
1997). The aggregation of progeny virions after budding from the plasma membrane of 
the infected cells is prevented by the activity of neuraminidase (Liu et al., 1995). 
Finally, the enveloped virus is released at the plasma membrane from infected cells by a 
process of budding in which the precise mechanism remains unknown. Scheiffele et al. 
(1999) proposed that virus budding occurs from lipid rafts in the plasma membrane 
which serves as sites for concentrating viral HA and NA. The M1 protein is believed to 
play a major role in the process of virus budding (Gomes-Puertas et al., 2000). In 
addition, virus budding is reported to be an active ATP-dependent process (Hui and 
Nayak, 2001). Mora et al. (2002) also demonstrates that apical viral budding is a shared 
function of various viral components such as HA, NA and/or NP protein rather than a 
role of the major viral envelope glycoprotein HA. 
1.11 Host range 
Influenza A viruses are able to infect a variety of animals apart from humans such 
as swine, equine, seals, whales, and also a wide range of birds. Predominantly three 
subtypes of influenza haemagglutinin (H 1N1, H2N2 and H3N2) have been documented 
in man. Brown et al. (1998 and 2000) reported that an avian-human H1 N2 influenza 
virus had been detected in pigs, resulting in the emergence of a new influenza strain and 
subtype in man. However, there are also three events of avian influenza virus isolated 
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from humans. Avian influenza viruses of the H7 subtype have been isolated from eye 
swabs of two individuals with conjunctivitis (Webster et al., 1981; Kurtz et al. 1996). In 
addition, the Hong Kong chicken influenza virus (A/Hong Kong/156/97, H5N1) was 
transmitted to humans in May and November 1997 (CDC, 1997); suggesting that there 
may be an increasing incidence in the emergence of new influenza A strain in man from 
birds probably via close contact. Subsequent workers provide evidence that avian 
influenza virus (H9N2) has been isolated from humans (Peiris et al., 1999; Capua and 
Alexander, 2002; Shaw et al., 2002; Hatta and Kawaoka, 2002). 
Human pandemic viruses may possibly be derived from the avian host reservoir 
(Schafer et al., 1993; Bean et al. 1992). Furthermore, molecular studies have suggested 
that all subtypes of HA have evolved from a common evolutionary ancestor (Scholtissek 
et al., 1985,1993, and 1997; Castrucci et al., 1993; Claas et al., 1994; Webster et al. 
1993). All subtypes of influenza A virus infect birds causing different severity of illness 
which varies with strains, although most avian infections are asymptomatic. In addition, 
there is increasing evidence that the viruses are evolutionarily stable in birds (Murphy et 
al., 1990; Webster et al., 1993; Guan et al., 1996; Alexander and Brown, 2000; 
Brownlee et al., 2001; Zambon, 2001; Webby and Webster, 2001; Capua and 
Alexander, 2002; Chin et al., 2002; Scholtissek et al., 2002). However, avian influenza 
A viruses from Asia are recognised as the source of genes that reassorted with human 
viral genes to generate the Asian/57 (H2N2) and Hong Kong/68 (H3N2) pandemic 
strains occurring earlier last century (Scholtissek et al., 1978; Kawaoka et al., 1989). 
This may suggest that a variety of avian species may have served as the reservoir of 
influenza viruses that may be responsible for the pandemic strain of 1918. In swine, 
both H1N1 and H3N2 subtypes of viruses have been isolated, whilst the H1N1 subtype 
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has been isolated from a variety of origins of avian, swine and human. Swine influenza 
viruses are also known to infect humans (Smith et al., 1976; Top et al., 1977; Kendal et 
a., 1977; Hinshaw et al., 1978; Rota et al., 1989; Wentworth et al., 1994) but their role 
in serving as a reservoir of generating a newly reassorted pandemic strain for human 
remains unclear and obscure. The viruses, which infect seals, minks and whales, are all 
thought to be of avian origin. Viruses of all subtypes (H1-H15 and N1-N9) are present 
in wild aquatic birds and they often replicate in the respiratory or intestinal tract without 
causing disease (Rohm et al., 1981; Hinshaw et al., 1982). 
Although influenza A and B viruses do not infect mice in the wild, mice have 
provided extremely useful experimental models for studying influenza infection via 
various routes of infection. Embryonated chick hens' eggs have served as useful tools 
for propagation and isolation of influenza virus both in the allantoic and amniotic 
cavities (Smith 1935; Burnet, 1940; Burnet and Bull, 1943; Horsfall, 1955). Influenza 
viruses may be cultured in a number of cell culture systems. The most commonly used 
system in the laboratory has been the MDCK cell line (Kendal et al., 1979; Scholtissek 
and Murphy, 1978; Shimizu et al., 1982,1983). 
1.12 Antigenic variation 
RNA viruses have much higher mutation rates than that of DNA viruses (Holland 
et al., 1982). Thus RNA viruses have a greater potential for antigenic change and 
evolution. There are two types of antigenic variation occurring in influenza viruses: 
antigenic drift and antigenic shift, which lead to epidemics and pandemics of 
influenza 
infection respectively. The antigenic changes occur via a number of 
different 
mechanisms including point mutations (antigenic 
drift), gene reassortment (antigenic 
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shift), and RNA recombination. All eight of the RNA segments of the virus readily 
undergo mutations but the nucleotide substitution rate is much higher in RNA segments 
4 and 6, which code for the two surface glycoproteins, haemagglutinin and 
neuraminidase, respectively (Smith and Palese, 1989). All types of influenza viruses are 
able to undergo antigenic drift that is constantly occurring due to minor changes in the 
amino acid sequence of the haemagglutinin and the neuraminidase glycoproteins (Laver 
et al., 1979; Moss et al., 1980). The changes are the result of spontaneous mutations. 
The new strain of virus can infect individuals as the host's immune system can no 
longer recognise the altered surface glycoproteins. However, the mutant strains of 
viruses cause localised outbreaks rather than severe epidemics. The substitutions occur 
at a higher rate in the nucleotides coding for the HA gene and increase progressively 
from time to time regardless of seasonal factors. There may be a small scale of antigenic 
heterogeneity within a single isolated outbreak of influenza as evidenced by the study of 
minor antigenic heterogeneity in viruses isolated at any particular time (Oxford et al., 
1983). Antigenic drift can occur when influenza A is grown in chick eggs; mutations 
occur near surface receptor positions of the haemagglutinin which affect the antigenicity 
in laboratory tests (Schild et al., 1983). 
Influenza A viruses also undergo a major antigenic change termed antigenic shift. 
The process of inducing antigenic shift is complex and is shown by the serological types 
of haemagglutinin and neuraminidase contained in the major shifted influenza virus A 
strain. The processes for HA and NA undergoing antigenic shift are independent with 
the appearance of a new subtype of virus in the human population respectively 
(Alexander and Brown, 2000; Brownlee and Fodor, 2001; Capua and Alexander, 2002; 
Suzuki and Nei, 2002; Yewdell and Garcia-Sastre, 2002). There have been four major 
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antigenic shifts in the last century and two more minor incidences which have occurred 
at infrequent time intervals, the most deadly being the emergence of Spanish influenza 
(H 1N 1) in 1918 which was serologically related to classic swine influenza A virus 
(Table 1.1). 
Table 1.1: Major and minor antigenic shifts of human influenza A viruses occurring 
during the 20th century 
1918 111 NI Shift Unknown mechanism of reassoriment 
Possible emergence from swine or an avian host of a 
HIN 1 related virus 
1957 H2N2 Shift Possible mixed infection of an animal with human H1N1 
and avian H2N2 virus strains in Asia 
H1N1 virus disappeared 
1968 H3N2 Shift Possible mixed infection of an animal with human H2N2 
and avian H3Nx virus strain in Asia 
Swine H1N1 virus outbreak in army camp (1976-77) 
(Kendal et al., 1977) 
1977 H1N1 Shift Reappearance of 1950 human H1N1 virus (Kendal et al., 
1979; Six et al., 1983; Raymond et al., 1986; Nakajima et 
al., 2000) 
1997/8 H5N1 Drift Direct mixed infection of a human H1N1 with avian H5N1 
(de Jong et al., 1997; Claas et al., 1998; Subarrao et al., 
1998) 
2000s ??? ??? Human H3N2 and H1N1 virus strains have co-circulated 
since 1968 and 1977 respectively 
Avian H7N7 isolated from humans in 1995 (Kurtz et al., 
1996) 
Avian H5N1 isolated from humans in 1997 (de Jong et al., 
1997; Claas et al., 1997; Subbarao et al., 1997) 
Avian H9N2 isolated from humans in 1999 (Peiris et al., 
1999) 
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Reassortment of genes may occur between two influenza A strains in which 
infection of a single cell by two different influenza A viruses results in their replication 
and the subsequent exchange of any of the eight genes of each parent which may lead to 
the progeny viruses containing a mixtures of each parent's genes. During antigenic shift 
the change in amino acid sequences of the shifted haemagglutinin and/or neuraminidase 
proteins is so large that the shift is not caused by simple mutation of the preceding strain 
(Stuart-Harris, Schild and Oxford, 1983). Influenza A viruses are also able to infect 
animals and birds, which naturally result in a situation in which double infections with 
viruses of human and non-human origin occur at time intervals with genetic 
compositions differing from those circulating in the community of humans (Zambon, 
2001; Hatta and Kawaoka, 2002). Studies have suggested that the pandemic viruses of 
1957 and 1968 were reassortants between human and avian viruses with the PB1, HA, 
and/or NA derived from avian viruses (Kawaoka, Krauss and Webster, 1989; Kawaoka 
et al., 1993). Furthermore, a swine influenza strain (H1N1) was found to be responsible 
for influenza observed in military recruits (Kendal et al., 1977). Hinshaw and Webster 
have also documented a case in which an identical virus was isolated from a farmer and 
a pig in Wisconsin farm of America (1982). Swine influenza A H1N1 was responsible 
in 1976 for a fatal case of human influenza virus in the USA (Wentworth et al., 1994). 
Avian influenza A H7N7 was isolated from one adult with conjunctivitis in the UK 
(Kurtz et al., 1996). More recently, avian influenza virus, A/Hong Kong/ 156/97, caused 
disease in humans in Hong Kong, which was closely related to the isolate 
AChicken/Hong Kong/ 258/97 (de Jong et al., 1997; Claas et al., 1997; Subbarao et al., 
1997). The latter virus was responsible for severe outbreaks of disease in three farms in 
Hong Kong during March 1997 during which thousands of chickens died. By December 
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1997 there were 18 confirmed human cases in Hong Kong suffering from avian 
influenza infection of which six were fatal (Yuen et al., 1998). The Hong Kong chicken 
influenza virus (H5N1) has demonstrated that a direct infection of a human's with avian 
H5N1 can occur. Most recently, an outbreak of H5N1 has resulted in 2 deaths in a single 
family and the timing of the infection does imply that human to human transmission 
may have occurred. It had been suggested earlier that most new human pandemics and 
variant viruses could have originated in China (Webster et al., 1993). China and nearby 
areas are also places where outbreaks of novel viruses often firstly occur due to close 
contact in those regions between humans and animals. 
The H2N2 subtype causing the 1957 pandemic spreading from Asia to Europe was 
replaced by the H3N2 subtype of Hong Kong influenza virus in 1968 (Webster et al., 
1971). The Hong Kong pandemic strain was proved to be less virulent in comparison 
with the Asian 1957 virus possibly due to the existence of a common NA antigen, and 
hence induced antibody which was cross reactive and which had provided a degree of 
cross-immunity to the newly emerged virus (Scholtissek et al., 1978). The reappearance 
of the H1N1 strain in 1977 caused a less dramatic but nevertheless a pandemic-like 
influenza outbreak and infected most persons who were born after 1957. The older 
population had pre-existing immunity. The H1N1 subtype virus has co-circulated with 
H3N2 virus in humans since 1977 to the present day, 2003. 
1.13 Transmission, infection, and clinical features of influenza 
Influenza is an acute and febrile illness caused by infection with influenza type A 
or B virus that occurs in outbreaks of varying severity almost every year (Alexander and 
Brown, 2000; Zambon, 2001; Yewdell and Garcia-Sastre, 2002). Influenza is a seasonal 
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disease that is most prevalent during the winter months, except in equatorial regions 
where several outbreaks may occur at any time during the year. Influenza A virus is 
spread rapidly from person to person via the aerosol route. Most transmission probably 
occurs by coughing and sneezing due to inhalation of respiratory secretions from an 
infected person. Some virus may be spread by direct contact. The incubation period of 
the virus is usually from 1 to 4 days, and virus remains most easily transmissible from 
infected patients for the first 3 to 5 days of the illness. The peak of virus replication 
occurs 2-3 days post-infection. There is almost no shedding of virus after 6 to 8 days 
post-infection (Murphy et al., 1973). The whole respiratory tract may be affected but 
from the point of view of disease severity the most significant pathological changes 
occur in the lower respiratory tract (Mulder and Hers, 1972). There may be a variety of 
clinical symptoms post-exposure, including fever, chills, malaise, headache, generalised 
muscular aches, which may be accompanied by hoarseness and a cough. 
Tracheobronchitis with pneumonia are more serious consequences. Infection with 
influenza virus may produce similar but milder clinical syndromes to other respiratory 
viruses such as common cold, and cause pharyngitis. Conversely, some other respiratory 
viruses such as Respiratory Syncytial Virus and adenovirus may produce infections with 
clinical manifestations indistinguishable from those resulting from mild influenza virus 
infection, but such infections do not occur in epidemics. The most important features of 
influenza are the epidemic nature of the disease and its pulmonary complication 
reviewed by Yewdell and Garcia-Sastre (2002). Laboratory diagnosis is the only reliable 
method for confirming the diagnosis of influenza. 
There are three types of severe pneumonia which appear after influenza infection 
of adults and children, but are most commonly observed in the very young, the elderly 
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and those with underlying disease such as diabetes, chronic heart or kidney disease and 
asthma reviewed by Nathan et al. (2001). Firstly, primary influenzal pneumonia appears 
most frequently in individuals at high risk of influenza complications. The patient 
suddenly deteriorates with the onset of severe respiratory distress and symptoms of 
hypoxia, dyspnoea, and cyanosis, followed by circulatory collapse. There may be no 
significant bacterial infection detected at post mortem. Secondly, there is a combined 
viral-bacterial pneumonia, which occurs more commonly than primary viral pneumonia. 
The combined pneumonia usually develops later in the course of influenza and is due to 
secondary invasion of the lungs by bacteria such as Staphylococcus aureus, 
Haemophilus influenzae, or Streptococcus pneumoniae. The elderly and 
immunocompromised patients are among the high-risk groups of such superinfection by 
bacteria or those with pre-existing pulmonary or cardiac disease. There may be a high 
mortality rate. Thirdly, there is a bacterial pneumonia, which occurs approximately 4-5 
days after influenza infection with a lower fatality rate. 
1.14 Aim of this thesis 
The aim of this work was three-fold. Firstly, it was to establish a model system of 
influenza virus replication in the mouse brain via intracerebral infection with 
neurovirulent influenza A NWS and WSN viruses and to study possible persistent 
infection of influenza in the mouse brain that could act as a model of encephalitis 
lethargica. An animal model system using neurotropic strains of influenza viruses (NWS 
and WSN) for intracerebral inoculation in mice could also provide a better 
understanding of conditions which could allow influenza viruses to persist and to 
possibly trigger late neurological complications. 
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Secondly, it was to utilise the unique and documented clinical samples of brains 
from cases of encephalitis lethargica from the 1916-1920 pandemic era stored in the 
archives of the Institute of Pathology (The Royal London Hospital) and to analyse 
samples by a PCR assay for influenza genes. 
Finally, it was to investigate the localisation of influenza gene sequences from 
sections of mouse brain intracerebrally infected with influenza A NWS virus using an in 
situ hybridisation technique. 
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2.1 Viruses 
2.1.1 Propagation of viruses in embryonated hens' eggs 
Seed viruses were obtained from NIBSC. All viruses were propagated in the 
allantoic cavity of 10- to 11-day-old embryonated hens' eggs using classical techniques 
(Burnet 1942). In brief, fertilised eggs were candled for viability of the embryos with the 
air-sac (blunt-end) uppermost, 100µ1 of seed virus (allantoic fluid) was inoculated at a 
dilution of 1 in 103 or 104 in sterile PBS"A" (Oxoid) with the presence of 
penicillin/streptomycin (Sigma) into the allantoic cavity, and the holes in the eggs were 
sealed with wax (Fisons). The infected eggs were incubated at 35°C for 3 days. Eggs 
were chilled for 60-90 minutes at -20°C or stored overnight at 4°C. The allantoic fluid 
was then harvested and tested for the presence of virus by the haemagglutination test 
(2.1.3). Allantoic fluid was aliquoted and stored at -70°C until used in the experiments. 
The viruses propagated in embryonated hens' eggs were A/NWS/33, E13770; 
A/WSN/33,16085, XE1; A/ WS/33, E7875; A/PR/8/34,15790, XE1; 
A/sw/Cambridge/39; A/Singapore/1/57, August 1980; A/Japan/305/57, H2N2; 
AJTokyo/3/67,14225; A/HongKong/1/68, E12575; A/New Jersey/8/76, E8475; 
A/Brazil/11/78, E12485; A/Califonia/10/78, E4169; A/Chile/1/83,14185, E10; 
A/Taiwan/l/86,15340; A/Beijing/352/89,15100; A/Johannesberg/33/94,16860 
(NIBsc). 
2.1.2 Recovery of A/NWS/33 virus from intracerebrally infected mouse brains 
using embryonated hens eggs 
Each mouse brain sample intracerebrally infected with influenza A NWS virus 
was mixed in 2 ml of sterile PBS"A" and spun 'at 1,800 rpm for 15 minutes. Supernatant 
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fluid from each processed mouse brain sample was diluted with sterile PBS"A" at a 10- 
fold dilution to 1010 in the presence of antibiotics (penicillin/streptomycin), one hundred 
micro-litres of each diluted mouse brain samples was inoculated into the allantoic cavity 
as previously described (2.1.1). After harvesting the allantoic fluids from inoculated 
fertilised hens' eggs, influenza virus was detected by the HA test (2.1.3) and the fluid 
stored at -70°C. A sample from brain of each animal was bacteriologically tested for the 
absence of bacteria. 
2.1.3 Haemagglutination (HA) assay 
Serial 2-fold dilutions of the virus (allantoic fluid) were made with an equal 
volume of PBS in 96 well microtitre V-plates (Sterilin). Equal volumes of 0.65% to 
0.75% turkey red blood cells (NIBSC) were added to each well. The plates were allowed 
to stand for approximately 30 minutes at room temperature and the HA titre was 
recorded as the reciprocal of the highest dilution causing 50% agglutination of the red 
blood cells. Non-agglutinating red blood cells streamed when the plate was tilted. 
2.2 Animal work 
2.2.1 Virus 
Egg-grown influenza A viruses, A! NWS/33 and A/WSN/33, were used as an HA 
titre of 196 and 64 respectively. Each virus was made at a 10-fold serial dilutions with 
sterile PBS"A" in the presence of penicillin/streptomycin before each of animal 
inoculations, and appropriately diluted virus was kept on ice prior to infection. 
Appropriate virus dilutions used for animal inoculation were freshly prepared an hour 
before inoculation for each of the animal models. 
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2.2.2 Inoculation of virus into animals 
Three- to four-week-old female Swiss CD I mice with average weight of 15-18 g 
were used in all experiments. Mice were weighed before intracerebral and intranasal 
inoculation and before sacrifice. A 10-fold dilution of stock NWS and/or WSN virus in 
sterile phosphate buffered saline "A" (PBS"A") was used for all animal work. All 
animal inoculations were conducted under light halothane anaesthesia. Each mouse was 
intracerebrally inoculated with 20µl of the virus preparation by puncture of the sterilised 
scalp (70% ethanol) in the central frontal region using a Hamilton syringe (Sigma) with 
#27 hypodermic needle (Fisons). Mice from the control group were similarly inoculated 
using sterile PBS"A" as the inoculum. The Hamilton syringe was sterilised with 70% of 
ethanol before and after each inoculation. Sterile disposable needles were used for each 
dilution for animal inoculation. 
2.2.3 Mouse brain samples after intracerebral infection with influenza virus 
Mice were sacrificed by asphyxiation with CO2 according to the UK Home Office 
guidelines. Mice were sacrificed at various time intervals post-infection. Direct heart 
puncture was immediately performed to withdraw the blood for serological studies. 
Each mouse was immersed in 70% formol saline, the scalp was exposed by incision 
with a sterile surgical blade and surgical scissors, and the brain was removed rapidly 
using a sterile scalpel and surgical scissors, minced up and emulsified into a sterile 
plastic universal bottle (Sterilin) containing 2 ml of sterile PBS"A" for virus isolation 
(Section 2.1.2) and PCR studies. Emulsified brain samples were centrifuged at 1,800 
rpm for 15 minutes and the supernatant fluid was aliquoted and stored at -70°C. Mouse 
brain samples, for histological, in situ hybridisation and PCR studies prior to paraffin 
65 
Chapter 2 Materials and Methods 
wax embedding, were presented using an injection of 70% formol saline which was 
administered via a tail vein after exposure to carbon dioxide The formalin-fixed mouse 
brain was then removed by surgical scissors and placed into a container containing a 
large volume of 70% formalin prior to paraffin wax embedding. 
2.2.4 Preparation of homogenates of mouse brain, heart, lung, liver, spleen and 
kidneys after intracerebral and intranasal infection with influenza viruses 
Mice were sacrificed as previously described (Section 2.2.3). Mouse organs were 
exposed by incision with a separate set of sterile surgical blade and scissors and 
dissected with sterile surgical scissors and forceps. Each organ was removed into a 
sterile Eppendorf containing 0.3ml minimal essential medium (MEM) (Sigma) and kept 
in an icebox. Organs removed from each mouse were separately mixed with 
approximately 1g of sterile sand (Sigma) and 1.7ml of MEM and then ground for 1-2 
minutes with a set of sterile mortar and pestles at room temperature. Each organ from 
each mouse was homogenised twice with a total volume of 3ml of MEM. Universal 
bottles containing a mixture of homogenised mouse tissues of each organ, MEM and 
sand were centrifuged at 1,800 rpm for 15 minutes to deposit large tissue fragments. 
Supernatant fluid was aliquoted and stored at -70°C. The process of homogenisation 
was performed under the hood in an icebox. Separate sets of sterile mortar and pestles 
were used for each organ. 
2.2.5 Serum separation 
66 
Chapter 2 Materials and Methods 
Blood samples from each mouse were incubated at 37°C for 0.5 hour, left at 4°C 
for 1 hour and spun at 1,500 rpm for 15 minutes. The sera were collected and stored at - 
20°C. 
2.3 The Haemagglutination-Inhibition (HI) test 
The HI tests were carried out using standard procedures. Briefly, mouse sera were 
pre-treated and incubated overnight at 37°C with receptor-destroying enzyme (RDE) 
(NIBSC) at a1 in 4 dilution, and then heated at 56°C for 1 hour to remove non-specific 
inhibitors prior to the HI test. The virus antigens were prepared from neurotropic NWS 
and WSN viruses, which were cultivated in embryonated hens' eggs and antigens, and 
used at 8 haemagglutinating units. Serial 2-fold dilutions of the RDE treated sera were 
made in PBS using 96 well microtitre V-plates. An equal volume of viral antigen (50µl) 
was added to each well. An equal volume of 0.65-0.75% turkey red blood cells was 
subsequently added to each well and the plate was read after 30 minutes at room 
temperature. A stream was formed by non-agglutinated red blood cells when the plate 
was tilted. The reciprocal of the highest dilution of serum allowing streaming was 
recorded as the HI antibody titre. HI antibody titres of >_ 40 HI units were considered to 
indicate that the NWS or WSN virus infected mice. 
2.4 Molecular Biology: Polymerase Chain Reaction (PCR) 
2.4.1 Study design 
Optimisation of the PCR technique was conducted using mouse brain samples as 
mock samples prior to analysis of the 1916 to 1920 human brain samples. Briefly, the 
procedure was carried out as follows: 
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(i) Set up PCR laboratories and methodology to ensure that the possibility of PCR 
contamination between pre-PCR preparations and post-PCR analysis was 
excluded. 
(ii) Select and design specific influenza primers for human, equine, swine and avian 
strains of influenza genes. 
(iii) Examine all primers with a segment-specific primer for cDNA synthesis of 
extracted influenza RNAs using fresh egg-grown viruses and influenza A (NWS) 
virus from infected mouse brains as clinical samples. 
(iv) Introduce random hexamers to replace the influenza segment-specific primers in 
the reverse transcription step. 
(v) Search for viral nucleic acid sequences from paraffin wax-embedded mouse brain 
tissues, as follows: 
0 Optimise the incubation temperature during proteinase K digestion to 
determine which incubation temperature would give the best recovery of 
influenza RNA from paraffin wax-embedded mouse brain samples prior to RNA 
extraction. (42°C or 55°C) 
" Compare the recovery of RNA from mouse tissues which have been 
formalin fixed for 6/7 days and 6 months prior to paraffin wax embedding, to 
demonstrate if the lengths of time for clinical samples to be formalin-fixed and 
paraffin wax-embedded would have any adverse effect on PCR amplification. 
(vi) Finally, analysis of the 1916-1920 human brain samples for the presence of 
influenza specific sequences. 
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2.4.2 A general outline of PCR amplification for target sequences 
Fresh / archival paraffin wax-embedded human and animal brain samples 
4 
Deparaffinisation 
Proteinase K digestion 
4 
RNA extraction 
4 
Complementary DNA (cDNA) synthesis / Reverse Transcription 
4 
PCR 
U 
Nested PCR (nPCR) 
2.4.3 Preparation and sectioning of human and mouse samples 
Disposable gowns, gloves, masks and shoes were worn during each sectioning of 
the 1916-1920 tissue blocks. A separate disposable microtome blade for each block of 
fresh and archival paraffin wax-embedded samples was used. Five-micrometer thick 
sections were individually collected into clean sterile Eppendorf tubes, sealed and stored 
at 4°C until used in a PCR assay. Ten 5µM-thick sections from each tissue block were 
cut from paraffin wax-embedded human brain samples from 1916-1920. Paraffin wax- 
embedded mouse brain and lung samples were also sectioned and stored at 4°C. Five- 
micrometer thick samples were cut for PCR studies, H&E staining and in situ 
hybridisation studies. 
2.4.3.1 Animal samples 
69 
Chapter 2 Materials and Methods 
Mouse brain samples, which had been formalin-fixed for six months prior to 
paraffin wax embedding, were obtained from previous animal models (refer to Chapter 
3). A mouse model was conducted as previously described (Section 2.2.2) using egg- 
grown influenza A NWS virus via intracerebral inoculation. Mice were sacrificed on 
day 3 or 4 post-infection. The brain samples from both infected and uninfected groups 
of mice were formalin-fixed immediately after being sacrificed, paraffin wax-embedded 
on day 7 and sectioned 5µM thick sections prepared as both positive and negative 
controls for the development of a PCR assay and the subsequent study on human brain 
from 1916-1920. The extracted influenza RNA was resuspended in 300µl sterile water, 
aliquoted and stored at -20°C until used for experiments as a positive PCR control for 
influenza. 
2.4.3.2 Human clinical samples 
The Department of Histopathology and Morbid Anatomy of the Royal London 
Hospital (RLH) provided eight brain samples from patients who died of encephalitis 
lethargica from victims of the 1916-1920 pandemic of the encephalitis lethargica. Eight 
cases of EL were identified from the autopsy files at the Royal London Hospital for the 
years 1916-1920 for which formalin-fixed and paraffin wax-embedded brain samples 
were available in the archives. The related post-mortem number and their year of death 
for the 1916-1920 human brains were 668/16,669/16,645/19,15/20,393/20,397/20, 
712/20, and 741/20 (Casel/1916, Case2/1916, Case3/1919, Case4/1920, Case5/1920, 
Case6/1920, Case7/1920 and Case8/1920). A paraffin wax block of brain tissue from a 
patient who had died of Alzheimer's disease in 1996 was used as a negative control for 
the 1916-1920 brain samples (262/96). Each clinical sample was sectioned in 5µM 
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sections from individual paraffin blocks of tissues. Ten sections from each clinical 
sample were studied using an optimised PCR assay. Sectioning of human brain samples 
was carried out in the Department of Histopathology and Morbid Anatomy (RLH). 
Sections of tissues were kept in sterile Eppendorf tubes, sealed and stored at 4°C until 
used for PCR analysis. 
2.4.4 Primers 
Primers specific for the influenza genome were selected from relatively conserved 
regions among the different species of influenza viruses. The line-up of sequences for 
each segment of influenza gene studied was obtained from Dr J. S. Robertson, NIBSC. 
Few degeneracies within each primer were incorporated for improved detection of 
influenza sequences from strains of human, swine, equine and avian viruses. Sequences 
were selected from four segments of the influenza genome: the HA/segment 4, 
NP/segment 5, M/segment 7, and NS/segment S. A list of primers used is shown in 
Tables 2.1-2.2. 
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2.4.5 Deparaffinisation of paraffin wax-embedded tissue samples 
Each section was transferred into a sterile 1.7m1 Eppendorf tube under a fume 
hood and incubated in 1 ml n-octane (Sigma) for 50-60 minutes on a rotor mixer at 
room temperature. N-Octane was discarded and the same incubation period was 
repeated. Tissues were washed and centrifuged twice with absolute ethanol (Hayman) 
for 10 minutes at room temperature and for 2 minutes at top speed in a microfuge. 
Sections were left to air-dry overnight and each tube was covered with a plastic bag 
(Fisons) and kept in a fume hood. Sections of brain tissues from mice intracerebrally 
infected with influenza A NWS virus and sterile PBS"A" respectively were 
deparaffinised in parallel with the 1916-1920 clinical sample during each PCR assay 
used as positive controls. Sections of brain tissues from mice intracerebrally infected 
with influenza A NWS virus and sterile PBS"A" respectively and sections of a human 
brain from a patient who did not die of encephalitis lethargica (262/96) were 
deparaffinised in parallel with the 1916-1920 clinical sample during each PCR assay as 
negative controls for influenza. 
2.4.6 Proteinase K digestion prior to nucleic acid extraction 
Proteinase K digestion buffer containing 5µi 1M Tris pH8.0 (Sigma), 0.2µl 0.5M 
EDTA (Sigma), 0.5µl Tween 20 (Sigma), 2µl 10 mg/ml proteinase K (Sigma), and 
923µl sterile water (Sigma) were freshly prepared for each analysis and 100µl of the 
above buffer was added to each tube containing deparaffinised tissues. An empty tube 
containing only the proteinase K digestion buffer was also processed as a blank / 
negative control (KI) for each PCR assay. All tubes were sealed with paraffin 
film 
(Fisons) and incubated at 42°C or 55°C for 3 hours, then at 99°C for 5 minutes 
in a 
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water bath to terminate. Tubes were briefly centrifuged using a microfuge prior to RNA 
extraction and the RNA was immediately processed afterwards. 
2.4.7 RNA extraction 
To each reaction tube consisted of 2O0µ1 fresh material of allantoic fluid, 
homogenates of mouse organ or 100µl deparaffinised and proteinase K digested tissues 
from each paraffin wax-embedded sample, 225µl of lysis solution containing 0.02 M 
Tris (pH7.5), 0.01 M EDTA, 25µl 1% SDS (Sigma), 1 mg/ml proteinase K (Sigma) and 
3µl glycogen (Boehringer Mannheim) was added and tubes were incubated at 42°C for 
30 minutes. Samples were extracted once with an equal volume of phenol/ chloroform/ 
isoamyl alcohol (25: 24: 1) (Sigma), and twice with equal volumes of chloroform 
(Sigma). One tenth volume of 3M sodium acetate (pH 5.2) (Sigma) was added to the 
final aqueous phase with 1µl of 10mg oyster glycogen (Sigma) and 2.5 volumes of cold 
absolute ethanol (stored at -20°C) to precipitate RNA. After 20 minutes on ice, the 
precipitated RNA was collected by centrifugation at 13,000 rpm for 20 minutes at 4°C, 
the pellet was washed with 70 % ethanol at 4°C or room temperature for 5 minutes, air 
dried, and resuspended in 4.45µl of sterile water ready for cDNA synthesis / reverse 
transcription. A clean water control (X1) was extracted in parallel with the clinical 
sample. 
2.4.8 Complementary (cDNA) synthesis / reverse transcription 
Complementary DNA (cDNA) to viral RNA (vRNA) and human ß-actin mRNA 
was synthesised from the RNA suspension using reverse transcriptase (RT: AMV- 
derived) (Advanced Biotechnologies). Reaction mixes (l0µ1) contained 1µl 100 mM 
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DTT (Sigma), 2µl 0.5mM dNTP mix (2mM each dNTP, Pharmacia), 1.25µl RT buffer 
(0.8M Tris pH8.3 at 42°C, 1.12 M KC1,80 mM Mg2+; Sigma), 0.3µl ribonuclease 
inhibitor (IU, CP labs) and 0.3µl RT (6U; Advanced Biotechnologies), with 4,15µl 
RNA extract and 1µl of either 27µM random hexamers (Pharmacia) or 10µM segment- 
specific primer for influenza, measles or ß-actin sequences (Perkin Elmer) (see Table 
2.3). Tubes were incubated at 42°C for 60 minutes and then boiled for 2 minutes to 
terminate the reactions. A clean water control (X2) was included and reverse transcribed 
in the same manner. A prepared and extracted viral RNA recovered from infected 
mouse brain was also incorporated in this step as a positive control for influenza. 
Table 2.3: The segment-specific primers for influenza and ß-actin used for cDNA 
synthesis 
Segment-specific Primer Sequence of primer (5' --- 3') 
A/M/32/1 CTTCTAACCGAGGTCGAAACGTA 
A/NP/44/1 TCATGGCGTCyCAAGGCACCAAACG, y= C/T 
ANS/540/1 GAGGATGTCAAAAATGCAATTGG 
A/HA/8/1 GCAGGGGAAAATAAAAACAACC 
ß-actin (Baf 1) GAAGAGCTACGAGCTGCCTGACGG 
2.4.9 PCR amplification for target sequences of nucleic acids 
All templates of cDNAs synthesised from egg-grown influenza A viruses and 
paraffin wax-embedded human and infected animal tissues were subjected to both 
rounds of PCR amplification. Each 50µl PCR mix contained 1µl of cDNA template, 
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0.25 µM of each forward and backward oligonucleotide primers (outer set of primers, 
see Tables 2.1-2.3) (Perkin Elmer), 16µl dNTP mix (1.25 mM each dNTP), 5µl reaction 
buffer (100mM Tris pH8.3,25mM Mgt+, 500 WANT KC1), and 1µl (5U) AmpliTaq 
polymerase (Perkin Elmer). Reaction tubes were overlaid with 50µ1 of mineral oil 
(Sigma) and subjected to 30 cycles of amplification in a DNA thermal cycler (Perkin 
Elmer). Each nested reaction tube contained 1 µl of PCR product from the first round of 
amplification, an inner set of primers and fresh reaction mix, were run for 30 cycles of 
amplification in a DNA thermal cycler. The PCR cycling conditions for influenza and ß- 
actin are listed in Table 2.4. Two clean water controls consisting of reaction mixture 
were amplified in the same manner as the first and nested PCR (X3 & X4). 
Table 2.4: PCR cycling conditions employed for the study 
Gene Denaturation Annealing Elongation No of cycles 
Influenza HA gene 94°C-0.5 min 55°C-1 min 72°C-1 min 30 
Influenza NP gene 94°C-0.5 min 50°C-1 min 72°C-1 min 30 
Influenza M gene 94°C-0.5 min 50°C-1 min 72°C-1 min 30 
Influenza NS gene 94°C-0.5 min 50°C-1 min 72°C-1 min 30 
ß-actin gene 94°C-0.5 min 50°C-1 min 72°C-1 min 30 
2.4.10 PCR product analysis 
First round and nested PCRs were screened for double-stranded DNA products by 
loading 1Oµl of each reaction on 2% agarose (Flowgen) gels, electrophoresing at 80V 
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for 60 minutes (gel running buffer, 0.5X TBE; Sigma), and subsequent staining with 
50µ1 of ethidium bromide (1 mg/ml) (Sigma). Samples were run against 0.5µg of a 
pUC 19/Sau3A digest (Advanced Biotechnologies) to allow sizing of products which 
were visualised and photographed on a UV transilluminator for PCR signals. 
2.4.11 Viral RNAs from recovered infected mouse brains as a positive control for 
influenza PCR 
Influenza A/NWS/33 virus from intracerebrally infected mouse brains and 
allantoic fluids were extracted and precipitated as previously described (2.4.7). The 
pellets were resuspended in 300µl, 500µl, and 1000µl water; respectively. The RNAs 
were well mixed before being aliquoted and stored at -20°C. A total of 4.45µl of RNA 
suspensions were pipetted and reverse-transcribed as a positive control for the influenza 
PCR assay. 
2.4.12 PCR analysis of the 1916-1920 clinical samples 
The detailed technique was described previously. The steps of deparaffinisation, 
proteinase K digestion, RNA extraction and reverse transcription were carried out in a 
laboratory in the Pathology Building (RLH) where no influenza work had been 
performed to avoid contamination. Alongside ten sections from each of the 1916-1920 
human brain samples, fresh paraffin wax-embedded sections of human and mouse 
samples were run in parallel as negative and positive controls. In addition, freshly 
prepared reagents were made up before beginning each PCR assay. All pre-PCR 
reagents were stored in a clean room where no work on DNA or RNA was carried out. 
Reverse transcribed RNAs (cDNAs) were stored at -70°C for later analysis for the 
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presence of other influenza gene sequences. For each 1916-1920 clinical sample, the 
housekeeping ß-actin gene was amplified in parallel during both rounds of PCR 
amplification using the combinations of BAR1/BAF1 and BAR2/ BAF2 as outer and 
inner sets of primers respectively as a control for the recovery of RNA from the 1916- 
1920 clinical samples. 
An outline of the PCR assay performed for each of the 1916-1920 human brain 
sample plus controls shown in Figs 4.8 - 4.11 (Chapter 4): 
Deparaffinisation: 
10 sections of tissues from a human brain sample from 1916-1920 
1 section of infected and paraffin wax-embedded mouse brain tissues 
1 section of uninfected and paraffin wax-embedded mouse brain tissues 
1 section of uninfected human brain tissues 
4 
Proteinase K Digestion: 55°C 
U 
RNA Extraction: phenol / chloroform extraction 
U 
Reverse Transcription: random hexamers 
U 
First Round of PCR amplification of targeted sequences with specific set of outer 
primers: 
influenza and housekeeping gene 
4 
Nested or 2"d round of PCR amplification of targeted sequences: 
inner set of specific and respective primers 
4 
Sequencing (if any positive sample present except for housekeeping gene) 
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2.4.13 Outline of positive and negative controls introduced in each step of the PCR 
and run in parallel with each clinical brain sample 
Each analysis of human material by PCR included the following control samples: 
(i) Deparaffinisation controls 
For PCR analysis of 1916-1920 human brain 
-A section of positive and negative mouse brain 
-A section of uninfected human brain (Control, 262/96) 
(ii) Proteinase K digestion: A negative control containing mixture of reagents 
for proteinase K digestion, termed K1. 
(iii) RNA extraction: a clean water control, termed X I. 
(iv) Reverse transcription: a clean water control, termed X2; a positive influenza RNA 
extracted from homogenates of infected mouse brain. 
(v) First round of PCR: a clean water control, termed X3. 
(vi) Nested PCR: a clean water control, termed X4. 
The final result from each human sample from 1916-1920 was reported only if all 
negative controls introduced in each step remained negative and all positive controls 
showed positive signals on the gel with the expected length of amplified PCR product 
when visualised under a UV transilluminator. 
2.5 Histological studies 
2.5.1 Study design 
Sequences of short oligonucleotides were selected from the NP, NS, and M 
segments of influenza genes as influenza probes. All probes were labelled with 
digoxigenin prior to hybridisation and were used for the study of paraffin wax- 
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embedded brain from infected and uninfected mice. An alternative radioactive labelling 
system for the influenza probe was introduced because the use of digoxigenin labelling 
system had failed to show the presence of influenza gene in mouse brains. Sections of 
brain were cut to see whether radioactively-labelled influenza NP probes remained 
detectable in the brains of infected mice sacrificed at various time intervals post- 
intracerebral infection. 
2.5.2 Mouse brain samples 
Five-micrometer thick mouse brain samples were prepared from mice sacrificed 
on days 3,4,5,7,12,18 and 24 post-intracerebral infections with influenza A NWS 
virus. Samples of brain from mice sacrificed on day 3 post-infection were immersed in 
30% formol solution for 4 days before being paraffin wax-embedded, whereas the rest 
were immersed in formalin for 6 months prior to paraffin wax-embedding (all sections 
of mouse brains were cut by the Department of Histopathology and Morbid Anatomy, 
RLH). 
2.5.3 Nucleotide sequences of NP, NS, and M probes 
Nucleotide sequences of influenza nucleic acids consisting of 59-60 nucleotides 
from genes of segment 5,7 and 8 were selected from the most conserved regions of each 
influenza gene with incorporation of degenerate nucleotides as appropriate. The 
selection and design of the influenza probes was based on the consensus sequences 
alignments from different strains of human influenza viruses of each sequenced gene 
(the pile-up sequences of each selected influenza gene using the "PRETTY" software 
were obtained from Dr J. S. Robertson, NIBSC). 
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NP probe: Degeneracy code: y= C/T, r= G/A, w= A/T 
5' -TCA TGG CG T CyC AAG GCA CCA AAC GrT CwT AyG ArC ArA TGG ArA 
CTG rTG GrG AA CGC - 3' ; nucleotide positions between 44-102. 
NS probe: 
5' - GAG GAT GTC AAA AAT GCA ATT GGr rTC CTC ATC GGA GGA CTT 
GAA TGG AAT GAT AAC - 3' ; nucleotide positions between 539-595. 
M probe: 
5' - CTT CTA ACC GAG GTC GAA ACG Tay GTT CTC TCT ATC rTy CCr TCA 
GGC CC CCT CAA AGC C- 3' : nucleotide positions between 32-91. 
Three influenza probes were labelled with digoxigenin, whereas the NP probe was 
radioactively labelled for the current study. 
2.5.4 Labelling of influenza probes 
The method for oligonucleotide tailing with DIG-dUTP/dATP was performed 
according to the manufacture's instruction described for a standard assay with 100 pmol 
3'-OH ends (Boehringer Mannheim). Nucleic acid molecules were enzymatically non- 
radioactively labelled at their 3'-end with terminal transferase by addition of a longer 
nucleotide tail. The steroid hapten digoxigenin (DIG) was linked via a spacer arm to the 
corresponding nucleotide. DIG-labelled influenza RNA probes were detected, after 
hybridisation to target nucleic acids, by enzyme-linked immunoassay using an antibody 
conjugate. A subsequent enzyme-catalysed colour reaction with 5-bromo-4-chloro-3- 
indolyl phosphate (BCIP) and nitro blue tetrazolium salt (NBT) produced an insoluble 
blue precipitate, which visualised the hybrid molecules. 
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2.5.5 Radioactive labelling of the influenza NP probe 
35S dATP was thawed on ice (1200 Ci/mmol). Addition of the following reagents 
into the tube containing 35S dATP on ice in order: 4. i1 of influenza NP oligonucleotides 
(4 pmol), 10µl of 5X tailing buffer, 28µl of ultrapure water to give a total volume of 
50µl, 3 i1 of dATP and 5µl of terminal deoxynucleotidyl transferase. 
The mixture was centrifuged, incubated at 37°C for 1 hour, and separated by 
"Nick" column. Excess liquid was poured away and the mixture rinsed once with 
equilibration buffer. The bottom cap was removed, filled with 3m1 equilibration buffer, 
and allowed to run through. The probe was loaded onto the column where was filled 
with 4O0µ1 equilibration buffer. The elute was then discarded. Another 400µl 
equilibration buffer was added into the column and collected in a tube containing 5µl 
IM DTT. The tube containing the labelled probe was freeze-dried for about 3 hours. 
2.5.6 In situ hybridisation for probe labelled with digoxigenin method 
A modified method obtained from the Department of Experimental Pathology (the 
Royal London Hospital) was employed. Slides with 5µM sections of mouse brain tissues 
were pretreated with xylene for two changes of two minutes each; immersed in 100% 
alcohol for 2 changes of two minutes each, in DEPC water for 2 changes of 2 minutes 
each and, in 1X PBS for 2 changes of 3 minutes each. Sections of slides were digested 
in proteinase K tris buffer for 5 minutes before being digested with proteinase K for 30 
minutes at 37°C in a humidified incubation chamber with DEPC water. The working 
solution of proteinase K was between 15-20 pg/ml in proteinase K tris 
buffer for each 
tissue section. Sections were washed with 1X PBS for 1 minute and post-fixed 
in 4% 
paraformaldehyde/PBS for 5 minutes. Sections were then washed with 
1X PBS for 2 
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changes of 3 minutes each and were placed in 0.25% acetic anhydride in TAE for 10 
minutes. Sections were applied with 3Oµ1 prehybridisation solution consisting of 50% 
formamide, 0.3% bovine serum albumin, 250µg/ml salmon sperm, 2XSSC and water; 
and incubated for 30 minutes at 42°C in a humidified chamber with DEPC water. Slides 
containing sections of tissues were drained and each section was applied with 30µl of 
digoxigenin-labelled influenza probe in hybridization buffer, covered with a heat 
sterilised coverslip and incubated at 42°C overnight in a humid chamber. The coverslip 
was removed from of each hybridised section of tissue by a post-hybridisation wash 
involving 2x SSC, 1X SSC, and 0.5X SSC at 37°C each for 10 minutes. The section 
was then placed in TBS for 3 minutes and was incubated in blocking reagent containing 
10% of normal sheep serum diluted in PBS for 30 minutes at room temperature. Slides 
of the sections were drained and dried and 50µl of anti-digoxigenin alkaline phosphatase 
conjugated Fab containing 1% normal sheep serum was applied to each section. It was 
then incubated for 2 hours at room temperature. Finally all tissue sections were washed 
with TBS for 10 minutes prior to mounting. Sections containing tissues were washed in 
substrate buffer for 5 minutes. The slides were drained and 50µl of NBTBCIP mixture 
containing 175µg/ml of BCIP, 350µg/m1 of NBT, 1µl of levamisole in 1M, and lml of 
substrate buffer were added to each section. All sections were incubated in the dark for 
5 hours at room temperature. All slides containing tissue sections were rinsed in tap 
water for 5 minutes, counterstained in Mayers Haemalum for 10 seconds, washed by tap 
water for 30 seconds, air-dried and mounted in aqueous glycerol gelatin. Sections were 
viewed under the microscope. 
2.5.7 In situ hybridisation for radioactively-labelled probe 
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A modified method obtained from the Department of Neurosciences (QMW) was 
employed for the present study. 
2.5.7.1 Pre-treatment of sections 
Slides containing sections of mouse brain tissues were dewaxed in 250ml 
histoclear for 2 changes of 10 minutes each and were then placed in 250m1 100% 
ethanol for 2 minutes to remove most of the xylene. Slides were quickly transferred 
through 250 ml 100% ethanol (twice), 95%, 85%, 70%, and 50% ethanol. Slides were 
then transferred to 250m1 saline and PBS for 5 minutes each. Slides were post-fixed by 
immersing in 80m1 freshly prepared 4% paraformaldehyde in PBS for 20 minutes. 
Slides were washed, drained and placed horizontally with 250m1 PBS twice for 5 
minutes each. Each tissue section was overlaid with 20µg/ml proteinase K in 50mM 
Tris HCI, 5mM EDTA, pH8.0 and left for 5 minutes. Excess liquid was shaken off and 
sections were washed with 250m1 PBS for 5 minutes. Slides were re-fixed with 4% 
paraformaldehyde using the same solution. Slides were washed in PBS for 5 minutes 
and placed in a container with 250 ml 0.1M triethanolamine HCl, pH 8.0, with a rapidly 
rotating stir bar in a fume hood. Next, 500µl acetic anhydride were added in and left for 
10 minutes. All slides were washed with 250 ml PBS for a few minutes. Slides were 
dehydrated by quickly passing through 250 ml 70%, 95%, and 100% ethanol for 3-5 
minutes each. Slides were then washed in chloroform for 5 minutes, 100% ethanol for 3- 
5 minutes and 95% ethanol for 3-5 minutes. Slides were air-dried for 1 hour at room 
temperature. 
2.5.7.2 Hybridisation 
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Storage trays were lined with Whatman filter paper soaked in 50% formamide and 
50m1 4X SSC. The labelled influenza NP probe was heated at 55°C, mixed quickly and 
kept on ice. Ninety microlitres of probe was applied to each tissue section on the slide, 
covered with a coverslip and hybridised in a 37°C incubator overnight. 
2.5.7.3 Post-hybridisation washing 
Coverslips of slides containing sections of tissues were removed by washing in 
250ml 2X SSC for 15 minutes. Slides were washed twice in 250ml 2X SSC containing 
lµ1 mercapprethonol for 15 minutes each at room temperature. Two washes in 250 1X 
SSC for 15 minutes each at 50°C, one wash in 250ml 0.2X SSC at 50°C for 15 minutes 
and two washes in 250ml 1X SSC for 1 hour each at room temperature were carried out. 
Finally, all slides were washed in 70%, 95% and 100% ethanol for 5 minutes each. 
Slides were then air-dried before autoradiography. Slides were exposed to X-ray film for 
between 3-7 days. 
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3.1 Introduction 
The first human influenza virus was not isolated until 1933 (Smith et al., 1933) 
and termed the WS strain of human influenza virus. Over the next decade many workers 
studied the pathology of influenza using this virus. In 1938 Burnet and Lush reported 
that the virulent mouse WS virus also produced haemorrhagic encephalitis in the chick 
embryo (Burnet and Lush, 1938). Stuart-Harris described the development of a human 
strain of the WS virus that multiplied in the brain of the mouse after direct intracerebral 
inoculation, named the NWS (neurovirulent WS) strain of influenza virus (Stuart- 
Harris, 1939). A similar neurovirulent WS strain was reported by Francis and Moore 
(1940) and was termed as the WSN strain of influenza virus. 
Many neurological disorders have been reported in patients following influenza A 
infections, including acute psychosis, encephalopathy, depression, Guillain-Barre 
syndrome, post-influenzal encephalitis, and polyneuritis (Leigh, 1946; Greenfield, 1950; 
Jennings, 1952; Dubowitz, 1958; Goodbody et al., 1958; Stuart-Harris, 1965). 
Historically, Menninger (1919,1920,1921,1922,1926) documented a 
comprehensive study of the problem of the association of post-influenzal and 
neurological complications in the 1920s which include psychosis, epilepsy, melancholy 
and melancholia, and Schizophrenia. During the decade 1919-1928, there were more 
than a million cases of severe neurological disease, encephalitis lethargica (Von 
Economo's Disease or sleepy sickness), and which has been identified as the precursor 
of most of the post-encephalitic Parkinsonian disease occurring since that time 
(Poskanzer et al., 1963). In addition, many cases of encephalitis 
lethargica, both fatal 
and non-fatal, were described by Dubowitz 
1958, Goodbody and McGill 1958, Smith 
1958, Dunbar et al. 1958 which associated with attacks of influenza-like 
illness and 
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occurring at a time when Asian influenza (1957 pandemic) was prevalent. Wells et al. 
(Wells et al., 1959; Wells, 1971) documented positive sera from cases of neurological 
complications after infection with influenza virus A (1957/H2N2 and 1968/H3N2 
pandemics). 
Studies by Mattock et al. (1988) suggested that intrauterine influenza might act as 
a predisposing factor to the development of idiopathic Parkinson's disease in later life. 
Mattock et al. in 1988 therefore proposed that influenza was an obvious candidate 
cytotoxic agent to the developing foetal substantia nigra and resulting in later 
neurological complications in the afflicted individual. Encephalopathy associated with 
influenza epidemics have been reported by Japanese workers (Fujimoto et al., 1998; 
Togashi et al., 1997 and 1999; Mori et al., 1999; Hakoda et al., 2000; Kasai et al., 
2000). Fujimoto et al. (1998) detected influenza A sequences in cerebrospinal fluid 
samples using a PCR technique from 5 out of 7 patients who had evidence of recent 
influenza infection. 
The aim of the present animal model experimental series was two-fold. Firstly, it 
was to establish a model system of influenza virus replication in the mouse brain via 
intracerebral infection with neurovirulent influenza A NWS and WSN viruses. Samples 
of such brain could be used in parallel studies of human brain from EL material patients. 
Secondly, we wished to search for possible persistent influenza infection in the brain of 
infected animals that could also act as a model of encephalitis lethargica influenza 
potentially caused by influenza virus. 
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3.2 Results of Part A: NWS studies 
3.2.1 An animal model system of influenza virus replication in mouse brain via 
direct intracerebral infection with NWS virus (Table 3.1) 
The model used Swiss CD I strain female mice approximately 3 to 4 weeks old 
with an average weight of 16.6g. Eight groups of animals were intracerebrally 
inoculated with influenza A NWS virus with a series of 10-fold virus dilutions (Table 
3.1). A general observation was that all the mice in Groups I to V inclusive which 
received the highest concentrations of virus were ill on day 3. However, mice in Groups 
VI to VIII inclusive receiving the lower concentrations of virus remained well. 
Clinically, mice in Groups I-V huddled together with raised hair in the corner of a cage, 
depressed and lethargic. Further obvious signs of illness became more apparent with 
agitated movements from days 7 to 11 post-infection. The behaviour of the infected 
mice became more settled from day II onwards. 
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3.2.2 Study of longevity of infection after intracerebral inoculation of mice with 
influenza A NWS virus 
The aim of this study was to isolate influenza A NWS virus from intracerebrally 
inoculated mice at different time intervals. In addition, the longevity of infection and 
immune response was investigated in seven groups of mice. Mouse brain samples were 
also investigated for the presence of influenza virus RNA by PCR. 
Six mice in Group I received a 10-1 virus dilution. Mice showed severe signs of 
illness on day 3 post-infection. Two mice were sacrificed on days 3,4, and 5. One 
mouse had an HI titre of 40. Other mice had HI titres of <20. Influenza A NWS virus 
was isolated in eggs from each mouse brain sacrificed on days 3,4 and 5. Sections from 
other mouse brains sacrificed on days 4 and 5 showed inflammatory responses, 
meningitis and ventriculitis by in situ hybridisation (see Chapter 5). 
Six mice in Group II received a 10-2 virus dilution. Signs of illness appeared on 
days 3 and 4 post-infection. One death occurred on day 5. Three critically ill mice were 
sacrificed on day 3. The serum HI titres of the three mice were < 20. One of the two 
mice sacrificed on day 4 had HI titres of 80; the other was < 20. Influenza virus was 
isolated in eggs from three mouse brains sacrificed on day 3 and from a mouse brain 
sacrificed on day 4. Sections from a mouse brain sacrificed on day 4 showed 
inflammatory responses, meningitis and ventriculitis (see Chapter 5). 
Six mice in Group III received a 10-3 virus dilution. Mice were ill on day 3 post- 
infection. Two mice sacrificed on day 3 had HI antibody titres of < 20. Two mice 
sacrificed on day 4 had HI titres of 20 and 40 respectively. Influenza virus was isolated 
from two mouse brains sacrificed on day 3, from a mouse brain sacrificed on day 4 and 
94 
Chapter 3 Studies of influenza virus replication 
from two mouse brains sacrificed on day 5. Sections from a mouse brain sacrificed on 
day 4 showed inflammatory responses and ventriculitis (See Chapter 5). 
Six mice in Group IV received a 10-4 virus dilution. One death occurred on day 4 
following intracerebral infection. Influenza virus was isolated from each mouse brain 
sacrificed on days 4 and 5. Sections from each of the other mouse brains sacrificed on 
days 4 and 5 showed inflammatory responses and ventriculitis. No influenza virus was 
isolated from a mouse brain sacrificed on day 12. The HI titres for the 5 mice were < 20. 
Six mice in Group V received a 10-5 virus dilution. Signs of illness were observed 
on day 3 post-infection. Two mice sacrificed on days 5,12 and 18 had HI titres of < 20. 
Influenza virus was not isolated from the brains of mice sacrificed on days 5,12 and 18 
respectively. Sections from the other mouse brain sacrificed on day 5 showed slight 
inflammatory responses, whilst sections from a mouse brain sacrificed on days 12 and 
18 showed no pathological changes of infection. 
Six mice in Group VI received a 10-6 virus dilution. Mice showed much less 
illness compared to Groups I to V from day 3 post-infection. No influenza virus was 
isolated from the brain. Sections from mouse brains sacrificed on days 5,12, and 18 
showed no pathological changes of infection. 
Four mice in Group VII, the Control group, received sterile PBS"A". Mice were 
healthy from day 3 following intracerebral infection. Histological study showed no 
pathological changes of infection. 
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3.2.3 Long term detection of influenza nucleotide sequences from mouse brain 
samples infected intracerebrally with NWS (Fig 3.1, Table 3.2) 
In this study, 166 bp fragments of influenza NS 1 gene were detected in a mouse 
brain sample from Group I of the first study sacrificed on day 10, a mouse brain sample 
from Group III of the first study sacrificed on day 10 and from two mouse brain samples 
from Group V of study 2 sacrificed on day 7. 
Influenza NS 1 gene sequences were detected in three mouse brain samples from 
Groups IV, V and VI of the third study sacrificed on day 5, from two mouse brain 
samples from Group I of the third study sacrificed on day 6 and from two mouse brain 
samples from Group II of the third study sacrificed on day 6. 
Influenza NS 1 gene sequences were detected in a mouse brain sample from Group 
V of the fourth study sacrificed on day 18 (Fig 3.1, Lower Block, Lane 2), from three 
mouse brain samples from Groups I, II and III of the third study sacrificed on day 5 
respectively (Fig 3.1, Lower Block, Lanes 4-6). 
Of particular interest influenza RNA was detected in two mouse brain samples 
sacrificed on day 70 from Group V of the second study (Fig 3.1, Upper Block, Lanes 4- 
5), from two mouse brain samples sacrificed on day 70 from Group VI of the second 
study (Fig 3.1, Upper Block, Lanes 6-7), and from a mouse brain sample sacrificed on 
day 70 from Group VH of the second study (Fig 3.1, Upper Block, Lane 8) following 
intracerebral infection with influenza A NWS virus. 
Detection of influenza nucleotide sequences using nested PCR amplification from 
mouse brain samples sacrificed at various time intervals following intracerebral 
infection with influenza A NWS virus is shown in Table 3.2. The results were 
reconfirmed by PCR. 
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Fig 3.1: Detection of influenza NS gene sequences of 166 bp by nested PCR from 
mouse brain samples sacrificed at different time intervals following intracerebral 
infection with influenza A NWS virus. 
M indicates the maker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper Block: Lanes 1-2, two mouse brain samples from Group VII of the second study sacrificed on day 
49. Lane 3, a mouse brain sample from the control group of the second study sacrificed on day 49. Lanes 
4-5, two mouse brain samples from Group V of the second study sacrificed on day 70. Lanes 6-7, two 
mouse brain samples from Group VI of the second study sacrificed on day 70. Lanes 8-9, two mouse brain 
samples from Group VII of the second study sacrificed on day 70. Lane 10, a mouse brain sample from 
Group V of fourth study sacrificed on day 5. Lane 11, a mouse brain sample from Group VI of the 
fourth study sacrificed on day 5. Lane 12, a mouse brain sample from Group V of the fourth study 
sacrificed on 12 day. 
Lower Block: Lane 1, a mouse brain sample from Group VI of the fourth study sacrificed on day 12. 
Lane 2, a mouse brain sample from Group V of the fourth study sacrificed on day 18. Lane 3, a mouse 
brain sample from Group VI of the fourth study sacrificed on day 18. Lanes 4-6, three-mouse brain 
samples from Groups I, II and III of the third study sacrificed on day 5 respectively. Lane 7, a water 
control of X4. Lane 8, a nested water control of X I. Lane 9, a nested water control of X2. Lane 10, a 
nested water control of X3. Lane 11, a water control of X4. Lane 12, a nested positive control 
for 
influenza sequences. 
ý. 
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3.3 Results of Part B: WSN studies 
3.3.1 WSN virus infection in mouse brains following intracerebral inoculation 
A study was performed to investigate virus replication in the brains of mice using 
an alternative neurovirulent influenza A virus namely WSN following intracerebral 
infection. The model involved Swiss CD I strain female mice approximately 4 to 5 
weeks old. Eight groups of animals were intracerebrally inoculated with 10-fold serial 
virus dilutions. 
Six mice in Group I received a 10-1 virus dilution. A general observation was that 
all the mice in Groups I to V inclusive were ill from days 3 to 7 post-intracerebral 
infection. In contrast mice in Groups VI to VIII inclusive were well. No deaths occurred 
during the first five weeks post infection. Mice became healthy from day 7 in 
comparison with observations from the control group. The serum HI antibody titres for 
the six survivors were 160 and 320: two mice had HI titres of 160 and the other four had 
HI titres of 320. 
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3.3.2 WSN virus infection via intracerebral and intranasal routes 
A second study (Study 2) involved a more comprehensive model for investigation 
of a persistent infection of influenza A WSN virus in the brain of mice using the results 
and findings obtained from the first study described above. The model involved Swiss 
CD1 strain of female mice approximately 3 to 4 weeks old with an average weight of 16 
to 17g. Four groups of animals were intracerebrally inoculated with WSN virus whilst 
another four groups of animals in parallel were inoculated intranasally with the same 
Virus. 
3.3.2.1 Clinical course and serological results (Table 3.3) 
(i) Intracerebral infection 
Eight mice in Group I received a 10-1 virus dilution (Table 3.3). One mouse was 
sacrificed on days 4,5, and 6 when obvious signs of illness were seen. Further mice 
were sacrificed on days 28,35,42,49 and 56. Mice sacrificed on days 4,5 and 6 had HI 
antibody titres of < 10, _< 
10 and 20 whilst high HI titres were obtained from mice 
sacrificed on days 28,35,42,49 and 56. 
Eight mice in Group II received a 10-2 virus dilution. Two mice were sacrificed on 
days 4,5 and 6 based on the severity of illness seen. These six mice had HI titres of < 
10, <_ 10 and 15. Further mice were sacrificed on days 28 and 35 and 
had HI antibody 
titres of 80 and 60. No deaths occurred in this group. 
Eight mice in Group III received a 10-4 virus dilution. One 
death occurred on day 6 
post-intracerebral infection. Two mice were sacrificed on 
day 4 and one mouse was 
sacrificed on days 5 and 6 on the basis of their severity of 
illness. These four mice had 
HI titres of < 10 or <_ 10. One mouse sacrificed on 
days 28 and 35 had HI titres of 20 and 
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80 respectively. Two mice in Group IV, the control group, received sterile PBS"A" 
Two mice sacrificed on days 5 and 56 from the control group had HI titres of < 10. 
(ii) Intranasal infection 
Five mice in Group I received a 10-1 virus dilution (Table 3.3). Mice showed more 
severe illness than the intracerebral inoculation groups from days 3 to 7 post-intranasal 
infection. One mouse died on day 7. Mice sacrificed on days 4 and 7 had HI titres of < 
10. 
Five mice in Group II received a 10-2 virus dilution. Mice were less ill than Group 
I post-intranasal infection. One death occurred on the first day. Mice sacrificed on days 
4 and 5 had HI titres of < 10 whilst mice sacrificed on days 28 and 35 had HI titres of 80 
and 60 respectively. 
Six mice in Group 1111 received a 10-4 virus dilution. Mice were less ill than Group 
I from days 3 to 7 post-intranasal infection. One mouse sacrificed on day 4 had an HI 
titre of < 10. Mice sacrificed on days 28,35,42,49 and 56 had HI titres of 320,10,120, 
120, and 160 respectively. 
Two mice in Group IV, the control group, received sterile PBS"A". Mice 
sacrificed on days 5 and 56 had HI titres of < 10. 
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Chapter 3 Studies of influenza virus replication 
3.3.2.2 PCR detection of influenza gene sequences from homogenates of mouse 
organs following intracerebral and intranasal infection with WSN virus (Tables 
3.4-3.5) 
Influenza nucleotide sequences were detected from mouse brain samples 
following intracerebral infection and, from mouse lung and heart samples following 
intranasal infection using both rounds of PCR amplification (Table 3.4). Influenza 
sequences were not detected from other organs (lungs, kidneys, ' spleens, sera, livers and 
hearts) from groups of mice sacrificed at various time intervals following intracerebral 
infection, suggesting that influenza A WSN virus had not infected and replicated in 
other parts of tissues apart from brain following intracerebral route of infection (Table 
3.4). 
Influenza nucleotide sequences were detected in mouse brain samples from 
Groups I, II and III sacrificed on days 4 and 5 and in a mouse brain sample from Group 
III sacrificed on day 6 post-intracerebral infection by the first round of PCR. Shorter 
viral sequences were detected using nested PCR in mouse brain samples from Groups I, 
II and III sacrificed on days 4,5 and 6 and in mouse brain samples from Group I 
sacrificed on days 28 and 35. It was noted that shorter nucleotide sequences of influenza 
were only detected using nested PCR from mouse brain samples from a group of mice 
infected with highest infective viral particles (Group I) when mice were sacrificed at 
week intervals (Table 3.5). 
Of particular interest, influenza nucleotide sequences remained detectable from 
homogenates of a brain sample from a mouse sacrificed on day 35 using nested PCR 
amplification. 
Influenza gene sequences were detected by both rounds of PCR in homogenates of 
mouse lung samples from animals from Group I, II and III sacrificed on day 4, from 
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Group II sacrificed on day 5 and from Group III sacrificed on day 7 following intranasal 
infection with WSN virus. Influenza gene sequences were also detected by both rounds 
of PCR in homogenates of mouse heart samples from Groups I, II and III sacrificed on 
day 4, from Group II sacrificed on day 5 and from Group I sacrificed on day 7 (Table 
3.5). Homogenates from heart and lung samples were analysed separately on two 
occasions. No influenza sequences were detected in homogenates of mouse brain, 
kidney, liver, serum, and spleen samples following intranasal infection with WSN virus 
(Tables 3.4 and 3.5). 
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Chapter 3 Studies of influenza virus replication 
Table 3.5: Detection of influenza nucleotide sequences (NP/NS sequences) by both 
rounds of PCR from homogenates of mouse brain, lung and heart samples following I. C. 
or I. N. infection with influenza A WSN virus 
Mice sacrificed on f. U. / Brain: I. C. /Brain: 1. N. / t. N. / Heart: 
Day: Group / virus PCR / NP n. PC"R / NP 1., u n g: ii PUR I NS 
dilution nPCR / NS 
D4: Group I/ 10-1 ++++ 
Group II / 10-2 +/ +* +/+++ 
Group III/ 10-4 
D5: Group I/ 10' ++ 
Group 11/ 10-2 
Group III / 10-4 ++ 
D6: Group I/ 10' 0+ 
+/+ Group II / 10-2 0/0 
Group 1111 / 10-4 ++ 
D7: Group I/ 10' +/+/+ +/+/+ 
D28: Group I/ 10-` 0+ 
Group II/ 10-2 0000 
Group HI/ 10-4 0000 
D35: Group I/ 10-` 0+ 
Group II / 10-2 0000 
Group III / 10-4 0000 
D42: Group I/ 10-` 00 
Group III / 10-4 00 
D49: Group I/ 10-' 00 
Group III / 10-4 00 
0 D56: Group 111 /10-4 
* each + indicates a single mouse was sacrificed and was analysed 
by PCR 
+ indicates detection of influenza sequences by PCR and/or nPCR 
0 indicates no detection of influenza sequences by PCR and/or nPCR 
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3.4 Discussion 
We have studied general patterns of influenza infection with influenza A NWS 
and influenza A WSN viruses in the brains of mice. The first experiment of the NWS 
model gave a full picture of NWS virus replication in the brains of mice and was studied 
through clinical observations and serological studies. Mice become sick and many die 
from day 3 to day 8 post-intracerebral infections from groups intracerebrally inoculated 
with the lower, most concentrated, virus dilutions. Mice showing signs of neurological 
illness have been observed from day 3 to day 7 before death, and most deaths occur on 
days 6 and 8 post-intracerebral infection. Mice infected with the lower dilution series of 
egg-grown influenza A NWS virus (Group VI - VII) showed mild discomfort and no 
deaths were recorded throughout the period of infection. A consistent clinical picture 
was observed from day 3 to day 7 post-intracerebral infections in the second study of 
NWS virus infection. 
The earliest detectable HI antibodies from sera of sacrificed mice appears on day 4 
post-intracerebral infection, indicating that infection of influenza has occurred early in 
the brains of mice and a rapid immune response has been developed by infected mice. 
The serum HI antibodies are detected on day 7 post-intracerebral infection, 
demonstrating that mice have developed a protective immunity against influenza A 
NWS infection in survivors from Groups I-VI. 
Infectious influenza virus could not be isolated using conventional techniques 
from infected mouse brains sacrificed after day 6 post-intracerebral infections. Influenza 
A NWS virus replicated in the brains of mice during its acute infection ranging from 
day 
1 to day 5 and virus was isolated from mouse brains sacrificed on those days post- 
infection. 
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On the other hand, the detection of influenza genes from some of those mouse 
brains using nested PCR has suggested that parts of the NWS gene group remain in the 
mouse brain following intracerebral infection but are incapable of inducing a full cycle 
of virus replication within the infected brain tissues. Alternatively a low degree of 
replication may occur requiring more sensitive co cultivation techniques for detection. 
In the present NWS study, a most surprising result was the detection of influenza 
nucleotide sequences from intracerebrally infected mouse brain samples in samples on 
day 70 following intracerebral infection with NWS virus. Those mice had been infected 
with higher viral dilutions (Groups V-VII) and showed no symptoms during the course 
of acute infection. 
This finding could be extrapolated to suggest a potential persistent influenza 
infection in the central nervous system from survivors of infected human subjects. The 
NWS antigen was demonstrable from brains of patients who suffered from post- 
encephalitic Parkinsonism (Gamboe et al., 1974). Parts of the influenza A NWS genome 
may exist in a defective form in infected mouse brains or there may be a low level of 
viral replication. Defective genomes may be incapable of inducing a full cycle of virus 
replication but enable the virus to persist and to trigger later complications in the central 
nervous system (CNS) months or years after its initial acute infection. It is well 
documented that the rare neurological disease, subacute sclerosing panencephalitis 
(SSPE), is caused by a persistent measles virus infection (Cattaneo et al., 1987; 
Swoveland et al., 1989; Schneider-Schaulies et al., 1990; Schmid et al., 1992). Virus 
can be recovered by sensitive co cultivation methods. It seems reasonable to suggest that 
other negative strand RNA viruses such as influenza virus could induce persistent 
infection in the CNS and possibly trigger late neurological complications in humans. 
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In the WSN study, a significant numbers of mice were found dead with obvious 
sickness and weight loss on days 6 and 7 post-intracerebral infection, which was similar 
to the results obtained from the NWS study. Influenza nucleotide sequences were not 
detected in mouse kidneys, heart, liver, lung, sera, spleen, stomach from mice 
intracerebrally infected with influenza A WSN virus. Therefore we concluded that the 
influenza virus can only replicate in the brain tissues of infected mice during its acute 
infection by direct intracerebral inoculation. However, the results have shown that 
influenza WSN virus also has a biological property in persistent infection in the brains 
of infected mice since short segments of influenza sequences remain detectable after a 
long period of time following intracerebral infection. The detection of influenza gene 
sequences can be traced up to day 35 from mouse brain samples intracerebrally infected 
with the highest number of viral particles and detected by nested PCR. In contrast, 
detection of short influenza sequences is traced up to day 70 from mice intracerebrally 
infected with lower numbers of NWS viral particles (see above). 
An unexpected finding was that mice survived from WSN infection in Group I, 
which was intracerebrally infected with the lowest viral dilution (viz. the most 
concentrated virus). This may reflect the presence of von Magnus or defective virions in 
the WSN sample (von Magnus, 1951 and 1954; Dimmock et al., 1986; Dimmock, 1996; 
Duhaut et al., 2000 and 2002). 
The overall comparison between the two animal model studies suggest by 
extrapolation that a persistent infection of influenza could possibly occur either 
in the 
infected brains of humans with obvious clinical symptoms and illness or in humans who 
were mildly attacked by influenza virus with asymptomatic or mild 
discomfort. Within 
the two opposite ranges of infected subjects, subjects would either 
die or the survivors 
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could develop later neurological complications. We have not investigated whether 
influenza infected mice observed for long periods of time could also develop late 
neurological symptoms, but this is worthy of further research. 
However, according to the present studies using animal models (NWS and WSN), 
a hypothesis of a persistent neurological influenza infection is proposed, which could 
provide an explanation for encephalitis lethargica being triggered many years after an 
initial influenza infection. The simple hypothesis is also deduced on the basis of the two 
sets of results obtained from the two animal models. For the Swiss CD 1 strain of mouse, 
the average life span is 2 to 3 years (equivalent to 728 - 1092 days) compared to the 
average life span of a human of 60 to 70 years (21840 - 25480 days). In the case of 
influenza NWS virus used for intracerebral infection in the mouse and extrapolating to 
humans, short nucleotide sequences of influenza in the brain of infected subject might 
be expected to remain detectable during the period of 3.8 to 6.7 years post-infection 
since influenza sequences were detected up to the day 70 post-intracerebral infections in 
the brains of mice. In the case of influenza A WSN virus used for intracerebral infection 
and extrapolating to humans: short nucleotide sequences of influenza might be expected 
to remain detectable in the brain of infected human for at least during the period of 1.9 
to 3.3 years since influenza sequences were detected up to the day 35 post-intracerebral 
infection in the brains of mice. 
Therefore by extrapolation if a human was infected by a potentially neurovirulent 
influenza virus circulating in the community, the length of time during which influenza 
virus might trigger neurological complications or defects in the brain tissues could 
be 
expected to be within 1.9 and 6.7 years after initial exposure to 
infection. The length of 
time that short segments of influenza sequences may remain 
demonstrable from the 
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brain tissues of infected subjects among initial survivors using molecular technique 
would be within a period of 1.9 to 6.7 years. The survivors may live for years with no 
obvious signs of symptoms and illness until the lesions of the brain tissues and their 
related functions produce more adverse effects or damage manifesting in any form of 
later neurological symptoms or illness. The particular area of the brain tissues attacked 
by the virus during its initial exposure to influenza infection that may lead to more 
adverse lesions of the affected brain tissues has not been fully studied and is the subject 
of Chapter 5 of this thesis. 
We failed to detect influenza gene sequences from other organs of mice following 
intranasal infection, suggesting that the WSN virus was not infecting and replicating in 
tissues of organs other than heart and lung in a same mouse. It is interestingly to notice 
that nucleotide sequences of influenza were detected in mouse heart samples by both 
rounds of PCR amplification. Our results may imply that influenza virus can infect and 
replicate in the hearts of infected subjects during its acute infection. The replication of 
influenza virus in the hearts of infected mice might possibly occur through the 
pulmonary circulation when the oxygenated blood is returned to the atria of the heart by 
way of pulmonary veins from lungs during acute infection of influenza. The replication 
of influenza virus in the hearts of infected subjects may be strain-specific since 
influenza viruses have primarily been shown to replicate in the ciliated respiratory 
epithelial cells of the respiratory system. Our result also confirms the findings of other 
workers (Oseasohn et al., 1959) who isolated influenza virus from the bloodstream and 
heart of patients, although the isolation of virus seems to be dependent on the specific 
strain of the virus circulating at the time of epidemic or pandemic. In addition, the 
experimental finding may indicate that infection of influenza could 
lead to various heart 
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diseases such as myocarditis and pericarditis if the virus is replicating in the tissues of 
the heart in infected subjects. This has been recorded (Miura et al., 2001; Agnino et al., 
2002). 
It is unlikely that the presence of influenza nucleotide sequences from mouse heart 
samples was due to cross-contamination between mouse hearts and mouse lungs during 
dissection because simultaneous detection of influenza nucleotide sequences would be 
expected from blood samples from each of the same infected mice. We did not detect 
influenza RNA sequences in blood. The mouse heart and lung samples were repeatedly 
analysed by PCR, respectively. 
The overall results from the present study have suggested by extrapolation that 
influenza may induce persistent infection in the brains of a proportion infected subjects 
and trigger neurological complications months or years later after their initial exposure 
to infection. More studies are required to clarify the subject of influenza persistent 
infection in the model system particularly following intranasal infection. 
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4.1 Introduction 
The precise cause of the high mortality during the exceptionally severe pandemics 
of encephalitis lethargica and influenza of 1918 remains unknown. At present genetic 
analysis of HA and NA genes of 1918 influenza virus have failed to identify virulence 
motifs (Taubenberger et al., 1997 and 1999; Reid et al., 1999 and 2000). This 1918 
"Spanish" influenza was the worst infectious pandemic in the last century. Concomitant 
with the pandemic of influenza and extending to the late 1920s, encephalitis lethargica 
occurred in epidemic proportions. A previous epidemic of encephalitis lethargica also 
appeared at the time of the influenza pandemic of 1889 (Hall, 1924). In 1918, epidemic 
encephalitis was reported in many places such as Europe, Australia and USA in the 
months of September and October, coinciding with the deadly 2nd wave of 1918 
influenza (Hall, 1924; Crafts, 1927). Studies by Gamboe. et al. (1974) demonstrated the 
presence of influenza antigen in brain from cases of postencephalitic Parkinsonian 
patients, although others have not confirmed this observation. In particular Ravenholt 
and Foege (1982) suggested that the influenza virus of 1918 was the responsible agent 
for causing encephalitis lethargica and collected strong circumstantial data to support 
the association. 
During the past decade, the polymerase chain reaction (PCR), which is based on 
the sequential replication of a target nucleotide sequence, has been the most commonly 
used gene amplification technique. The sensitivity and specificity of PCR in detecting 
target sequences have been applied to both fresh tissues and old formalin-fixed and 
paraffin blocked sections (Shibata et al., 1988; Jackson et al., 1989 and 1990; Woodall 
et al., 1993). Thus, it was of interest to study clinical brain samples from patients who 
died of epidemic encephalitis prior to, during, and post-pandemics of the two diseases 
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so as to give a better understanding as to whether the two diseases were possibly caused 
by the same infectious agent, viz. influenza A virus. 
The aim of this study was to investigate at the molecular level the presence of 
influenza genetic material (nucleotide sequences) in human brain samples using a 
specifically established PCR assay and subsequently to characterise the influenza 
sequences if there was any positive detection for the influenza genome among clinical 
samples. We wished to compare such material with isolates with influenza viruses from 
the 1930's to detect major sequence changes which could correlate with virulence 
including neurovirulence. In the previous Chapter we describe the infection of mouse 
brains with influenza A NWS virus which were sacrificed at time intervals post- 
infection. Formalin fixed and paraffin wax-embedded brain samples were firstly studied 
for the development of the PCR technology and to act as positive controls (refer to 
Chapter 3). Both fresh and old paraffin wax-embedded mouse brain sections were then 
studied to establish the sensitivity by PCR in order to optimise a PCR assay for this 
project. Subsequently eight carefully characterised brain samples from patients who died 
of encephalitis lethargica in 1916-1920 in London Hospital were examined by PCR 
analysis for the presence of influenza gene sequences. 
During the course of this project, studies by Taubenberger et al. (1997) 
demonstrated the presence of influenza sequences in a paraffin wax-embedded lung 
sample from a victim of the 1918 influenza pandemic. Their subsequent characterisation 
of the influenza virus has provided evidence that the sequences of the influenza HA and 
NA genes were consistent with a novel H1N1 influenza A virus that formed a subgroup 
of strains of human origin rather than the swine or avian subgroups (Taubenberger et al., 
1997; Reid et al., 1999). 
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4.2 Results 
4.2.1 Detection of (3-actin and influenza sequences from sections of paraffin wax- 
embedded influenza infected mouse brain (Figs 4.1 - 4.2) 
PCR laboratories and a methodology for detecting influenza sequences were 
established using egg-grown influenza A virus (data not shown). The primers selected 
for influenza genes of nucleoprotein (NP), matrix protein (M), non-structural protein 
(NS), and haemagglutinin protein (HA) were assessed using different strains of egg- 
grown influenza A viruses and both infected, uninfected and paraffin wax-embedded 
mouse brain sections as clinical samples. 
A brain sample from a mouse sacrificed on day 4 post-intracerebral infection with 
influenza A NWS virus, was formalin-fixed for six months prior to paraffin wax- 
embedding and sectioned in 5µM thickness for studying the effects of using gene- 
specific primers and random hexamers in the RT-step on PCR (Figs 4.1 and. 4.2). In this 
study, fragments of ß-actin and influenza gene sequences were detected in sections of 
paraffin wax-embedded mouse brain using random hexamers for ß-actin gene and a 
segment-specific primer for influenza gene during cDNA synthesis (Fig 4.1). The same 
sizes of fragments of ß-actin and influenza gene sequences were detected in different 
sections of the same paraffin wax-embedded mouse brain sample using random 
hexamers during cDNA synthesis (Fig 4.2). 
ß-actin gene sequences were detected successfully in sections of paraffin wax- 
embedded mouse brain by nested PCR ( Fig 4.1; Upper Block, Lanes 1-6; Fig 4.2; 
Upper and Lower Blocks, lanes 3-4), using random hexamers during cDNA synthesis, 
with the correct product size of 274 bp. Sequences of influenza M, NP, and NS 
segments were amplified successfully by nested PCR with the correct product sizes of 
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117 bp, 159 bp and 166 bp respectively by using segment-specific primers for cDNA 
synthesis (Fig 4.1; Lower Block: Lanes 1-2,3-4, and 5-6, respectively). 
Influenza NP gene sequences were detected by nested PCR in sections of paraffin 
wax-embedded infected mouse brain with the correct size product of 159 bp (Fig 4.2; 
Lower Block, Lanes 1-2), when a segment-specific primer (NP/44/1) was replaced by 
random hexamers during cDNA synthesis. 
The results from both Figs 4.1- 4.2 show that targeted sequences of nucleic acids 
for influenza NP and ß-actin genes were detected in sections of paraffin wax-embedded 
mouse brain by PCR amplification using either a segment-specific primer or random 
hexamers for cDNA synthesis. The sensitivity and specificity for detecting targeted 
sequences of nucleic acids were increased by the second (nested) round of PCR from 
sections of paraffin wax-embedded brain tissues. The NP gene sequences were detected 
in each case only in nested PCR 
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- 274bp 
166bp 
F- 159bp 
ll 7bp 
Fig 4.1: Detection of target ß-actin and influenza M, NP and NS gene sequences by 
nested PCR with each product size of 274 bp, 117 bp, 159 bp and 166 bp from sections 
of influenza A NWS virus-infected and paraffin wax-embedded mouse brain tissues 
using a segment-specific primer for each influenza cDNA synthesis 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper Block: Lanes 1-6, six sections of paraffin wax-embedded mouse brain. Lane 7, a positive PCR 
control for unfixed influenza virus-infected mouse brain tissue. Lanes 8-9, water negative controls of PCR 
(X3, X4). 
Lower Block: Lanes 1-2, two sections of paraffin wax-embedded infected mouse brain with M/32/1 as a 
segment-specific primer in cDNA synthesis. Lanes 3-4, two sections of paraffin wax-embedded infected 
mouse brain with NP/44/1 as a segment-specific primer in cDNA synthesis. Lanes 5-6, two sections of 
paraffin wax-embedded infected mouse brain with NS/540/1 as a segment-specific primer in cDNA 
synthesis. 
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Fig 4.2: Detection of target ß-actin and influenza NP gene sequences by both rounds of 
PCR amplification with each pair of product sizes of 373/274 bp and 283/159 bp from 
sections of influenza A NWS virus-infected and paraffin wax-embedded mouse brain 
tissues using random hexamers during cDNA synthesis 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. Upper 
block showed the first round of PCR products, whereas lower block was the nested PCR products. 
Upper and. Lower Blocks: Lanes 1-2, two sections of NWS-infected mouse brain for the 
detection of 
influenza NP sequences. Lanes 3-4, two sections of NWS-infected mouse brain for the detection of 
3- 
actin sequences. Lane 5, a section of mouse brain from an uninfected mouse 
brain as a negative control for 
influenza PCR introduced in the step of deparaffinisation. Lane 6, a negative control (K1) introduced in 
the proteinase K digestion step. Lane 7, a positive influenza PCR control 
introduced in the cDNA 
synthesis step. Lane 8, a negative influenza B control introduced in the cDNA synthesis step as a negative 
control for influenza NP sequences. Lane 9, water control 
(X1) introduced in RNA extraction step. Lane 
10, water control (X2) in the cDNA synthesis step. Lane 
11, water control (X3) introduced in the first 
round of PCR amplification. Lane 12 in Lower 
Block, water control (X4) introduced in the nested PCR. 
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4.2.2 Optimisation for proteinase K incubation temperature of 42°C or 55°C with 
and/or without addition of RNase inhibitors during cDNA synthesis (Table 4.1 and 
Figs 4.3 - 4.5) 
The brain of a mouse, sacrificed on day 4 following intracerebral infection with 
influenza A NWS virus, was formalin-fixed for six months prior to paraffin wax- 
embedding and sectioned 5µM in thickness for the PCR studies (mouse brain was from 
Chapter 3). A series of PCR comparison tests for optimising the best temperature for 
proteinase K digestion following deparaffinisation was conducted to obtain the best 
recovery of influenza RNAs from influenza A NWS virus-infected and paraffin wax- 
embedded mouse brain tissues. Concurrently, the PCR tests were performed to 
determine as to whether addition of RNase inhibitors would yield better quantities 
cDNAs from samples of paraffin wax-embedded tissues during reverse transcription. 
Random hexamers were used for all ten sections of a mouse brain during cDNA 
synthesis. Table 4.1 shows results from the ten sections of a mouse brain used for the 
optimisation tests of the PCR (Fig 4.3). 
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Table 4.1: Summary of the various conditions used for PCR optimisation tests from ten 
sections of a mouse brain sample 
Section of a mouse Proteinase K Proteinase K With or without 
brain digestion at digestion at 42°C addition of RNase 
55°C inhibitors 
1+-- 
2+-- 
3+-+ 
4+-+ 
5+-+ 
6-+- 
7-+- 
8-++ 
9-++ 
10 -++ 
+: Conditions used for detection of influenza RNA of the section 
-: Conditions not used for detection of influenza RNA of the section 
Influenza NP gene sequences with the correct product size of 283 bp were 
detected in five sections of a mouse brain incubated at 55°C during proteinase K 
digestion following deparaffinisation of each section using the influenza NP primers by 
the first round of PCR amplification (Fig 4.3; Upper Block, Lanes 1-5), whereas other 
sections of a mouse brain incubated at 42°C showed no detection of influenza gene 
sequences by the first round of PCR amplification. 
Influenza NP gene sequences were detected in ten sections of paraffin wax- 
embedded infected mouse brain by nested PCR at both 42°C and 55°C for proteinase K 
digestion following deparaffinisation of each section (Fig 4.3; Lower Block, Lanes 1- 
10). The results also show that addition of RNase inhibitors incorporated in the reverse 
transcription step during cDNA synthesis seems to have little or no effect on better 
recovery of influenza RNAs from mouse brain sample post RNA extraction. 
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+- 283bp 
F- 159bp 
Fig 4.3: Detection of influenza NP gene sequences of 283 bp and 159 bp by both rounds 
of PCR amplification from sections of influenza A NWS virus-infected and paraffin 
wax-embedded mouse brain using random hexamers for cDNA synthesis with and/or 
without addition of RNase inhibitors during reverse transcription 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper and. Lower Blocks: Lanes 1-2, two sections of a mouse brain digested with proteinase K at 55°C 
without RNase inhibitors during cDNA synthesis. Lanes 3-5, three sections of a mouse brain digested with 
proteinase K at 55°C with RNase inhibitors. Lanes 6-7, a section of mouse brain digested with proteinase 
K at 42°C without RNase inhibitors. Lanes 8-10, three sections of a mouse brain digested with proteinase 
K at 42°C with RNase inhibitors. 
The upper block shows analysis of first round PCR products, whilst the lower block shows results for the 
nested reactions. C indicates a positive control for amplification off an extract of a mouse brain infected 
with A/NWS/33 which had not undergone formalin-fixation and wax-embedding. 
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A PCR titration of templates using a 10-fold dilution from 1 in 10 to 1 in 105 from 
a previously synthesised cDNA was conducted to demonstrate an end-point for recovery 
of influenza RNAs from paraffin wax-embedded mouse brain samples to optimise the 
proteinase K incubation temperature of 42°C or 55°C after deparaffinisation (Fig 4.4). 
A 10-fold increased detection for influenza NP gene sequences was obtained from 
sections of mouse brain incubated at temperature of 55°C compared to the temperature 
at 42°C during proteinase K digestion following deparaffinisation of each section of a 
mouse brain using the nested PCR (Fig 4.4; Lower Block, Lanes 1-2 and 6-7). 
A 10-fold increased detection for ß-actin gene sequences was also obtained from 
sections of paraffin wax-embedded mouse brain sample incubated at 55°C following 
deparaffinisation of each section. Addition of RNase inhibitors during cDNA synthesis 
for both targeted influenza NP and ß-actin sequences do not show much difference in 
specific RNA enhancement post-extraction. 
Defined sequences of ß-actin genes were detected in different sections of 
influenza A NWS infected and paraffin wax-embedded mouse brain sample (Fig 4.5). 
Neither the temperature for proteinase K digestion following deparaffinisation of each 
section nor the presence or absence of RNase inhibitors during cDNA synthesis affected 
the amplification of ß-actin sequences using nested PCR. The present results have 
demonstrated that a temperature at 55°C for proteinase K digestion following 
deparaffinisation is more efficient for target RNAs to be amplified and detected using 
the nested PCR amplification. 
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Fig 4.4: Detection of influenza NP gene sequences of 159 bp by nested PCR from 10- 
fold serial dilutions of templates from 1 in 10 to 1 in 105 from sections of influenza A 
NWS virus-infected and paraffin wax-embedded mouse brain sample 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper Block: Lanes 1-5,10-fold dilutions of template from 1 in 10' to 1 in 105 from a section of a mouse 
brain sample digested with proteinase K at 42°C without RNase inhibitors. Lanes 6-10,10-fold dilutions 
of template from 1 in 10' to 1 in 105 from a section of a mouse brain sample digested with proteinase K at 
42°C with RNase inhibitors. Lane 11, a positive control for influenza NP sequences. 
Lower Block: Lanes 1-5,10-fold dilutions of template from 1 in 10' to 1 in 105 from a section of a mouse 
brain sample digested with proteinase K at 55°C without RNase inhibitors. Lanes 6-10,10-fold dilutions 
of template from 1 in 101 to 1 in 105 from a section of a mouse sample digested with proteinase K at 55°C 
with RNase inhibitors. Lanes 11-12, water negative controls of PCR (X3, X4). 
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Fig 4.5: Detection of ß-actin gene sequences of 274 bp by the nested PCR amplification 
using 10-fold serial dilutions of templates from 1 in 10 to 1 in 105 from sections of 
influenza A NWS virus-infected and paraffin wax-embedded mouse brain sample 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper Block: Lanes 1-5,10-fold dilutions of template from a section of a mouse brain digested with 
proteinase K at 42°C without RNase inhibitors. Lanes 6-10,10-fold dilutions of template from a section of 
a mouse brain digested with proteinase K at 42°C with RNase inhibitors during cDNA synthesis. Lane 11, 
a positive PCR control for ß-actin sequences. 
Lower Block: Lanes 1-5,10-fold dilutions of template from a section of a mouse brain digested with 
proteinase K at 55°C without RNase inhibitors. Lanes 6-10,10-fold dilutions of template from a section of 
a mouse brain digested with proteinase K at 55°C with RNase inhibitors. Lanes 11-12, water negative 
controls of PCR (X3, X4). 
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4.2.3 Detection of ß-actin and influenza gene sequences from sections of influenza 
infected mouse brain samples which were formalin-fixed and also ß-actin gene 
from samples of human brain from EL patients (Figs 4.6 - 4.7) 
It was of interest to investigate if the detection of targeted sequences of nucleic 
acids using PCR from sections of influenza A NWS virus-infected and paraffin wax- 
embedded mouse brain samples were affected by the length of time in formalin fixation 
prior to paraffin wax-embedding. Influenza RNAs might have degraded in clinical 
samples with time, particularly with respect to the clinical samples that had been 
formalin-fixed and paraffin wax-embedded since 1916. We also wished to study 
whether the ß-actin gene sequences could be detected from a human brain from a patient 
who did not die of encephalitis lethargica (262/96) after two years in paraffin wax 
embedding. It was uncertain whether nucleotide sequences of human ß-actin would 
remain detectable from the 1916-1920 samples. Additionally, sections from a human 
brain (262/96) was also pre-tested for both the absence of influenza gene sequences and 
the presence of ß-actin gene sequences. Mouse influenza A NWS virus-infected and 
uninfected brain samples, samples inoculated with different numbers of infective viral 
particles were sacrificed on day 3 or 4 post-intracerebral, were formalin-fixed for 6 or 7 
days prior to paraffin wax-embedding and were sectioned 5µM in thickness for the 
current PCR studies. The human brain sample was formalin-fixed for a week prior to 
paraffin wax embedding and was sectioned 5µM in thickness for the PCR studied (Figs 
4.6-4.7). 
Influenza NP gene sequences were not detected in two sections of a human brain 
sample from a patient who did not die of encephalitis lethargica 
(262/96) by both rounds 
of PCR (Fig 4.6; Upper Block, 
Lanes 1-2). Other sections from the same human brain 
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sample were later used as a negative control and were run in parallel with the studies of 
the 1916-1920 human brain samples for detection of influenza gene sequences starting 
at the deparaffinisation step. 
As expected influenza NP gene sequences were not detected in sections of 
uninfected mouse brain samples by both rounds of PCR amplification (Fig 4.6; Upper 
Block, Lanes 3-4) and, other sections from these mouse brains were also used as a 
negative control when later 1916-1920 brain samples were analysed by the PCR assay. 
Influenza NP gene sequences were detected with the correct product size of 159 
bp in sections of infected and paraffin wax-embedded mouse brain samples by nested 
PCR (Fig 4.6; Upper Block, Lanes 5-10), whilst influenza gene sequences were not 
detected in these sections by the first round of PCR amplification. Other sections from 
these mouse brain samples were used in later experiments as a positive PCR control run 
in parallel with ten sections of a human brain from the 1916-1920 samples. 
The recovery of influenza NP gene sequences from mouse brain samples was not 
influenced by the length of time in formalin-fixation prior to paraffin wax-embedding in 
comparison to Figs 4.1 - 4.5, where each of the mouse brain samples was formalin fixed 
for 6 months prior to paraffin wax-embedding. Other influenza gene sequences (NS and 
MP) were also detected from those mouse brain samples. Therefore the present study 
showed that PCR detection of influenza gene sequences from influenza infected mouse 
brain samples was not affected by prolonged formalin fixation prior to paraffin wax- 
embedding. 
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Fig 4.6: Absence of influenza NP gene sequences of 159 bp by the nested PCR from 
sections uninfected human brain (262/96), uninfected mouse brain, influenza A NWS 
virus-infected, formalin-fixed for 6-7 days and paraffin wax-embedded mouse brains 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper Block: Lanes 1-2, two sections of a human brain sample (262/96) who did not die of encephalitis 
lethargica. Lanes 3-4, two sections of a paraffin wax-embedded mouse brain following intracerebral 
infection with sterile PBS"A" (uninfected mouse brain). Lanes 5-6; two sections from a mouse brain from 
Group IV sacrificed on day 4 following intracerebral infection with influenza A NWS virus and formalin- 
fixed for 6 days prior to be paraffin wax embedding. Lanes 7-8, two sections of a mouse brain from Group 
III sacrificed on day 3 post intracerebral infection and formalin-fixed for 7 days prior to be paraffin wax 
embedding. Lanes 9-10, two sections of a mouse brain from Group III sacrificed on day 4 post-infection 
and formalin-fixed for 6 days prior to be paraffin wax embedding. 
Lower Block: Lane 1, a negative control (K1) introduced in the proteinase K digestion step. Lane 2, 
water control (XI) introduced in the RNA extraction step. Lane 3, water control (X2) introduced in the 
cDNA synthesis step. Lane 4, water control (X3) introduced in the first round of PCR amplification. 
Lanes, a negative control (X4) introduced in the nested PCR. Lane 6, a positive PCR control for influenza 
NP sequences. 
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ß-actin gene sequences were detected in sections of a human lung, a human brain, 
a mouse lung and a mouse brain by both rounds of PCR amplification (Fig 4.7). The 
recovery of ß-actin RNAs from sections of human and mouse tissues using PCR assay 
were not influenced by prolonged the length of time for tissues to be formalin-fixed 
prior to be paraffin wax-embedding in comparison with Fig 4.5. 
The results obtained from Figs 4.1 - 4.7 were used to develop the PCR assay for 
the studies of the 1916-1920 human brain samples. In general, random hexamers were 
used as a primer for reverse transcription throughout the analysis of the 1916-1920 
clinical samples. The incubation temperature for proteinase K digestion following 
deparaffinisation for each PCR studies was at 55'°C. During the cDNA synthesis 
following RNA extraction from sections of paraffin wax-embedded samples, the 
addition of RNase inhibitors was incorporated in each of the 1916-1920 PCR analysis. 
The detection of targeted sequences of nucleic acids using both rounds of PCR do not 
appear to be influenced by prolonged formalin fixation prior to be paraffin wax- 
embedding. Influenza genes were detectable from all sections of influenza virus infected 
and paraffin wax-embedded mouse brains using nested PCR. Finally, targeted sequences 
of ß-actin gene (RNA) were recoverable from all sections of tissues studied by both 
rounds of PCR amplification. 
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Fig 4.7: Detection of target ß-actin gene sequences of 373 bp and 274 bp by the first and 
nested PCR from sections of paraffin wax-embedded human brain (Control/96), mouse 
brain tissues following intracerebral infection with influenza A NWS virus 
M indicates the marker lane (pUC19/Sau3A) and shows bands of known size on a DNA ladder. 
Upper and Lower Blocks: Lanes 1-2, two sections of a human brain from a patient who did not die of 
epidemic encephalitis (Control/96). Lanes 3-4, two sections of an uninfected and paraffin wax-embedded 
brain from a mouse sacrificed on day 3 post intracerebral infection. Lanes 5-6, two sections of an 
uninfected and paraffin wax-embedded human lung from a patient who did not die of bronchopneumonia / 
pneumonia or epidemic encephalitis (134G/96). Lanes 7-8, two sections of a paraffin wax-embedded lung 
from a mouse sacrificed on day 4 post-intracerebral infection. Lane 9, negative water control (X3) 
introduced in the first round of PCR. Lane 10 in upper block and Lane 11 in lower block, an infected and 
paraffin wax-embedded mouse brain. Lane 10 in the lower block, negative water control (X4) for the 
nested PCR. 
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4.2.4 Analysis of the 1916-1920 human brain samples from patients with diagnosed 
encephalitis lethargica for the presence of influenza genes by PCR (Tables 4.2 - 4.3 
and Figs 4.8 - 4.11) 
Review of archived tissue samples 
Eight cases of EL were identified from the autopsy files at the Royal London 
Hospital for the years 1916-1920 for which formalin-fixed and paraffin wax-embedded 
brain samples were available. Original slides were available and old blocks were 
resectioned. Outline details are given in Table 4.2. A paraffin wax block of brain tissue 
from a patient who had died of Alzheimer's disease in 1996 was used as a negative 
control (262/96). 
The sections of brain from the eight archival cases of EL were reviewed 
histologically. The principal neuropathological finding in all but one case was a florid 
lymphocytic rhomboencephalitis, without either necrosis or viral inclusions. In four 
cases the cervical cord was also affected. The histological findings are summarised in 
Table 4.2. Limited clinical material was available for Case 1, a 3-year-old male, and 
despite having been diagnosed clinically as having EL, this could not be confirmed 
neuropathologically on the remaining tissue sections. Nevertheless, the autopsy report 
strongly suggested the original diagnosis of EL was correct. 
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Table 4.2: Main features of post-mortem samples from cases of encephalitis lethargica 
Case no: Sex Autopsy and Cause of Histological Findings 
and. year Age (yr) Death 
1.1916 M/3 Clinically, fulminating Sections of cerebral cortex, 
EL. Brain swelling. brain stem, thoracic cord are 
normal. 
2.1916 F/ adult EL. Clinical diagnosis 
botulism. 
3.1919 F/ 44 EL. 
Brain swelling. 
4.1920 M/ 17 EL. 
Brain swelling. 
5.1920 F/37 EL. Rapid loss of 
consciousness. Died 
within 24 hours. 
6.1920 M/ 41 Deterioration in 
conscious level over one 
week. 
Brain swelling. 
Perivascular inflammation in 
the pons and medulla. 
Widespread perivascular 
cuffing, principally in the 
brain stem and spinal cord. 
Meningoencephalitis, 
principally affecting the brain 
stem and spinal cord. 
Cerebral oedema, and 
inflammation in the brain 
stem. 
Inflammation in the upper 
brain stem. 
7.1920 M/0.25 EL. Inflammation in the upper 
Admitted unconscious brain stem and spinal cord. 
after a3 day illness. Died 
the same day. 
8.1920 M/ 17 EL. Extensive inflammation in the 
Bronchopneumonia and brain stem and upper cervical 
influenza. cord. 
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Ten sections from each paraffin-embedded human brain tissue 5µM in thickness 
were analysed by first and nested PCR amplification for the presence of defined 
influenza sequences using an optimised PCR technique described above. All 1916-1920 
human brain samples were studied one at a time with fresh sections of human uninfected 
brain tissue (Control/1996) and mouse uninfected brain tissue as negative controls, and 
a section of influenza A NWS virus-infected mouse brain tissue as the positive control 
run in parallel throughout the process from deparaffinisation to nested PCR along with 
other negative and positive controls. In each PCR analysis, ten sections were analysed 
(Figs 4.8 - 4.9). Templates of cDNAs derived from one section from each of the eight 
human brain samples were also analysed for the presence of influenza M and NS gene 
sequences using both rounds of PCR amplification (Figs 4.10 - 11). 
Ten sections of a 1919 human brain sample from a patient who died of 
encephalitis lethargica (Case 3,645/19) were studied by first (Fig 4.8a) and nested (Fig 
4.8b) PCR amplification for the presence of influenza NP gene sequences. Influenza NP 
gene sequences were detected in a positive control from the positive influenza RNAs 
introduced in the cDNA synthesis step and from the section of influenza A NWS virus- 
infected and paraffin wax-embedded mouse brain tissue run in parallel at the beginning 
of deparaffinisation through to the nested PCR amplification (Figs 4.8a and 
4.8b). All 
negative controls run in parallel with each step of the PCR process remained negative 
for the presence of influenza sequences, indicating that no cross-contamination of the 
PCR for the 1919 brain tissues being studied. The result shows that influenza NP gene 
sequences were not detected from the 10 sections of 
1919 human brain tissue (Case 3, 
645/19). 
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ß-actin genes were not only detected in recently uninfected and paraffin-embedded 
human brain tissues (Control/1996) and from infected and uninfected mouse brain 
tissues but also detected in all ten sections of paraffin-embedded 1919 human brain 
tissues (Case 3) by both rounds of PCR with defined sizes of PCR products: 373 bp and 
274 bp respectively (Figs 4.9a and 4.9b). 
Ten sections from each of the remaining seven 1916-1920 human brain samples 
from patients who died of encephalitis lethargica were similarly analysed on an 
individual basis using both rounds of PCR detection for the presence of influenza NP 
and ß-actin gene sequences. Influenza NP gene sequences were not demonstrable from 
any of the eight human brain samples. In contrast, ß-actin gene sequences were 
recoverable from all 10 sections from each of 8 human brain samples of 1916-1920. 
Further investigations were performed to determine if other nucleotide sequences 
of influenza genes might remain detectable from the 1916-1920 human brain samples 
using influenza primers of NS and M genes (Figs 4.1Oa - 4.1Ob and Figs 4.11 a-4.11 b, 
respectively). 
Influenza NS gene sequences with defined sequences of PCR products were 
detected in templates of influenza A NWS virus-infected mouse brain tissues and in a 
positive control for influenza (Figs 4.10a and 4.10b). Similarly, positive PCR signals 
showing detection of influenza M gene appeared in sections of influenza A NWS virus- 
infected mouse brain tissues and in a positive control for influenza (Figs 4.11 a and 
4.1 lb). However, neither influenza NS or M gene sequences were detected in the eight 
human brain samples from 1916-1920. Table 4.3 shows the absence of influenza NP, 
NS and M sequences but the presence of 
ß-actin sequences both rounds of PCR 
amplification from the 8 brain samples of the 
1916-1920. 
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Chapter 4 Studies of influenza genes in tissues 
Fig 4.8a: Absence of influenza NP gene sequences of 283 bp from ten sections of a 
paraffin wax-embedded human brain of a patient who died of encephalitis lethargica 
(Case 3/1919) by the first round of PCR amplification 
M indicates marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-10,10 sections of paraffin wax-embedded human brain tissue from a patient who 
died of encephalitis lethargica (Case3/1919). 
Lower Block: Lane 1, a section of paraffin wax-embedded human brain of a patient who did not die of 
epidemic encephalitis (Control/1996). Lane 2, a section of an uninfected and paraffin wax-embedded 
mouse brain following intracerebral infection with sterile PBS"A". Lane 3, a negative PCR control 
introduced in the proteinase K digestion step (K1). Lane 4, water control (X1) included in the RNA 
extraction step. Lane 5, water control (X2) introduced during cDNA synthesis. Lane 
6, water control (X3) 
introduced in the first round of PCR amplification. Lane 7, a positive PCR control for influenza sequences 
from a section of a paraffin wax-embedded mouse brain sacrificed on 
day 3 following intracerebral 
infection with influenza A NWS virus. Lane 8, a positive PCR control 
for influenza sequences introduced 
in the reverse transcription step. 
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Fig 4.8b: Absence of influenza NP gene sequences of 159 bp from ten sections of a 
paraffin wax-embedded human brain of Case 3/1919 by nested PCR amplification 
M indicates marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
In Fig 4.8b; the orders of lanes in both upper and lower blocks were the same as previously described in 
Fig 4.8a, except lanes 7-9 in lower block 
Lower block: Lane 7, water control introduced in the nested PCR. Lane 8, a positive PCR control for 
influenza NP sequences from a section of an influenza A NWS virus-infected and paraffin-embedded 
mouse brain. Lane 9, a positive PCR control for influenza sequences. 
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Fig 4.9a: Detection of ß-actin gene sequences of 373 bp from ten sections of a paraffin 
wax-embedded human brain of Case 3/1919 by the first round of PCR amplification 
M indicates the marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-10, ten sections of a paraffin wax-embedded human brain of Case 3/1919. 
Lower Block: Lane 1, a section of a paraffin wax-embedded human brain of Control/1996 from a patient 
who did not die of encephalitis lethargica as a negative PCR control for influenza. Lane 2, a section of 
uninfected and paraffin wax-embedded mouse brain as a negative PCR control for influenza. Lane 3, a 
section of an infected and paraffin wax-embedded mouse brain as a positive PCR control for influenza. 
Lane 4, a positive PCR control for influenza NP sequences introduced in the cDNA step. Lane 5, water 
control (X3) introduced in the 1St round of PCR amplification for ß-actin gene. 
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Fig 4.9b: Detection of ß-actin gene sequences of 274 bp from ten sections of a paraffin 
wax-embedded human brain of a patient who died of encephalitis lethargica (Case 
3/1919) by nested PCR 
M indicates the marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-10, ten sections of paraffin wax-embedded human brain tissue of Case3/1919. 
Lower Block: Lane 1, a section of a paraffin wax-embedded human brain of Control/1996 from a patient 
who did not die of encephalitis lethargica as a negative PCR control for influenza. Lane 2, a section of an 
uninfected and paraffin wax-embedded mouse brain as a negative PCR control for influenza. Lane 3, a 
section of an infected and paraffin wax-embedded mouse brain as a positive PCR control for influenza. 
Lane 4, a positive PCR control for influenza introduced in the cDNA synthesis step. Lane 5, water control 
(X3) introduced in the 1St round of PCR amplification for ß-actin sequences. Lane 6, water control 
introduced in the nested PCR (X4). 
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Fig 4.10a: Absence of influenza NS gene sequences of 320 bp from templates of 
cDNAs derived from one section from each of the 1916-1920 era human brain samples 
by the first round of PCR amplification 
M indicates the marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-8, templates of cDNA derived from one section from each of the 1916-1920 
human brain samples: Casel/1916, Case2/1916, Case3/1919, Case4/1920, Case5/1920, Case6/1920, 
Case7/1920 and Case8/1920. Lane 9, template of cDNA derived from a human brain of Control/1996 
from a patient who did not die of encephalitis lethargica as a negative PCR control for influenza. Lane 10, 
template of cDNA derived from uninfected mouse brain tissue as a negative detection for influenza NS 
sequences. 
Lower Block: Lane 1, template derived from uninfected mouse brain tissue as a negative PCR control for 
influenza. Lane 2, template derived from infected mouse brain tissue as a positive PCR control for 
influenza. Lanes 3, template taken from a positive control for influenza introduced in the step of cDNA 
synthesis. Lane 4, template derived from a negative control for influenza introduced in the proteinase K 
digestion step (K1) as negative detection for influenza sequences. Lane 5, template derived from a water 
control (X 1) introduced in the RNA extraction step. Lane 6, template derived from a water control (X2) 
introduced in cDNA synthesis. Lane 7, water control (X3) introduced in the 1" round of PCR 
amplification. 
143 
Chapter 4 Studies of influenza genes in tissues 
Fig 4.10b: Absence of influenza NS gene sequences of 166 bp from templates derived 
from one section from each of the 1916-1920 era human brain samples by nested PCR 
(nested PCR of Fig 4.1Oa) 
M indicates the marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-8, templates derived from Casel/1916, Case2/1916, Case3/1919, Case4/1920, 
Case5/1920, Case6/1920, Case7/1920 and Case8/1920 respectively. Lane 9, template derived from a 
human brain of Control/1996. Lane 10, template derived from an uninfected mouse brain. 
Lower Block: Lane 1, template derived from an uninfected mouse brain. Lane 2, template derived from 
an infected mouse brain. Lane 3, template derived from a positive PCR control for influenza. Lane 4, 
nested PCR of K1. Lane 5, nested PCR of X1. Lane 6, nested PCR of X2. Lane 7, nested PCR of X3. 
Lane 8, water control introduced in the nested PCR amplification for the absence of influenza sequences 
(X4). 
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Fig 4.11a: Absence of influenza M gene sequences of 242 bp from templates derived 
from one section from each of the 1916-1920 era human brain samples by the first round 
of PCR amplification 
M indicates the marker lane and shows bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: Lanes 1-8; templates of cDNA derived from each of 1916-1920 brain samples, 
Casel/1916, Case2/1916, Case3/1919, Case4/1920, Case5/1920, Case6/1920, Case7/1920 and 
Case8/1920 respectively. Lane 9, template of cDNA derived from an uninfected human brain of 
Control/1996 from a patient who did not die of encephalitis lethargica. Lane 10, template of cDNA 
derived from an uninfected mouse brain. 
Lower Block: Lane 1, template derived from an uninfected mouse brain as a negative PCR control for 
influenza. Lane 2, template derived from an infected and paraffin wax-embedded mouse brain as a 
positive PCR control for influenza. Lane 3, template derived from a positive control for influenza 
introduced in the step of cDNA synthesis. Lane 4, template derived from a negative PCR control (K1) 
introduced in the step of proteinase K digestion post-deparaffinisation. Lane 5, template derived from a 
water control (X1) introduced in the step of RNA extraction. Lane 6, template derived from a water 
control (X2) introduced in the step of cDNA synthesis. Lane 7, water control (X3) introduced in the first 
round of PCR amplification for the absence of influenza M sequences. 
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Fig 4.11b: Absence of influenza M gene sequences of 117 bp from templates derived 
from one section from each of the 1916-1920 era human brain samples by nested PCR 
(nested PCR of Fig 4.1 lb) 
M indicates the marker lane showing bands of known size on a DNA ladder (pUC19/Sau3A). 
Upper Block: nested PCR products of the 1916-1920 human brain samples of Casel/1916, Case2/1916, 
Case3/1919, Case4/1920, Case5/1920, Case6/1920, Case7/1920 and Case8/1920 respectively. Lane 9, a 
nested PCR of a human brain of Control/1996. Lane 10, a nested PCR of an uninfected mouse brain. 
Lower Block: Lane 1, a nested PCR from an uninfected mouse brain. Lane 2, a nested PCR of an infected 
mouse brain. Lane 3, a nested PCR of a positive PCR control for influenza. Lane 4, a nested PCR of K1. 
Lane 5, nested PCR of X1. Lane 6, nested PCR product of X2. Lane 7, nested PCR product of X3. Lane 
8, water control for the nested PCR. 
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4.3 Discussion 
In the present study, and using a number of PCR applications we have detected 
specific nucleic acids of a defined product size from influenza A virus-infected animal 
tissues. First of all, sequences of influenza virus genes can be amplified from sections of 
influenza A NWS virus-infected, formalin-fixed, and paraffin wax-embedded mouse 
brain tissues using first and nested PCR amplification with a segment-specific primer 
during reverse transcription. Random hexamers recognising sequences in the viral RNA 
genes can also amplify fragments from several influenza genes in the mouse tissues 
studied (HA, M, NP and NS genes). The current PCR studies has also demonstrated that 
sensitivity of PCR amplification for target fragments of genes from different species is 
enhanced using an inner set of specific primers for a nested PCR amplification. 
Nucleic acid was recovered following deparaffinisation and proteinase K digestion 
of thin tissue sections. The proteinase K digestion temperature at 55°C was more 
effective than at 42°C following deparaffinisation and increased by 10-fold the yield of 
influenza RNA from sections of brains from mice infected intracerebrally with influenza 
A NWS virus. 
Studies of experimental tissue fixation times between 6/7 days and 6 months in 
formalin prior to tissue paraffin wax embedding, still allowed detection of viral RNA. 
We have no evidence to suggest that the recovery of influenza sequences from mouse 
brain samples was influenced by the length of time in forinalin-fixation prior to paraffin 
embedding. Finally, the optimised PCR technique, starting at deparaffinisation of tissue 
sections, proteinase K incubation temperature of 55°C, in corporation of RNase 
inhibitors during cDNA synthesis to nested PCR amplification for target and defined 
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fragments of genes using animal tissue sections as a mock model for each step of study, 
was applied to the analysis of the 1916-1920 human brain samples. 
No influenza gene sequences were detected in human brain tissue sections from 
patients who died of encephalitis lethargica between 1916 and 1920 using nested PCR 
amplification. However, the eight human brains studied showed recovery of ß-actin 
genes with the correct product sizes using the first and nested PCR amplification. We 
consider that the current results are valid and accurate due to the fact that all 
incorporated PCR negative controls in each respective step of the process remained 
negative for detection of target influenza sequences while positive controls gave positive 
detection of influenza gene sequences. In addition, sections from the same brain samples 
from the 1916-1920 were also concurrently analysed by another worker (Dr R. S. 
Daniels, NIMR), and the results showed no detection of influenza gene sequences in the 
same samples using PCR assay (Personal Communication, Lo et al., 2002, in press). P- 
actin RNA molecules were detected in influenza virus-infected and uninfected mouse 
brains, from all of the fresh and archival human brain samples. 
There are a number of factors that may have contributed to the negative results 
obtained from current RT-PCR analysis of archival tissue sections. Firstly, it is possible 
but unlikely that the clinical cases were more incorrectly diagnosed. Secondly, given the 
age of the clinical material, it is possible that RNA degradation occurred during tissue 
collection and storage which may limit the detection of target sequences. The quantity of 
extracted RNAs consisting of a variety of species of RNA from each section of paraffin 
wax-embedded block is usually low compared to fresh clinical material. The use of 
random hexamers as a primer for cDNA synthesis might reduce the chance of 
recovering targeted nucleic acid compared to the species-specific primer during reverse 
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transcription. We optimised the test using nested primers which amplified short 
sequences (< 180 bp), which were used for increased sensitivity and specific detection 
of target sequences. Thirdly, delays between sample collection and formalin fixation 
after death of the patient may have resulted in a loss of viral RNA through autolysis. 
Some investigators have found that RT-detection of RNA was influenced by the nature 
of the tissue fixative (Biagini et al., 1994; Foss et al., 1994; Gruber et al., 1994). 
Furthermore, the duration of fixation prior to tissue paraffin wax embedding may also 
affect RNA integrity. Bresters et al. (1994) reported that fixation times in neutral 
buffered formalin greater than twenty-four hours resulted in reduced RNA yield. Gruber 
et al. (1994) also reported loss of detectable RNA with increasing storage time. The 
above factors might have contributed in the current study to the absence of detecting 
target viral sequences. Multiple sections (10) from each human block were analysed in 
parallel to minimise false negative results due to small sample size and focal distribution 
of viral RNAs within the tissue block. One more important factor in determining the 
sensitivity of the detection of influenza RNA molecules from sections of the 1916-1920 
brain blocks is that patients may have died of complicated encephalitis lethargica 
respectively as revealed by post-mortem examinations which had been performed in the 
1916-1920 era and, collection and processing of each sample might have been delayed. 
Finally, the virus might have been cleared away by the host's immune system after its 
acute infection if patients were infected with influenza virus, thus resulting in entirely 
negative detection for influenza gene sequences from the 1916-1920 clinical samples. 
During the course of this project, Taubenberger et al. (1997) reported isolation of 
the first influenza sequences from the 1918 influenza virus from the lungs of soldiers. 
Detection of A/South Carolina/1/18 RNA was reported from a patient whose post- 
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mortem examination had revealed a primary viral pneumonia. One sample was obtained 
from an army soldier who died in September 1918 in New York, the other sample was 
obtained from an Alaskan Inuit woman who had been interred in permafrost since 
November 1918 (Reid et al., 1999). Recently we have detected influenza RNA in lung 
samples from influenza archives that died in 1908,1918 and 1919 (Reid et al., in press; 
Elliott A, Daniel R, Oxford JS, personal communication). Furthermore, the negative 
molecular analyses presented here are consistent with those of other workers who failed 
to detect influenza genes in brain specimens of EL victims (McCall et al., 2001). 
However, the possibility of influenza infection causing the death of those 8 patients 
analysed in the present study cannot be excluded. The absence of detection of influenza 
gene fragments in extracts of human brains derived from EL victims does not rule out 
influenza virus as a contributory factor in the pathology of these cases. Indeed, most 
epidemiological evidence supports influenza being the most likely candidate virus to 
cause EL (Ravenholt and Foege, 1982). 
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Chapter 5 Figures 
Fig 5.1 Composition of choroid plexus. Spaces between endothelial cells 
of the choroid capillary show a possible route of movement for 
NWS viruses from blood into the choroid plexus. The anatomical 
locations of ependymal cells are also shown 160 
Fig 5.2 A sketch of a cast of the ventricular system, showing the anatomical 
and biological relationships between structures of lateral ventricles, 
third ventricle, cerebral aqueduct, and forth ventricle of the brain 160 
Fig 5.3 A sketch of the path followed by cerebrospinal fluid through the 
ventricles of a brain, showing a possible path for spread of 
infection of influenza A NWS virus through the ventricles 161 
Figs 5.4A & 5.4B A section of mouse brain intracerebrally infected with 
influenza A NWS virus and sacrificed on day 4, showing groups of 
mononuclear cells (immune cells, arrowed) in the choroid plexus (CP) 
and ependyma of the lateral ventricle (LV), stained with H&E and 
viewed at different magnifications 163 
Figs 5.5A & 5.5B Higher power magnification shows a section of mouse brain 
with immune cells (arrowed) in the choroid plexus, ependyma and 
lateral ventricle (LV) intracerebrally infected with NWS virus and 
sacrificed on day 4 after infection, stained with H&E. Fig 5.5B is a 
higher magnification from an area marked as "Box 1" in Fig 5.5A 164 
Fig 5.6 A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 3, showing immune cells within the choroid 
plexus (CP) and penetrating the ependymal lining of the lateral 
ventricle (LV), stained with H&E, Scale: 22.5µm 165 
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Figs 5.7A & 5.7B A section of mouse brain intracerebrally infected with NWS 
virus and sacrificed on day 4, showing immune cells (arrowed) within 
the lateral ventricle wall (LV) and in the lumen, stained with H&E 166 
Fig 5.8 A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 4, showing the cuffing phenomenon of the blood 
vessel (BV) with groups of immune cells (arrowed), stained with 
H&E, Scale: 22.5µm 167 
Figs 5.9A & 5.9B A section of mouse brain intracerebrally infected with 
NWS virus and sacrificed on day 6, showing only mild perivascular 
cuffing with sparse immune cells around the blood vessel (arrowed), 
stained with Toluidine Blue 169 
Fig 5.10A A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 7, showing only mild ventriculitis in the lateral 
ventricle and cuffing phenomenon of the blood vessel with sparse 
immune cells in the thalamus, stained with Toluidine Blue, 
Scale: 400µm 170 
Fig 5.10B Sparse immune cells around the blood vessels (arrowed) from the 
area marked as "Box 2" in Fig 5.1OA, Scale: 5 0µm 170 
Figs 5.10C & 5.10D A section of mouse brain intracerebrally infected with 
NWS virus and sacrificed on day 7, showing cuffing phenomenon 
with only sparse immune cells around the blood vessel from the area 
marked as asterisk in the thalamus in Fig 5.1 OA 171 
Fig 5.11 A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 3, showing ventriculitis (arrowed) in cells of 
ependyma in the lateral ventricle (LV), stained with Toluidine Blue, 
Scale: 400µm 173 
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Figs 5.12A & 5.12B The area marked as "Box 3" in Fig 5.11 showing 
epifluorescence of influenza ISH signals localised in cells of the 
ependyma of the lateral ventricle (LV) (arrowed, Fig 5.12A) and 
influenza A NWS virus-infected cells (arrowed, Fig 5.12B) viewed at 
higher magnification, stained with Toluidine Blue, Scale: 50µm 174 
Fig 5.13 A section of control mouse brain infected intracerebrally with sterile 
PBS"A" and sacrificed on day 3 and viewed at low power, showing the 
absence of ventriculitis, stained with Toluidine Blue, Scale: 400µm 176 
Fig 5.14 A section of mouse brain infected intracerebrally with NWS and 
sacrificed on day 3 and viewed at low power, showing cells in the lining 
of lateral ventricle (Box 4) and in the hippocampal formation (Box 5), 
stained with Toluidine Blue, Scale: 400µm 176 
Figs 5.15A & 5.15B High power view of the area marked "Box 4" in Fig 5.14, 
demonstrating flu ISH signals (arrowed, Fig 5.15A) in NWS 
virus-infected cells (arrowed, Fig 5.15B) in the lining of lateral 
ventricle, stained with Toluidine Blue, Scale: 50µm 177 
Figs 5.16A & 5.16B High power view of the area marked as "Box 5" in Fig 5.14, 
showing flu ISH signals (arrowed, Fig 5.16A) over NWS 
virus-infected neurons (arrowed, Fig 5.16B) in hippocampal formation, 
stained with Toluidine Blue, Scale: 50µm 178 
Fig 5.17 A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 3, showing cells in the lining of cerebral aqueduct (CA) 
and in cells of raphe nucleus (Box 6), stained with Toluidine Blue, 
Scale: 100µm 180 
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Figs 5.18A & 5.18B Higher power view shows flu ISH signals (arrowed, 
Fig 5.18A) over NWS virus-infected cells localised in the lining of 
cerebral aqueduct (arrowed, Fig 5.18B), stained with Toluidine Blue, 
Scale: 50µm 181 
Figs 5.19A & 5.19B Higher power views of the area marked "Box 6" in 
Fig 5.17 showing virus-infected neurons in the dorsal raphe nucleus. 
Fig 5.19A shows epifluorescent silver grain clusters detecting NWS 
RNA. Fig 5.19B is a view of the underlying cells of the raphe nucleus 
Arrows indicate cells of raphe nucleus infected with NWS virus, 
stained with Toluidine Blue, Scale: 50µm 182 
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5.1 Introduction 
Many viruses can cause disease of the central nervous system (CNS) and, the 
clinical manifestations of such viral infections are bewilderingly diverse. As well as 
producing acute meningitis and encephalitis, certain viruses are also recognised to be 
responsible for chronic neurological conditions. The chronic neurological sequelae of 
epidemic and/or pandemic influenza have not been well studied from the virological 
point of view, and the topographical localisation of influenza genes in the brains in 
infected subjects even in acute disease is not known. 
Many surviving cases of encephalitis lethargica were first diagnosed as cases of 
influenza during the 1918 pandemic. Psychotic disorders including persistent insomnia 
and various types of depression were fairly common sequelae of acute epidemic 
encephalitis both in children and adults, described by many workers at the time (Jelliffe, 
1918; Happ and Blackfan, 1920; Cooper, 1936), whilst sleeplessness and melancholia 
were also prominent among the nervous symptoms following an attack of influenza 
(Reilly, 1919). In the early 1920s, many cases of patients convalescing after an attack of 
influenza complained of heaviness in their eyelids and showed a great tendency to 
drowsiness (Goudie, 1920). The clinical course and manifestations varied widely from 
patient to patient. A further small epidemic of "influenza and encephalitis lethargica" 
was also described in the late 1950s (Dubowitz, 1958; Smith, 1958; Dunbar et al., 1958; 
Flewett et al., 1958), and although virus was not identified in the lesions of patients it 
was thought likely that the cases of encephalitis were the result of influenza caused by 
the Asian influenza pandemic of 1957 (Goodbody and McGill, 1958). McConkey et al. 
(1958) reported four patients with severe neurological diseases following a short febrile 
illness in whom there was positive serological evidence of infection by influenza A 
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virus (Asian/57 influenza pandemic, H2N2). Other workers (Bental, 1958; Lloyd, 1958) 
also reported acute psychoses and psychosis due to encephalitis following Asian 
influenza. More recently, the presence of influenza viral antigens in the brain was 
demonstrated by Conover and Roessmann (1990) using immunohistochemistry on 
sections of the brain of an infant with complex malformations of the central nervous 
system. Two cases of influenza A encephalitis were reported in children during an 
outbreak of influenza types A/England/427/88 (H3N2) and A/Taiwan/l/86 (H1N1) in 
December 1989 (Protheroe et al., 1991). In cases the encephalitis developed within 3 
days of the respiratory symptoms and the patient became comatose within 48 hours; 
virological studies showed that the patients had had recent influenza A infections. 
Studies by Fang et al. (1995) demonstrated that intranasal infection with influenza A 
viruses (H1N1 and H3N2) in experimental mice induced a profound and long-lasting 
increase of non-rapid eye movement sleep and suppression of rapid eye movement 
sleep. In 1997, a 3-year-old boy in Hong Kong contracted an influenza-like illness, went 
on to develop Reye's syndrome and died 12 days later with complications. Influenza 
virus, termed influenza A/Hong Kong/156/97 (H5N1), was isolated from his trachea 
(Subbarao et al., 1998). Kimura et al. (1998) examined ten children with influenza- 
related brain lesions using magnetic resonance imaging, and their results suggested that 
the brain lesions were toxic or metabolic damage, resulting from multiorgan failure 
caused by the influenza virus. Tokunaga et al. (2000) demonstrated that the brain 
lesions were more intensive oedema using diffusion-weighted imaging from a 20- 
month-old patient with influenza A infection who had presented acute encephalopathy. 
Two cases of influenza-A related acute encephalopathy due to the complications of 
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influenza A viral infection from two children were also reported by Munakata et al. 
(2000). 
However, the cause of the epidemic lethargica outbreaks that occurred in the 
1918-1928 era has not yet been satisfactorily established. 
Over the last 3-4 decades, new techniques employing immunological and 
molecular assays have had a major impact in histopathology. All nucleic acid 
hybridisation techniques rely on the annealing of complementary sequences of nucleic 
acid. The type of in situ hybridisation conducted here is based on hybridisation to 
cellular influenza mRNA, performed in situ on tissue sections. The hybridisation to 
mRNA sequences of influenza virus was performed using paraffin wax preparations 
from previously prepared mouse brains (Chapters 3 and 4). 
The histological studies were conducted as a complementary method to the PCR 
techniques, to detect the presence of nucleic acids of influenza virus in sections of the 
infected mouse brain in situ. Thus, in the present study, sections of intracerebrally 
infected mouse brain tissues and sacrificed during the acute phase of influenza infection 
were cut, and a radioactive probe hybridised to influenza mRNA which was detected by 
emulsion autoradiography. 
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5.2 Results 
5.2.1 Ventriculitis and cuffing of blood vessels with immune cells in sections of 
mouse brains (H&E or Toluidine Blue staining, Figs 5.4 - 5.10) 
The brains were removed from a cohort of mice reserved for histological study 
and in situ hybridisation from the PCR experiments (Chapter 3). Brains were sliced, 
processed and serially embedded in paraffin wax, and sections were stained with 
haematoxylin & eosin (H & E). 
A few structural and functional terminologies will be defined before each figure is 
presented in detail (Figs 5.1 - 5.3). The ependyma (Fig 5.1) is the extremely thin 
membrane in the brain and is made up cells of the glia (neurons) such as 
oligodendrocytes, astrocytes, ependymal cells, and microglia. The ependyma lines the 
ventricles of the brain and the choroid plexuses and is responsible for helping to form 
cerebrospinal fluid (CSF). The CSF is the clear watery fluid that surrounds the brain and 
spinal cord and circulates through them to reach the subarachnoid space (Fig 5.1). The 
choroid plexus (Fig 5.1) is a rich network of blood vessels, derived from those of the pia 
mater in each of the ventricles (both lateral ventricles, 3rd ventricle, and 4th ventricle). 
These are 4 fluid-filled cavities. Each lateral ventricle, termed the 1St and 2nd ventricles, 
is located one in each cerebral hemisphere (Fig 5.2). The lateral ventricle communicates 
with the 3 Td ventricle in the midline between them. This in turn leads through a narrow 
channel, the cerebral aqueduct, to the 4 tß' ventricle in the hindbrain, which is continuous 
with the spinal cord (Fig 5.2). The CSF circulates through all the ventricles (Fig 5.3). 
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Fig 5.1: Composition of choroid plexus. Spaces between endothelial cells of the choroid 
capillary show a possible route of movement for NWS viruses from blood into the 
choroid plexus. The anatomical locations of ependymal cells are also shown. 
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Fig 5.2: A sketch of a cast of the ventricular system, showing the anatomical and 
biological relationships between structures of lateral ventricles, third ventricle, cerebral 
aqueduct, and forth ventricle of the brain. 
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Fig 5.3: A sketch of the path followed by cerebrospinal fluid through the ventricles of a 
brain, showing a possible path for spread of infection of influenza A NWS virus through 
the ventricles 
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The following data was obtained from mice killed at the peak of virus replication 
namely 3-4 days post-cerebral injection. Parallel sham inoculated control mice were also 
studied, as were mice at the recovery stage. Ventriculitis is seen in Fig 5.4 - 5.8, with a 
mononuclear inflammatory cell infiltrate in the choroid plexus and in the ependymal 
lining of the ventricles, following intracerebral inoculation with influenza A NWS virus 
in animals sacrificed on days 3 and 4 post-infection. The cells are chiefly 
monocytes/macrophages and lymphocytes. Groups of mononuclear cells are localised 
along the V-shaped-like ependyma of the lateral ventricle, resulting in ventriculitis 
following intracerebral infection with NWS virus (Fig 5.4A, arrowed small black dots). 
Similar immune cells are also seen in the choroid plexus viewed at a higher 
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magnification power (Figs 5.4B). More than 450 immune cells were attracted to the 
choroid plexus (CP) of the lateral ventricle post-infection (Fig 5.5A), whilst 
approximately 150 immune cells were localised along the edge of the lateral ventricle as 
arrowed (Fig 5.5B) and viewed at a higher magnification power from "Box 1" of Fig 
5.5A. 
Immune cells are viewed at a higher power to demonstrate their intensive 
accumulations within the choroid plexus and are observed penetrating the ependymal 
lining of the lateral ventricle, following intracerebral infection with NWS virus (Fig 
5.6). Those immune cells are also found to have accumulated heavily within the lateral 
ventricle wall and in the C-shaped-like lumen (Fig 5.7A). Approximately 130 immune 
cells are found and viewed at a higher power (Fig 5.7B). 
Groups of mononuclear cells are seen in the meninges of the virus-infected mouse 
brain sacrificed on days 3 or 4, resulting in meningitis, following intracerebral infection 
with influenza A NWS virus (not shown). 
Perivascular cuffing by mononuclear cells is seen (Fig 5.8), suggestive of 
encephalitis. Approximately 180 immune cells surrounding the blood vessel, termed 
perivascular cuffing phenomenon of the blood vessel in the virus-infected brain, were 
seen from a section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 3 following infection (Fig 5.8). 
162 
Chapter 5 Histological studies of influenza 
Figs 5.4A and 5.4B: A section of mouse brain intracerebrally infected with influenza A 
NWS virus and sacrificed on day 4, showing groups of mononuclear cells (immune 
cells, arrowed) in the choroid plexus (CP) and ependyma of the lateral ventricle (LV), 
stained with H&E and viewed at different magnifications 
Fig 5.4A: Scale: 200µm 
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Figs 5.5A and 5.5B: Higher power magnification shows a section of mouse brain with 
immune cells (arrowed) in the choroid plexus, ependyma and lateral ventricle (LV) 
intracerebrally infected with NWS virus and sacrificed on day 4 after infection, stained 
with H&E. Fig 5.5B is a higher magnification from an area marked as "Box 1" in Fig 
5.5A 
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Fig 5.6: A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 3, showing immune cells within the choroid plexus (CP) and 
penetrating the ependymal lining of the lateral ventricle (LV), stained with H&E, 
Scale: 22.5µm 
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Figs 5.7A and 5.7B: A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 4, showing immune cells (arrowed) within the lateral ventricle 
wall (LV) and in the lumen, stained with H&E 
Fig 5.7A: Scale: 45µm 
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Fig 5.8: A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 4, showing the cuffing phenomenon of the blood vessel (BV) with 
groups of immune cells (arrowed), stained with H&E, Scale: 22.5µm 
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Inflammation was maximal in mice sacrificed on days 3 and 4; a reduction in the 
numbers of vessels cuffed with inflammatory cells was noticeable when sacrifice 
occurred on days 5,6 and 7 and at the recovery stage. Thus, photomicrographs of a 
section of brain from mice sacrificed on day 6 show mild ventriculitis and few 
inflammatory cells around the blood vessels (Figs 5.9A - 5.9B). Fewer immune cells are 
seen in the ventricular tissues, suggestive of mild ventriculitis only. In addition, 
perivascular cuffing is not clearly demonstrable in these 2 figures and only sparse 
immune cells were observed around the blood vessels in the thalamus. Approximately 
15-20 mononuclear cells are observed around the blood vessel (Fig 5.9B). 
Figs 5.1 OA to 5.1 OD demonstrate another mild ventriculitis and perivascular 
cuffing in the brain of a mouse sacrificed on day 7 post-intracerebral infection. Immune 
cells are sparsely seen in the ventricular tissues. Inflammatory cuffing of the blood 
vessels also tends to localise in tissues around the thalamus and remains demonstrable 
in brain when mice were sacrificed on days 5 to 7 post-intracerebral infections. 
No perivascular inflammatory cuffing is seen when samples were cut in sections 
of brain from mice sacrificed on days 12 and 24 post-infection (data not presented). 
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Figs 5.9A and 5.9B: A section of mouse brain intracerebrally infected with NWS virus 
and sacrificed on day 6, showing only mild perivascular cuffing with sparse immune 
cells around the blood vessel (arrowed), stained with Toluidine Blue 
5.9A: Scale: 100µm 
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Fig 5.10A: A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 7, showing only mild ventriculitis in the lateral ventricle and cuffing 
phenomenon of the blood vessel with sparse immune cells in the thalamus, stained with 
Toluidine Blue, Scale: 400µm 
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marked as "Box 2" in Fig 5.1OA, Scale: 50µm 
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Figs 5.10C and 5.10D: A section of mouse brain intracerebrally infected with NWS 
virus and sacrificed on day 7, showing cuffing phenomenon with only sparse immune 
cells around the blood vessel from the area marked as asterisk in the thalamus in Fig 
5.10A 
Fig 5.10C: Scale: 100 
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5.2.2 Localisation of virus-infected cells by in situ hybridisation (ISH) using a 
radioactively labelled influenza NP probe (Figs 5.11 - 5.19) 
Lateral ventriculitis identified in the preceding sections was further studied using 
an influenza NP probe by the ISH technique. A photomicrograph of a section of brain 
from a mouse sacrificed on day 3 post-intracerebral infection is shown in Fig 5.11 at 
low magnification. 
Proliferations of immune cells are seen in the ependyma of the lateral ventricle 
post-infection with NWS virus (Fig 5.11, arrowed). Positive influenza ISH signals from 
a section of infected mouse brain localised in cells of ependyma of lateral ventricles are 
shown in Figs 5.12A - 5.12B viewed at higher magnification than Fig 5.11 of the 
marked "Box 3". Fig 5.12A is an epifluorescent photomicrograph of Fig 5.12B showing 
influenza NWS virus-infected cells with positive influenza ISH signals localised in cells 
of the ependyma. A high concentration of influenza NP is seen in cells of the ependyma 
and in the lateral ventricle (as arrowed) in Fig 5.12A, whilst some immune cells and/or 
NWS virus-infected cells from the same area of Fig 5.11 marked as "Box 3" are seen in 
Fig 5.12B (arrowed). 
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Fig 5.11: A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 3, showing ventriculitis 
(arrowed) in cells of ependyma in the lateral 
ventricle (LV), stained with 
Toluidine Blue, Scale: 400µm 
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Figs 5.12A and 5.12B: The area marked as "Box 3" in Fig 5.11 showing 
epifluorescence of influenza ISH signals localised in cells of the ependyma of the lateral 
ventricle (LV) (arrowed, Fig 5.12A) and influenza A NWS virus-infected cells 
(arrowed, Fig 5.12B) viewed at higher magnification, stained with Toluidine Blue, 
Scale: 50µm 
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Fig 5.13 shows a section of a control mouse brain with no observable ventriculitis 
and no demonstrable ISH signals (not shown). The control mouse was inoculated 
intracerebrally with sterile PBS"A" and sacrificed on day 3 following injection. In 
contrast, a section of influenza NWS virus-infected brain shows ventricular changes 
with accumulation of immune cells and virus-infected cells in the lining of lateral 
ventricle and hippocampal (HPC) formation from a mouse sacrificed on day 3 post- 
intracerebral infection with influenza A NWS virus viewed at low magnification (Fig 
5.14), respectively. 
Ventricular changes are seen with positive influenza ISH signals of 
epifluorescence showing ventriculitis viewed at higher power than Fig 5.14 of an area 
marked as "Box 4" (Fig 5.15A and Fig 5.15B). 
Influenza NWS virus-infected neurons with changed morphology are further seen 
with strong influenza NP signals viewed at a higher magnification than Fig 5.14 of an 
area marked "Box 5" (Fig 5.16A, arrowed white aggregations). An epifluorescent 
photomicrograph of "Box 5" in Fig 5.14 is to demonstrate influenza ISH signals over 
hippocampal neurons viewed at a higher magnification. Hippocampus is a swelling in 
the floor of the lateral ventricle of the brain. Influenza NWS virus-infected neurons in 
hippocampus with each morphological changes viewed at a higher magnification are 
also demonstrated from a mouse brain inoculated intracerebrally and sacrificed on day 3 
following inoculation (Fig 5.16B, arrowed black masses). 
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Fig 5.13: A section of control mouse brain infected intracerebrally with sterile PBS"A" 
and sacrificed on day 3 and viewed at low power, showing the absence of ventriculitis, 
stained with Toluidine Blue, Scale: 400µm 
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Fig 5.14: A section of mouse brain infected intracerebrally with NWS and sacrificed on 
day 3 and viewed at low power, showing cells in the lining of lateral ventricle (Box 4) 
and in the hippocampal formation (Box 5), stained with Toluidine Blue, Scale: 400µm 
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Figs 5.15A and 5.15B: High power view of the area marked "Box 4" in Fig 5.14, 
demonstrating flu ISH signals (Fig 5.15A, arrowed) over NWS virus-infected cells (Fig 
5.15B, arrowed) in the lining of lateral ventricle, stained with Toluidine Blue, Scale: 
50µm 
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Figs 5.16A and 5.16B: High power view of the area marked as "Box 5" in Fig 5.14, 
showing flu ISH signals (arrowed, Fig 5.16A) over NWS virus-infected neurons 
(arrowed, Fig 5.16B) in hippocampal formation, stained with Toluidine Blue, Scale: 
50µm 
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Of particular interest was detection of influenza RNA in the ventricular tissues of 
the cerebral aqueduct and in cells of the dorsal raphe nucleus (Figs 5.17 - 5.19). Cells of 
raphe nucleus are a group of neurons which have been given a collective name. Their 
roles are in modulating the balance between sleep and wakefulness, especially in respect 
of their role in sleep rhythms. Some destruction of cells of the raphe nucleus is 
considered to lead to insomnia. 
A photomicrograph of this region is viewed at medium power (Fig, 5.17). An 
epifluorescent photomicrograph of Fig 5.18A shows influenza ISH signals in cells in the 
lining of the cerebral aqueduct viewed at a higher power than Fig 5.17 (Fig 5.18A). The 
cerebral aqueduct is a narrow channel that circulates the CSF from the 3rd ventricle to 
the 4th ventricle in the hindbrain (Figs 5.1 and 5.2). This is suggestive of spread of 
influenza infection from lateral ventricles through the cerebral aqueduct into the 3rd, the 
4th ventricles and to other areas of brain. 
Influenza ISH signals localised in neurons are seen and viewed at a higher 
magnification than Fig 5.17 of an area marked as "Box 6" (Fig 5.19A). Influenza NWS 
virus-infected cells of the dorsal raphe nucleus are seen and viewed at a higher 
magnification in Fig 5.19B from "Box 6" of Fig 5.17 (arrowed black masses). 
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Fig 5.17: A section of mouse brain intracerebrally infected with NWS virus and 
sacrificed on day 3, showing cells in the lining of cerebral aqueduct (CA) and in cells of 
raphe nucleus (Box 6), stained with Toluidine Blue, Scale: 100µm 
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Figs 5.18A and 5.18B: Higher power view shows flu ISH signals (arrowed, Fig 5.18A) 
over NWS virus-infected cells localised in the lining of cerebral aqueduct (arrowed, Fig 
5.18B), stained with Toluidine Blue, Scale: 50µm 
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Figs 5.19A and 5.19B: Higher power views of the area marked "Box 6" in Fig 5.17 
showing virus-infected neurons in the dorsal raphe nucleus. Fig 5.19A shows 
epifluorescent silver grain clusters detecting NWS RNA. Fig 5.19B is a view of the 
underlying cells of the raphe nucleus. Arrows indicate cells of raphe nucleus infected 
with NWS virus, stained with Toluidine Blue, Scale: 50µm 
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5.3 Discussion 
In the present study, the results have shown that influenza NWS virus can not only 
cause viral meningitis (inflammation of meninges) in infected mouse brains but also 
cause influenzal ventriculitis and influenzal encephalitis during the acute stage of 
infection following direct intracerebral inoculation. Viral ventriculitis is seen in mice 
sacrificed from day 3 to day 5 post-infection at the acute phase with influenza A NWS 
virus. In contrast, only mild ventriculitis can be demonstrated at the recovery phase on 
day 7 post-infection and no pathological changes were noted by day 12. No abnormal 
changes were noted in control uninfected mouse brains. During the acute stage of 
influenza infection in the mouse brain, the predominant inflammatory cells were 
macrophages and lymphocytes. 
Progressive disappearance of vascular cuffing from sections of infected mouse 
brain was seen in mice sacrificed on days 6,7,12,18, and 24 post intracerebral 
infection. Live influenza virus could not be isolated from the brains of mice sacrificed 
after the stage of acute infection (viz. days 3- 5). The limited number of survivors 
examined which recovered from infection and had protective immunity showed no 
residual meningitis, ventriculitis, or perivascular cuffing (refer to Chapter 3). 
The present study has demonstrated new findings for influenza infection in the 
CNS with respect to virus mRNA localisation in the brain tissues. In situ hybridisation 
detected a signal for influenza NP RNA in sections of day 3 post-intracerebral infection 
brain in cells closest to the ependyma and choroid plexus, hippocampal neurons of the 
lateral ventricle, to ependyma of the cerebral aqueduct, and cells of the dorsal raphe 
nucleus. The hippocampus is located in the floor of the lateral ventricle and forms part 
of the limbic system, which in turn is responsible for a wide variety of emotional 
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behaviour (Nolte, 1998). Infection of hippocampal neurons with influenza A NWS virus 
may interfere with limbic system function. The degree of adverse effect on the entire 
limbic system affected by influenza infection of the hippocampus is at present unclear. 
The detection of influenza mRNAs in the tissues of the cerebral aqueduct 
suggests that the spread of the influenza virus in the brain may occur via the CSF. More 
surprisingly, the positive influenza ISH signals localised in the dorsal raphe neurons 
maybe due to the fact that the dorsal raphe has projections to the periventricular region 
(Simpson et. el, 1998). Three of the seven projections are located in the medulla, whilst 
the others are in the midbrain including the cells of the dorsal raphe nucleus (Diamond 
et al., 1985). 
It is known that the chief physiological functions of raphe nucleus are associated 
with sleep and also depression. The localisation of intensive influenza ISH signals in 
dorsal raphe neurons suggests that influenza infection in these neurons may result in 
immediate effects on sleep disturbances and depression with various mental 
disturbances in subjects during their acute viral infection. These clinical features have 
been observed with intracerebrally infected mice (refer to Chapter 3) and were a 
particular feature of the encephalitis lethargica epidemic. The mechanism by which 
influenza infection could alter the physiological properties of these neurons is not 
known. Altered functions of the hippocampus and raphe neurons due to influenza 
infection may explain the variety of atypical clinical symptoms and movements 
observed in the infected mice (refer to Chapter 3): some were highly agitated, 
neurologically excited, and restlessly running around the cage, while others were very 
lethargic and slow moving. 
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Early infection with influenza A virus during neurodevelopment in the prenatal or 
neonatal life may increase the risks of developing later neurological defects of the 
central nervous system due to the ease of replication and spread of the virus in the 
tissues of infected brain via CSF. Further detailed studies of influenza infection in the 
brain of infected subjects and its potential role in triggering adverse acute and/or chronic 
effects will be required for a better understanding of the pathogenesis of possible later 
neurological complications, including encephalitis lethargica. 
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Chapter 6 General Discussion 
Encephalitis lethargica appeared with no definite climatic and geographic 
limitations. Influenza usually occurs in the winter season annually, but the infection 
occurred during the months outside the winter season in the Spanish influenza outbreak. 
There has been some diversity of opinion as to the age limits of occurrence of the two 
diseases. Disease appeared to have occurred freely at all ages, but with preponderance 
of serious infections and life threatening complication in the second, third and fourth 
decades of life. In the absence of serology the quantification of such clinical infection 
was not possible. Sex probably exercised no influence on the occurrence of the disease 
and occupation was not a determining factor. Social and economic status did not appear 
to be of any importance in the development of the respective clinical picture. There is 
no doubt that epidemic encephalitis was of infectious origin. However to what extent 
epidemic encephalitis can be considered as contagious from person to person remains 
open to question. Thus with the many thousands of cases of epidemic encephalitis 
closely studied in parts of the world between 1917 to 1924, there have been only a few 
instances of apparent direct transmission from one individual to another. Many cases 
occurred so nearly simultaneously as to suggest a common source rather than 
transference from one person to another. However, it is clear that the infectious agent 
responsible for the pandemic of encephalitis lethargica during the 1918 era was an air- 
borne agent based on its general behaviour, rapid spread and worldwide distribution. 
It is presumed that the nasopharyngeal mucosa or the pulmonary surfaces was the 
route of invasion by the causative infectious agent of epidemic encephalitis. However 
those cases beginning with virulent gastro-intestinal disturbances, such as vomiting, 
could indicate that the agent virus may have infected directly in the enteric mucous 
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surfaces. In contrast, the initial site of influenza virus replication during infection is 
certainly in the epithelial cells of the respiratory tract. 
The question as to a possible aetiological relationship between Spanish influenza 
and epidemic encephalitis has been the subject of wide divergence of views. Some 
observers have taken the ground that influenza virus is the causative factor in 
encephalitis lethargica (Crookshank, 1919; Olitsky and Gates, 1920; Greenfield, 1950; 
Mulder and Hers, 1972; Ravenholt and Foege, 1982). Others regard it as a post- 
influenzal process, or a variant manifestation of this virus in another form of its life 
history (Reilly, 1919; Claude, 1919; Lyon et al., 1919; Sharfin 1919; Menninger 1919, 
1920,1921,1922,1926; Goudie, 1920; Goodbody and McGill, 1958). Still others are 
convinced that there is no relationship whatever (Hall, 1918; Smith, 1921; Reid et al., 
2001; Jellinger, 2001). A precise association between the two diseases is difficult to 
establish due to the elapse of approximately eighty years since their initial and 
concurrent occurrences in the 1918 era. However, Taubenberger et al. (1997 & 1999) 
have recovered influenza genes from formalin-fixed lungs from two patients who had 
primary viral pneumonia and died in September 1918 during the Spanish influenza 
pandemic, and from an Alaskan Inuit woman who had been interred in permafrost since 
November 1918. More recently we have detected influenza genes in lungs of two 
patients at the London Hospital who died during the 1918 pandemic (Reid et al., 2002). 
Therefore molecular probing can be used to establish virus aetiology from pathology 
samples, presumably also including brain, stored as long as 80 years. 
In the present study, it can clearly be seen that the two neurotropic variants of the 
WS virus, A/NWS and A/WSN, have produced similar but yet different pictures of 
infection in the brains of mice following direct intracerebral inoculation. There are two 
common findings obtained by the two sets of animal models in regard to the 
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neurovirulent infection of influenza A virus. First of all, both neuroadapted influenza 
viruses can infect and replicate abundantly with a wide range of initial infective viral 
particles by direct intracerebral infection, producing signs of illness from asymptomatic 
to highly neurological variations and death of mice. Secondly, following influenza 
infection by the intracerebral route, virus has not been subsequently transmitted from 
mouse to mouse by keeping groups of infected and uninfected animals in different cages 
of the same room. 
In the NWS model, approximately 100 infective viral particles resulted in 100% 
of deaths with various signs of atypical agitation during the first week of acute 
infection. The MID50 of the NWS virus in mice on the 7th day post-infection was 
approximately 10 infective viral particles. Serological studies show that sera obtained 
from groups of infected mice, particularly those from influenza convalescents on the 
day later than 7th post-infection and after their recovery from the entire intracerebral 
infection, are found to have high titres of HI antibodies, demonstrating rapid 
development of post-infection immunity. Mice that have recovered from influenza 
infection by the intracerebral route are found in groups of mice infected with the lowest 
and the highest dilutions of the stock NWS virus: 1 in 10,1: 106, and 1: 107. The latter 
two were practically expected to contain 1 or less than one infective viral particle prior 
to inoculation. The survival of animals given the highest dose of virus was unexpected 
but could be explained by the von Magnus phenomenon with accompanying non- 
infective and interfering viruses. It is reported that at least some defective RNAs have 
been able to interfere with the multiplication of infectious virus (Nayak et al., 1978, 
1985; von Magnus, 1954). Such defective interfering RNAs have also been shown to 
protect from both homologous and heterologous influenza A virus subtypes in vivo 
(Dimmock, 1996; Dimmock et al., 1986; McLain et al., 1992; Morgan et al., 1992 & 
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1993). During the course of the virus life cycle, shorter defective RNAs are also 
generated, replicated and packaged alongside full-length genomic RNAs by internal 
deletion (Crumpton et al., 1979; Davis & Nayak, 1979; Davis et al., 1980; Winter et al., 
1981), and all defective RNAs possess the terminal 1-25 nucleotides from the 5' and 3' 
ends of the parent RNA segment (Luytjes et al., 1989; Odagiri & Toshiro, 1997). More 
recently, further molecular studies by Duhaut & Dimmock (2000 & 2002) suggest that 
defective RNAs possess at least >_ 150 nucleotides from the 5' end of the vRNA are 
essential for such interference, RNA passage stability, and possibly packaging. The 
reduction in infectivity may be due to the presence of interfering properties of defective 
influenza virus RNAs during the course of acute infection. However, it is most 
unexpected that influenza gene sequences have been demonstrable in the present study 
up to the 70th day post-infection by PCR assay from two groups of infected mouse 
brains showing merely signs of illness. There was no recovery of virus from brains of 
these two groups of mice using the conventional method of embryonated chick eggs. In 
summary mice inoculated intracerebrally with 10 infective particles showed positive 
detection for influenza NP gene, whereas mice inoculated intracerebrally inoculated 
with 1 infective viral particle were found to have detectable influenza NP gene in the 
brain on the 70th day post-infection. The results suggested that persistent infection of 
influenza A NWS virus might occur in the brain tissues of mice. The NWS virus may or 
may not replicate and cause acute influenza infection in the brains of these infected 
mice since the HI antibodies, which provide an indication of mice immune response 
after the acute infection were low or undetectable. The NWS virus may exist in a 
defective form in the brain tissues of infected mice which may trigger signs of 
neurological complications months after its initial infection. This aspect 
is worthy of 
further study. 
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In contrast, mice from the groups infected with highest infective viral particles of 
NWS survived from acute intracerebral infection and produced high titres of the HI 
antibodies, indicating that mice were infected but that a protective immunity had 
developed. It is noted that the immune response of mice appears to be as early as day 4 
following direct intracerebral infection with influenza A NWS virus. The early immune 
response may suggest that mononuclear cells of the defence system may recognise the 
presence of foreign antigen faster in the brain tissues than in other parts of tissues. 
Although mice were sick with all signs of illness during the first week of infection, the 
undetectable influenza gene sequences from these brains of mice on the 61St day post- 
infection may possibly suggest the complete phagocytosis and digestion of virus- 
infected brain cells by groups of immune cells. 
In relation to human influenza we conclude that, should the influenza virus gain 
entry it could survive in the brain tissues of influenza-infected subjects and could 
possibly result in a persistent infection for months or years after initial infection. 
The WSN virus was not found in the brains, kidneys, livers, spleen, and sera of 
mice after intranasal infection in our study using PCR analysis. Nor was WSN virus 
recovered from the lungs, hearts, kidneys, livers, spleens, and sera of mice following 
intracerebral infection. In contrast, Mori et at. (1995) reported that influenza A/PR/8 
virus produced viraemia in a mouse model during the acute phase of disease. As regards 
human studies, influenza RNAs of influenza A and B viruses were not detected from 
blood samples or CSF by PCR from 6 children infected with recent strains of influenza 
virus (Mori et al., 1997). The route of dissemination from the respiratory tract to other 
organs has not been determined, but viraemia remains as a reasonable candidate (Xu et 
al., 1997). McCullers et al. (1999) reported that influenza RNA was detected in CSF 
from a 6-year-old girl with acute influenza B virus encephalitis. Recent studies 
by Davis 
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et al. (2000) demonstrated that a viral pneumonia had developed with subsequent 
intermittent viraemia and non-permissive or abortive infection of brain, liver and 
skeletal muscle following intranasal infection of influenza B in mice. They suggested 
that a blood-borne route was more likely to have caused such transient viraemia and 
non-permissive infection of systemic organs. Seo et al. (2002) also reported a 
prolonged viraemia, fever and weight loss when pigs had been intranasally infected with 
H5N1 virus. The most interesting finding during the current study is that WSN virus 
was found to be present in the hearts of mice from all groups of infected mice during the 
first week of infection following intranasal route of infection using PCR detection for 
the presence of influenza gene sequences. This result suggested that the mechanism for 
spread of influenza infection might be by virtue of vascular circulation in the tissues of 
respiratory tract during acute infection, at least with this virus. Virus-infected cells or 
macrophages could infect brain tissues through the circulatory system. Persistent 
infection of influenza WSN virus in the brains of mice was noted in groups of mice 
inoculated intracerebrally with highest number of infective viral particles. Thus 
detection of influenza gene sequences by nested PCR from mice intracerebrally infected 
with WSN virus and sacrificed on day 35 may suggest a persistent infection of influenza 
WSN virus in the brains of mice. Fragments of influenza genes may exist in a defective 
form virus in the virus-infected brain cells. The absence of WSN gene sequences from 
mice brains sacrificed later than day 35 post-intracerebral infection may be due to the 
fact that either virus has exhibited a hit-and-run mechanism or that virus-infected cells 
have been fully phagocytosed by groups of immune cells, particularly in respect of 
macrophages of the CNS. This view is further supported by the histological studies, in 
which the chief immune cells causing inflammation, meningitis, and ventriculitis in the 
infected brains of mice are macrophages of the CNS. 
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In contrast, the NWS gene sequences remained detectable on day 70 post- 
infection in the brains of mice intracerebrally inoculated with minimal infective viral 
particles. The different results from the two animal models may be due to the difference 
in ways of neurotropic enhancement of the two strains of influenza virus. The NWS 
variant was derived from an adaptation of the WS virus to the nervous tissue of the 
chick embryo following serial cultivation on the choroiallantoic membrane of the egg, 
whilst the WSN strain of virus was obtained by cultivation of influenza WS virus in 
tissue cultures containing embryonic chick brain following serial intracerebral transfers 
in mice (Stuart-Harris, 1939; Francis and Moore, 1940). The progenitor WS virus of the 
NWS derived from a filtrate of infected mouse lungs had previously been passed 166 
times in ferrets and then 196 times in mice before being cultivated in chick embryo, 
whereas the WS progenitor virus of the WSN was directly taken from tissue culture 
containing embryonic chick brain for serial transfers. Presumably the neurotropic 
capacity was an inherent property of the WS virus, which had been enhanced j 
quantitatively by passage through brains of mice. As a result, the NWS strain of the 
virus might infect and replicate slightly more readily in the brains of mice due to its pre- 
adaptation to the nervous tissue of this species. However, there seems no doubt that the 
two strains of influenza virus may induce persistent influenza infection occurring in the 
brains of mice. To our knowledge this is the first description of direct influenza virus 
persistence in adulthood of mice, in vivo. More recently, Aronsson et al. (2002) reports 
that persistence of viral RNA in the brain of offspring occurred in mice infected with 
influenza A/WSN/33 virus during pregnancy in a mouse model. Viral RNA and 
nucleoprotein were detected in foetal brains and, the viral RNA persisted 
for at least 90 
days of postnatal life. They have also provided evidence for transplacental passage of 
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influenza virus in mice and the persistence of viral components in the brains of those 
animals into young adulthood (Arosson et al., 2002). 
Influenza virus might be more easily and readily able to infect foetal brains 
through the route of intrauterine transmission by the circulatory system and cause acute 
and/or chronic tissue damage such as the lung, heart or brains of foetus. Transplacental 
influenza A infection has never been adequately documented. The only virological 
confirmed cases of foetal infection occurred in a foetus whose mother died of 
overwhelming influenza infection (Yawn et al., 1971). Ruben and Thompson (1981) 
found positive cord blood lymphocyte responses to influenza A antigens in 6 of 46 
(13%) cord sample following an epidemic of influenza A/Port Chalmers/73 (H3N2). 
McGregor et al. (1984) reported a case of maternal and foetal influenza 
A/Bangkok/l/79 (H3N2) and virus was isolated from both maternal nasal washings and 
uncontaminated amniotic fluid, demonstrating transplacental passage of influenza A 
virus during the mother's acute illness. Recent studies found no evidence of 
transplacental infection by influenza (Irving et al., 2000). 
Observers have deduced that schizophrenia may have originated in genetic defects 
in the control of early brain growth, or in early environmental hazards such as prenatal 
exposure to maternal influenza, resulting in neurodevelopmental impairment (Sham et 
al., 1992; Murray et al., 1992 and 1994; Damato et al., 1994). The precise pathogenesis 
of influenza virus infection in the brain, responsible for inducing various phenomena 
typical of the schizophrenic psychoses or post-encephalitic Parkinsonian syndromes, 
may depend on the localisation of influenza virus and the precise site 
for virus infection. 
It is possible that foetal neurodevelopment could be severely 
disturbed during the 
trimester of gestation caused by maternal respiratory infection via 
live virus or disturbed 
maternal immune response, resulting in any forms of later and chronic neurological 
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syndromes. O'Callaghan et al. (1991) suggests that a significant proportion of cases of 
schizophrenia have their origins in foetal or neonatal life based on their computed 
tomography and magnetic resonance imaging studies showing cerebral ventricular 
enlargement and a decreased volume of temporal lobe structures. This may be due to the 
persistent influenza infection in the brains after its initial exposure to the influenza 
virus. Murray et al. (1991) reported that prenatal exposure to 1957-A2-influenza 
pandemic virus resulted in higher incidence of births of individuals who later developed 
schizophrenia. Some studies have established that birth dates during the winter and 
early months are more common in schizophrenic patients than in the general population 
(Damato et al., 1994), which is coincident with the seasonal distribution of influenza 
infection. Several epidemiological studies have suggested that maternal exposure to 
influenza during midgestation is a risk factor for later schizophrenia (Bunney et al., 
1995; Takei et al., 1996; Machon et al., 1997; Franzek, 1998). Bunney et al. (1995) 
reported the 2"d trimester of gestation as being a critical period for foetal brain 
development, especially for neuronal migration. They suggested that foetal trauma due 
to influenza infection during this trimester would increase the incidence of 
schizophrenia. More interestingly, mild ventricular enlargement is more often found in 
schizophrenic patients who were born in the winter months (Damato et al., 1994). Such 
a finding may suggest that cases of chronic schizophrenic may be associated with 
infection of influenza virus in the winter months during pregnancy. Such influenza 
infection in early life may have damaged neurodevelopment at the time of 
infection 
with or without later complete clearance of influenza genome in the brains of 
infants or 
children by the immune cells. In contrast, Sierrahonigmann et al. (1995) reported 
the 
absence of viral nucleic acids in the samples from 48 schizophrenic patients and 
suggested that schizophrenia was not associated with a persistent or 
latent viral 
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infection. Their finding cannot entirely exclude the viral infection associated with its 
neurological defects in the brain tissues. 
Influenza has occasionally been linked with idiopathic Parkinson's disease since 
the 1920s when it was recognised that post-influenza infection Parkinsonian syndrome 
could occur after an interval of weeks or several decades. Also Mattock et al. (1988) 
proposed that intrauterine influenza might predispose to the development of idiopathic 
Parkinson's disease in later life. Their positive finding of correlation between relative 
idiopathic Parkinson's disease risk and influenzal activity for the years 1900-30 
supported the proposal. Intrauterine influenza may be cytotoxic to the developing foetal 
substantia nigra, and affected individuals may be born without evidence of disability but 
with limited striated neurochemical reserves and a reduced nigral cell count. In later 
life, normal cellular involvement with aging or exposure to environmental neurotoxic 
factors may further erode these reserves to a degree where the substantia nigra fails and 
idiopathic Parkinson's disease becomes apparent. 
There are a number of mechanisms that may be responsible for an influenza virus 
to have a role in triggering a process that might eventually lead to schizophrenia and/or 
post-infectious Parkinson's diseases. One is that mothers who produce an effective 
immune response against the influenza virus and therefore have mild or subclinical 
infection might in some cases produce an anti-influenza immune response that cross- 
reacts with brain antigens and therefore damages the developing 
foetus. Another 
possibility is that infection of the foetus with influenza could lead directly to 
brain 
damage. It is also possible that such direct infection during maturation of 
the immune 
system can lead to alterations in the immune response repertoire, which makes 
autoimmune cross-reactions in response to subsequent 
influenza infections more 
probable. Influenza virus can establish persistent infection 
in tissue culture (Lucas et al., 
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1988) and transplacental passage of influenza virus persistent infection in mice 
(Aronsson et al., 2002), but to our knowledge our data in mice provide the first 
experimental evidence for viral gene persistence in vivo. Wang et al. (1990) reported 
that clearance of infectious virus and RNA had occurred at approximately the same time 
after oral infection of ducks with influenza virus (Alduck/Hokkaido/8/80). 
Studies by Fang et al. (1995) demonstrated that influenza viral infection in 
experimental mice induced profound and long-lasting increase of non-rapid eye 
movement sleep and suppression of rapid eye movement sleep. They have suggested 
that these viral induced changes in sleep likely represent a host-defence response. 
Sleepiness is a common perception during viral infection but very little is known about 
the effects of viral infection on sleep. 
It is not well understood why a brain lesion could develop following influenza 
infection. Kimura et al. (1998) examined ten children with presumed influenza-related 
brain lesions using magnetic resonance, and their results suggested toxic or metabolic 
damage due to multisystemic organ diseases induced by the influenza virus. Their 
findings including a description of cortical cell necrosis and thalamic lesions due to 
hyperpermeability of the blood vessels followed by severe oedema with or without 
microhaemorrhages, have demonstrated that influenza virus can infect brain tissues and 
cause a variety of brain lesions. In support, influenza A/Hong Kong virus (H3N2) was 
isolated from CSF of a pregnant woman with influenza encephalopathy (Hakoda & 
Nakatani, 2000). 
Mori et al. (1995) suggested that influenza virus could enter the 
bloodstream 
through the infected alveolar septum. Studies by Silvano et al. (1997) showed that 
severe circulatory disturbance with multiple foci of necrosis in major organs 
including 
the brain was found in chicks inoculated with highly pathogenic avian 
influenza virus. 
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Histological lesions revealed the enlargement of the vascular endothelial cells; and 
avian influenza antigens were detected initially in the vascular endothelial cells and then 
in the astrocytes, neurons and ependyma. Influenza viral endotheliotropism is further 
reported by Feldmann et al. (2000) who found receptors of a2,3- and a2,6-linked 
neuraminic acid on endothelial cells but not on tissues surrounding endothelia. A study 
by Wong (2000) suggested that the endothelium of small blood vessels in the central 
nervous system had been particularly susceptible to viral infection, resulting in 
disseminated endothelial damage with various neurological dysfunctions. 
Kimuratakeuchi et al. (1992) proposed that cytokines were possibly responsible in 
mediating the acute phase response in host defence mechanism during systematic 
influenza infection. Such destruction of the vascular endothelial cells via the activation 
of inflammatory cytokines by influenza virus would presumably be the 
pathomechanism of the neurological dysfunction (Togashi, 2000). Haemorrhages and 
oedema seen in the brain may possibly be due to impairments in the blood-brain barrier 
(BBB), which is mediated by inflammatory cytokines (Nakashita & Aoki, 2000). In 
addition, Hayashi (2000) also reported that some pathophysiological changes in 
infantile influenza encephalitis leading to brain thermo-pooling (elevation of brain 
tissue temperature) were due to damage of the blood-brain barrier by systemic influenza 
infection. Such a brain thermo-pooling phenomenon can further cause severe 
brain 
oedema by activation of cytokines and destruction of the blood-brain barrier 
(BBB) in 
systemic infection, resulting in poor prognosis without control of brain temperature. 
Nakamura et al. (2001) reported proliferation of macrophages engulfing 
fragmented 
erythrocytes in the air capillaries and blood capillary of the 
lungs of chicken infected 
with pathogenic avian influenza. Such proliferation of lung macrophages was associated 
with systemic proliferation of macrophages. Studies 
by Kaufmann et al. (2001) 
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demonstrated acute destruction of erythrocytes in avian influenza infection might have 
induced systemic hyperplasia of macrophages since monocytes/macrophages are highly 
susceptible to an infection with influenza A virus (Kaufmann et al., 2001). They 
reported that monocytes died by apoptosis within 24-48 hours post-infection, but 
infected monocytes had initiated a cell-specific immune response before cell death. 
Infection of monocytes with influenza A virus induced the selective expression of 
mononuclear leukocyte attracting chemokines. More recently, Ito et al. (2002) 
demonstrated that virulent avian influenza viruses induced apoptosis of vascular 
endothelial cells in liver, kidney, and brain; suggesting that viral replication induced 
apoptosis in the infected tissues of chickens. 
Therefore the pathogenesis of brain damage induced by influenza infection seems 
to have been highly variable (Kimura et al., 1998; Yoshikawa et al., 2001). Influenza A 
encephalitis is not easy to diagnose and serological confirmation can only be made after 
ten days. Protheroe et al. (1991) describes two cases on influenza encephalitis during 
the outbreak of influenza types A/England/427/88 (H3N2) and A/Taiwan/l/86 (H1N1) 
with virological confirmation, respectively. The lesions within the thalamic and pons 
were demonstrated in both cases on computed tomography of the brain. Fujimoto et al. 
(1998) investigated the CSF of ten patients (age range: 22 months to 4 years) who were 
admitted into the hospital with either encephalopathy or encephalitis. Examinations of 
CSF revealed that seven of the ten patients had influenza associated encephalopathy or 
encephalitis. All seven patients showed recent influenza infection and the nested PCR 
analysis suggested that parts of the influenzal genome persisted in the CNS. 
Other 
workers also reported detection of influenza gene from CSF of patients with 
influenza A 
encephalopathy or encephalitis (Mori et al., 1999; Hakoda and Nakatani, 
2000; Togashi 
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et al., 2000), suggestive of direct neurovirulence of strains of circulating influenza 
virus. 
Other severe complications of influenza infection apart from its encephalitic 
nature include myocarditis, renal damage, and Reyes syndrome. Renal damage caused 
by direct infection with influenza A virus of the kidney or by the deposition with the 
kidney of immune complexes of virus and antiviral antibody were reported by Kaji et 
al. (1959) and Oldstone et al. (1967). Myocardial changes suggestive of myocarditis 
were reported in about one third of fatal Asian/57 influenza cases (Oseasohn et al., 
1959). Engblom et al. (1983) reported the isolation of influenza A virus from the 
myocardial tissue and extensive lymphocytic infiltration with marked destruction of the 
myocardial cells by histological examination. Annerstedt et al. (1999) reported two 
cases of acute renal failure associated with influenza virus type A infection. Miura et al. 
(2001) reported a case of influenza subtype A virus-induced fulminant myocarditis. 
McGovern et al. (2002) also described a case of fulminant myocarditis following 
influenza A infection. In the above cases, viral aetiology was confirmed by serology. 
More recently, acute myocardiopericarditis as a consequence of influenza A virus 
infection is also reported (Agnino et al., 2002). Our studies of the mouse animal model 
with the recovery of virus genes from the hearts following intranasal infection using 
PCR may provide the supportive evidence that influenza can infect tissues of the heart 
which could lead to the mild or severe circulatory disturbance thereby facilitating the 
virus travelling up and infecting the brain tissues. 
Reye's syndrome is an acute childhood encephalopathy caused by influenza. 
Clinical symptoms include episodes of repeated vomiting, altered behaviour such as 
irritability and resistance, lethargy often progressing to disorientation and even coma 
in 
some cases (Kilbourne, 1987). These clinical symptoms are consistent with some of 
the 
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symptoms of encephalitis lethargica and many other cases of encephalopathy or 
encephalitis. A typical case was a 3-year-old boy in May 1997 in Hong Kong who 
showed influenza-like illness and died 12 days later with complications consistent with 
Reye's syndrome and with the isolation of influenza virus. Xu et al. (1998) reported that 
influenza B virus was isolated from the blood of children. Their studies suggested that 
the route of dissemination from the respiratory tract to other organs was probably due to 
viremia. More recently, influenza B virus encephalitis resulting in neurological sequelae 
was reported by McCullers (1999), in which the virus was detected from the patient's 
CSF. Other workers also reported that influenza B virus was isolated or serologically 
confirmed from patients with encephalitis/encephalopathy (Shiraishi et al., 2001; Kurita 
et at., 2001; Straumanis et at., 2002; Morishima et al., 2002; Hayase et at., 2002). 
Hayase et al. (2002) demonstrated that influenza B virus infected and persisted in the 
gastric mucosa under acid suppression conditions from patients with influenza B 
infection. They found that nucleoprotein gene of influenza B virus was detected after 37 
months by nested PCR. 
In the current study, viral cellular changes and inflammatory phenomena were 
further studied by in situ hybridisation (ISH) techniques. The results of the influenza 
ISH studies have demonstrated that ependymal cells of the choroid plexus, tissues of 
lateral ventricles, cerebral aqueduct, and the cells of the Raphe nucleus are sites for 
influenza virus infection and replication following the direct intracerebral route of 
infection with NWS virus in mice. The present study demonstrates that severe 
meningitis, ventriculitis, and cuffing phenomena were found to have occurred during 
the early stages of infection when the virus had replicated abundantly in the infected 
brain tissues with positive recovery of live virus from brains of infected mice. These 
results again suggest that the spread of influenza virus is via the route of circulatory 
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system post-infection. The intensity of the influenza ISH signals decreases from sites of 
infection in sections of brain from mice sacrificed on day 5 and later post-infection. The 
virus-infected cells may either be phagocytosed by mononuclear cells and/or be 
autophagocytosed by non-affected adjacent cells, but the entire elimination of infected 
cells by desquamation is not fully understood. 
The demonstration of influenza gene signals in the cells of the Raphe nucleus 
using influenza ISH may explain and answer the diversity of neurological defects 
observed in influenza infected patients. Some cells of the Raphe nucleus are known to 
have been involved in a complex and multi-functional centre of the CNS apart from its 
chief role in sleep rhythms. The localisation of the influenza virus in some cells of the 
Raphe nucleus during its acute infection in the mouse has suggested that influenza virus 
may also infect and replicate in neurons located in the reticular formation via neuronal 
transmission, which is chiefly responsible for forming the central core of the brainstem. 
These influenza ISH results could imply that a proportion of the regulatory functions of 
normal reticular formation could be interrupted. The degree of such aberrant destruction 
of brain cells caused by influenza infection affecting the entire functions of the CNS in 
a long term infection remains unknown. It is not fully understood how each influenza- 
infected cells of the Raphe nucleus could alter its respective functional role in the CNS. 
Descriptions of neurological complications associated with influenza A virus infection, 
such as encephalitis, acute encephalopathy, myelitis, postencephalitic Parkinsonism, 
and other neurological complications have increased in number especially among young 
children (Salonen et al., 1997; Fujimoto et al., 1998; Ryan et al., 1999; Mori et al., 
1999; Suwa et al., 1999; Munakata et al., 2000; Togashi et al., 2000; Tokunaga et al., 
2000; Yokota et al., 2000; Shinjoh et al., 2000; Hakoda et al., 2000; Ghaemi et al., 
2000; Okabe et al., 2000; Tsuchiya et al., 2000; Ohtsuki et al., 2000; Quan et al., 
2001; 
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Takahashi and Yamada, 2001; Voudris et al., 2001; Yoshikawa et al., 2001; Iijima et 
al., 2002; Morishima et al., 2002; Sugaya, 2002; Yamasaki, 2002). According to the 
results obtained from the current in situ hybridisation study in the mouse model, 
specific mechanisms involved in the route of influenza virus invasion into the CNS can 
be taken into account. Firstly, the distribution of the brain lesions may be due to the 
transneuronal invasion of the virus via cranial nerve fibres into the brain as proposed by 
Shinya et al. (1998). Secondly, replicating influenza virus in the respiratory mucosa 
may ascend to the CNS via sensory nerve routes, lead to lesions in the brain stem, and 
then spread trans-synaptically in the CNS (Shinya et al., 2000). Thirdly, the replicating 
influenza viruses in the nasopharyngeal epithelium during acute infection may disrupt 
the olfactory mucosa and gain access to the brain via the olfactory nerve system 
(Yokota et al., 2000). Fourthly, virus infection may follow axonal spread of the 
influenza virus (Sawaishi et al., 1999) and finally, replicated influenza viruses could 
travel from the respiratory tract to the areas of brain via the circulatory system and 
result in various lesions seen in the infected areas of the brain (Davis et al., 2000; Mori 
et al., 2002). Migita et al. (2001) also described two cases of influenza with impaired 
ocular movement: one had ptosis and impaired ocular movement, the other suffered 
from Guillain-Barre syndrome with paralysis of the extraocular muscles. Their report 
may reflect that an alternative mechanism in spread of influenza infection may be 
required for such observation and explanation. 
The lethargy, a characteristic of cases during the acute and fatal form of influenzal 
and encephalitic diseases in the pandemics of the 1918 era, may possibly be induced by 
inflammation and oedema in the region of the corpora quadrigemina interfering with the 
circulation of the CSF through the cerebral aqueduct. In the present study, the 
distribution and localisation of influenza A (NWS) mRNA in the cerebral aqueduct, 
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lateral ventricles, ependymal cells of the choroid plexuses and some cells of raphe 
nuclei may provide the supportive evidence to establish a relatively closer relationship 
between the two diseases occurring in the 1918 era, providing a mechanism, from which 
the 1918 influenza strain of the virus could directly infect the CNS. Nakajima (1997) 
reported that influenza WSN antigens were detected in meningeal and ependymal areas, 
neurons of circumventricular regions, the cerebral cortices, the substantia nigra zona 
compacta, and the vental tegmental area, and hippocampus from mouse brain 
intracerebrally infected with WSN virus. Nobusawa (2000) show that influenza antigens 
were found in the hippocampus and substantia nigra zona compacta from mouse brains 
intracerebrally infected with influenza WSN virus. These results suggest that the 
distribution of influenza antigens seem to be strain-specific for the influenza virus 
studied. The present finding of influenza mRNA localised in Raphe nuclei is clearly a 
contributory factor which could lead to various disturbances in sleep rhythm. 
Avian influenza A virus could be more neurotropic than human and swine viruses 
once it gains its entry to infect humans by a direct transmission and cause acute and 
fatal infection in the CNS with or without an interspecies as a mixing vessel. The 
outbreak of Hong Kong chicken virus in 1997 infecting thousands of chickens in Hong 
Kong is an illustration of such direct cross-infection from avian to human. The 
transmission of virus was directly from chicken to human, rather than person-to-person, 
resulting in 6 deaths by the newly mutated strain of the virus. The pathway for such 
virus becoming more neurovirulent within the chickens might be due to 
its natural role 
in enabling conversion from avirulent to virulent through passages 
in the brain of 
chickens. Avian-to-human transmission of H9N2 influenza viruses was 
further reported 
to have infected two children in Hong Kong (Lin et al., 2000). Silvano et al. 
(1997) 
reported severe circulatory disturbances with multi foci of necrosis which appeared 
in 
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major organs including the brain in experimental chicks inoculated with an avian strain 
of influenza A/Whistling Swan/Shimane/499/83 (H5N3) via the air sac route. 
Immunological staining revealed that avian influenza virus antigen initially appeared in 
the vascular endothelial cells and then in the astrocytes, neurons and ependyma. 
Influenza antigen was detected in neurons, glial cells and vascular endothelium in the 
brain lesions of experimental mice intranasally inoculated with an avian influenza virus. 
The authors suggested that the brain lesions seemed to have indicated transneuronal 
invasion of the influenza virus via cranial fibres into the brain. 
Studies by Mori et al. (2002) suggested that the presence of glutamic acid at 
position 92 of the NS 1 molecule was a contributory factor for the mechanism of the 
high virulence of H5N1 influenza viruses in humans. In contrast, Hatta and Kawaoka 
(2002) found that the high virulence of the H5N1 virus involved an amino acid change 
in the PB2 protein. A new influenza A virus subtype (H1N2) was isolated in pigs 
(Brown et al., 1998). Their further genetic analyses showed that the RNA segments 
encoding PB2, PB1, PA, NP, M and NS were most closely related to those of avian 
viruses. It seems that reassortment of human and avian influenza viruses can potentially 
result in a more potently neurovirulent influenza virus, which could enable the virus to 
directly infect the CNS of humans. 
In the molecular part of the current study, influenza viral nucleic acid sequences 
were not detected in archival brain samples from patients who died of encephalitis 
lethargica when analysed by established RT-PCR technology. The mouse model was 
used as a source of formalin-fixed wax-embedded brain tissues from control animals 
and those infected with a neurovirulent strain of influenza, to allow 
development of a 
sensitive RT-PCR assay. Using either random hexamers or gene-specific primers 
in the 
RT step followed by gene specific nested PCR, host 
(3-actin mRNA derived gene 
204 
Chapter 6 General Discussion 
fragments of defined size were detected in all archival tissue sections and in both rounds 
of PCR. Similarly, when either random hexamers or influenza gene-specific primers 
(for M, NP, and NS genes) were used in the RT step and influenza gene-specific 
primers in PCR, products of defined size were detected in samples derived from 
A/NWS/3 3 -infected animals but usually after the second (nested) round of PCR only. 
The latter result probably indicates a lower level of influenza RNA (vRNA/mRNA) in 
the tissue extracts compared with that of ß-actin mRNA. Random hexamer priming of 
RT followed by gene-specific nested PCR was applied to RNA extracts of eight archival 
human brain tissue sections derived from patients who died of encephalitis lethargica 
between 1916 and 1920 and another who died of Alzheimer's disease in 1996. Again, 
for all tissue sections, both rounds of PCR yielded products of defined size for the ß- 
actin gene but none of the human samples yielded influenza gene-specific products. It is 
not surprising to recover ß-actin gene from the archival materials since the gene is 
expressed in all parts of tissues in abundant quantity, but its detection indicated a degree 
of preservation of the tissue. 
A facile explanation for the negative results obtained for the RT-PCR analysis of 
human archival tissue sections conducted here would be that the influenza gene-specific 
primers used were incompatible with the infecting influenza. This seems unlikely as the 
three genes studied show good sequence conservation between influenza A subtypes. A 
number of other factors may have contributed to the negative results of the current 
study. Firstly, it is possible that the clinical samples either were not 
infected with 
influenza virus or that even if influenza had caused the disease, the mechanism could 
have been hit and run with only small foci of infection being established. 
Multiple 
sections, 10 from each human block, were analysed in parallel to minimise 
false 
negative results due to small sample size and possible 
focal distribution of viral RNAs 
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within the tissue block. Secondly, the possibility of RNA degradation during tissue 
collection and storage may have limited the detection of target sequences. However, 
we optimised the test by using nested primers which amplified shorter sequences 
(<180bp) to increase the sensitivity of detection of target sequences, and ß-actin gene 
fragments of 373bp and 274bp were detected. Thirdly, delays between sample 
collection and formalin fixation after death of the patient may have resulted in loss of 
viral RNA through autolysis. This seems unlikely given the sizes of ß-actin gene 
fragments recovered and the fact that the human brain contains low levels of 
ribonucleases and high levels of ribonuclease inhibitors compared to organs such as the 
lungs (Futami et al., 1997; Nadano et al., 1994). Fourthly, the titre of influenza in 
human brain might have been extremely low compared to that which was reached in the 
lung of persons infected with the same virus and which can be detected in formalin 
fixed lung samples (Reid et al., 2002; Taubenberger et al., 1997). In support of the latter 
point, isolation of influenza gene sequences from formalin-fixed wax-embedded lung 
tissue specimens of two US soldiers who died of primary viral pneumonia during the 
1918 influenza pandemic has been reported (Reid et at., 1999; Taubenberger et al., 
1997). More recently, we have located formalin-fixed wax-embedded lung samples in 
the Royal London Hospital archive from civilian patients who died of pneumonia 
during the 1918-1919 pandemic that have yielded influenza haemagglutinin gene 
sequences (Reid et al., 2002, in press). 
The absence of detection of influenza gene fragments in extracts of 
human brains 
derived from EL victims does not rule out influenza virus as a contributory 
factor in the 
pathology of these cases. Indeed, most epidemiological evidence supports 
influenza 
being the most likely candidate virus to cause EL. However 
infection of influenza 
cannot be excluded from those patients since the virus might 
have been only present 
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during the acute infection. The negative molecular analyses presented here are 
consistent with those of other workers who also failed to detect influenza genes in brain 
specimens of EL victims (McCall et al., 2001; Jellinger, 2001). McCall's study revealed 
that no influenza RNAs were detected in archival brain tissues from patients of acute 
encephalitis or of postencephalitic Parkinsonism (PEP). 
In a review of McCall's 5 cases of EL and 2 cases of PEP (Table 6.1), a number 
of common features are seen. Firstly, the most common pathological features observed 
among all diagnosed EL and/or PEP cases including ours are diffuse lymphocytic 
infiltrate, markedly dilated vessels and perivascular infiltration in the section of the 
brain, suggestive of systemic spread via vascular system and subsequently vascular and 
CSF transmissions in the CNS by a causative agent. Secondly, it is noted that diffuse 
lymphocytic infiltrates and haemorrhages were observed in caudate, choroid plexus, 
medulla and cord most marked near the floor of the 4th ventricle. This coincides with 
our results from animal and in situ hybridisation studies. Immune cells have been seen 
in the choroid plexus, ventricles, and cerebral aqueduct; suggestive of an infectious 
agent spreading via the CSF circulation within the 4 ventricular systems. The detection 
of influenza NP sequences in our mouse model in the cerebral aqueduct, which 
circulates the CSF communications from the 3rd to the 4th ventricles in the brain, is 
further supportive for such spread of influenza virus. Finally, the neurons, which were 
degenerated or markedly decreased in number in McCall's EL/1922 and PEP/1926 
cases, suggest that a causative agent such as neurovirulent influenza virus may 
have 
infected directly those areas of neuron and led to various degenerations of neurons and 
to a decrease in number. This is supported by our studies which show that 
influenza 
mRNAs are localised in the hippocampal neurons and Raphe nuclei 
in mouse brain 
sections sacrificed on day 3 post-intracerebral 
infection. Other investigators 
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(Schlesinger et al., 1998) suggest that the 1918 influenza virus may have been 
associated with chronic CNS persistence in cases of EL and PEP. Our animal studies 
have supported their speculation since short influenza gene sequences remain 
demonstrable in NWS and WSN virus-infected mouse brain tissues sacrificed on days 
70 and 35 post-intracerebral infections, respectively. The absence of detection of 
influenza RNA sequences from human brains of encephalitis lethargica does not 
exclude that influenza virus may have been a contributory factor in the pathology of 
these cases and indeed most epidemiological evidence support this causation. In spite of 
the negative molecular analysis studied here and by McCall et al. (2001), influenza A 
remains a candidate causative virus. 
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Table 6.1: Main features of post-mortem samples from McCall's cases of EL and PEP 
(McCall et al., 2001) 
Case no Sex / Age Autopsy & Cause Histological Findings 
& yr (yr) of Death 
1.1922 M/39 EL, myoclonic type Irregular & patchy perivascular 
infiltration in the brain 
Advanced degeneration in the 
ganglion cells of the medulla 
2. NB NB Acute EL Unknown 
3.1923 M/45 Acute EL (Possible) Diffuse lymphocytic infiltrate in 
caudate, choroid plexus, medulla & 
cord most marked in section 
through 4tß' ventricle 
Numerous haemorrhages in small 
and medium sized vessels most 
marked near the floor of the 4th 
ventricle 
4.1926 M/40 Acute EL (Possible) Grossly normal in the CNS 
Bronchopneumonia 
Had influenza in 1918 
5.1927 M/ 19 Acute EL (Possible) Markedly dilated vessels in the 
Had influenza in 1918 brain and cord 
Vascular engorgement & 
perivascular infiltration throughout 
the brain 
6. PEP /M/ 60 Chronic EL Normal dura and brain 
1950 Pale & rarified substantia nigra 
Markedly decreased number of 
neurons with considerable gliosis 
7. PEP /M/ 71 Bronchopneumonia Marked gyral atrophy in the 
frontal 
1968 lobes 
No abnormality in the pons or 
medulla 
NB: The date and clinical history of this case were unknown. 
The file diagnosis of acute 
EL was supported by histological examination. 
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Whether the relationship between influenza and encephalitis lethargica is more 
intimate than we are at present aware of, or whether their association was purely 
accidental, are questions which have not yet been answered. Many cases of encephalitis 
lethargica were, in their early stages, regarded as cases of influenza, and both diseases 
were characterised pathologically by the haemorrhagic nature of their inflammatory 
lesions. A much larger group of symptoms in epidemic encephalitis varies with the 
incidence of the inflammatory process in different parts of the CNS. That the symptoms 
of an inflammation of the brain should vary in almost every case seen is not a matter of 
surprise. However, it cannot be excluded that the 1918 pandemic strain of influenza 
virus with high ability in bringing a direct attack of the CNS in afflicted individuals was 
responsible for causing the millions of deaths from EL. If the 1918 pandemic strain of 
human influenza virus were a reassortant between avian and human viruses, the 
reassortant could directly attack the CNS in humans producing potent neurovirulent 
infection. Genetic studies from the three 1918 human lung samples have found that the 
1918 pandemic strain of influenza is closely related to classical swine virus 
(Taubenberger et al., 1997) which is suggestive of the hypothesis. Since pigs exhibit a 
low species barrier towards avian as well as human strains of virus, they are regarded as 
"mixing vessels" by becoming doubly infected with human and avian influenza A 
viruses with relative ease. Alternatively, any new reassortant between avian and 
human 
influenza viruses could have been directly neurotropic without prior adaptation, 
replicated in multiple organs and mammalian species including geese, pigs, rats, and 
mice, caused lethal pneumonia, and spread systemically to the 
brain similarly to the 
H5N1 virus (Shortridge et al., 1998; Lu et al., 1999). The emergence of virulent 
avian 
influenza A viruses from poultry is highly unpredictable. 
Viruses with HA genes 
derived from avian influenza viruses seem to have the potential 
for pandemic spread 
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when the human population lacks protective immunity against the new HA (Subbarao & 
Katz, 2000; Claas, 2000). 
The neurovirulent potential of influenza viruses has been demonstrated by 
infection of mouse brains and has led to an understanding of the underlying mechanisms 
of viral adaptation to allow growth in neural tissues (Ward, 1996). Ward has also 
suggested that the increased virulence of the HA gene has occurred by at least 3 
different mechanisms: loss of a glycosylation site, a change at the cleavage site, and a 
substitution which may increase the pH of fusion. Further, in developing a mouse model 
for Reye's syndrome, RT-PCR detection of influenza gene fragments in a variety of 
tissues including brain has been reported (Davis et al., 2000). Whilst studies in humans 
have been somewhat limited, cases of influenza-related encephalitis have been reported 
where cerebrospinal fluid (CSF) has proven either RT-PCR or isolation positive for 
influenza (Fujimoto et al., 1998; Hakoda et al., 2000; McCullers et al., 1999; Togashi et 
al., 2000). For an autopsied paediatric case of suspected influenza-induced 
encephalopathy, immunohistochemical staining identified influenza antigen in the 
meningeal and ependymal areas, neurons of the circumventricular regions, the cerebral 
and cerebellar cortices and zona compacta of the substantia nigra, whilst RT-PCR 
analysis indicated infection of limited parts of the brain (Takahashi et al., 
2000). In 
many of these studies, the severity of disease and its presentation 
has been considered 
inconsistent with the levels of influenza detected and 
it has been suggested that 
influenza may act in concert with other infectious agents such as 
human herpesvirus 6 
or 7 (Sugaya et al., 2002). If influenza is a causative agent of 
EL, then influenza 
pandemic(s) predicted for the 21St Century should provide 
further clinical material for 
molecular investigations. In the meantime, investigation of current 
cases of EL, though 
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diagnoses are rare, could shed light on the wider range of potential causative agents and 
thereby allow directed re-analysis of the valuable but limited archived samples. 
A wide variety of viruses, which are capable of causing aseptic meningitis and 
encephalitis, have been detected from CSF or fresh brain tissue by PCR assay 
(Sacramento, et al., 1991; Kalmovarin et al., 1993; Read et al., 1997; Crepin et al., 
1998, Huang, et al., 1999). The mode of viral transmission into the CNS of infected 
humans is not always clear. However it might be possible to assume that neurovirulent 
derivatives of other viruses may utilise common strategies to permit replication in the 
brain. Whether the 1918 strain of influenza A virus might have had unusual virulence 
determinants is still unknown. Further studies will be required for a better understanding 
of pathogenic mechanisms, the immune response and pathogenesis involving the 
disease of the CNS induced by human influenza A virus and their associated chronic 
and neurological disorders. 
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